
<html lang="en"     class="pb-page"  data-request-id="d6ef7afc-6c02-4700-b070-3afafb9c4c0a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm401881q;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2014.57.issue-7;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Imidazol-1-ylethylindazole Voltage-Gated Sodium Channel Ligands Are Neuroprotective during Optic Neuritis in a Mouse Model of Multiple Sclerosis" /></meta><meta name="dc.Creator" content="Lorcan  Browne" /></meta><meta name="dc.Creator" content="Katie  Lidster" /></meta><meta name="dc.Creator" content="Sarah  Al-Izki" /></meta><meta name="dc.Creator" content="Lisa  Clutterbuck" /></meta><meta name="dc.Creator" content="Cristina  Posada" /></meta><meta name="dc.Creator" content="A. W. Edith  Chan" /></meta><meta name="dc.Creator" content="Dieter  Riddall" /></meta><meta name="dc.Creator" content="John  Garthwaite" /></meta><meta name="dc.Creator" content="David  Baker" /></meta><meta name="dc.Creator" content="David L.  Selwood" /></meta><meta name="dc.Description" content="A series of imidazol-1-ylethylindazole sodium channel ligands were developed and optimized for sodium channel inhibition and in vitro neuroprotective activity. The molecules exhibited displacement ..." /></meta><meta name="Description" content="A series of imidazol-1-ylethylindazole sodium channel ligands were developed and optimized for sodium channel inhibition and in vitro neuroprotective activity. The molecules exhibited displacement ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 21, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm401881q" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm401881q" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm401881q" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm401881q" /></link>
        
    
    

<title>Imidazol-1-ylethylindazole Voltage-Gated Sodium Channel Ligands Are Neuroprotective during Optic Neuritis in a Mouse Model of Multiple Sclerosis | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm401881q" /></meta><meta property="og:title" content="Imidazol-1-ylethylindazole Voltage-Gated Sodium Channel Ligands Are Neuroprotective during Optic Neuritis in a Mouse Model of Multiple Sclerosis" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/large/jm-2013-01881q_0011.jpeg" /></meta><meta property="og:description" content="A series of imidazol-1-ylethylindazole sodium channel ligands were developed and optimized for sodium channel inhibition and in vitro neuroprotective activity. The molecules exhibited displacement of a radiolabeled sodium channel ligand and selectivity for blockade of the inactivated state of cloned neuronal Nav channels. Metabolically stable analogue 6 was able to protect retinal ganglion cells during optic neuritis in a mouse model of multiple sclerosis." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm401881q"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm401881q">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm401881q&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm401881q&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm401881q&amp;href=/doi/10.1021/jm401881q" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 2942-2952</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm401879z" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm401924s" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/acs.jmedchem.5b00508"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Imidazol-1-ylethylindazole Voltage-Gated Sodium Channel Ligands Are Neuroprotective during Optic Neuritis in a Mouse Model of Multiple Sclerosis</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lorcan++Browne">Lorcan Browne</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Katie++Lidster">Katie Lidster</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sarah++Al-Izki">Sarah Al-Izki</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lisa++Clutterbuck">Lisa Clutterbuck</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cristina++Posada">Cristina Posada</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=A.+W.+Edith++Chan">A. W. Edith Chan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dieter++Riddall">Dieter Riddall</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Garthwaite">John Garthwaite</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Baker">David Baker</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+L.++Selwood">David L. Selwood</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Biological and Medicinal Chemistry, Wolfson Institute for Biomedical Science, University College London, Gower Street, London WC1E 6BT, United Kingdom</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Neuroimmunology, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, London E1 2AT, United Kingdom</span></div><div class="corresp-info"><strong>*</strong>Phone: +44 20 7679 2000. E-mail: <a href="/cdn-cgi/l/email-protection#17733964727b607878735762747b39767439627c"><span class="__cf_email__" data-cfemail="8aeea4f9efe6fde5e5eecaffe9e6a4ebe9a4ffe1">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm401881q&amp;href=/doi/10.1021%2Fjm401881q" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 2942–2952</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 6, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>6 December 2013</li><li><span class="item_label"><b>Published</b> online</span>21 March 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 April 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm401881q" title="DOI URL">https://doi.org/10.1021/jm401881q</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice/index.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by text">with CC-BY<a href="/page/policy/authorchoice_ccby_termsofuse.html" title="License">license</a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm401881q"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1874</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">6</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm401881q" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Imidazol-1-ylethylindazole Voltage-Gated Sodium Channel Ligands Are Neuroprotective during Optic Neuritis in a Mouse Model of Multiple Sclerosis&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Lorcan&quot;,&quot;last_name&quot;:&quot;Browne&quot;},{&quot;first_name&quot;:&quot;Katie&quot;,&quot;last_name&quot;:&quot;Lidster&quot;},{&quot;first_name&quot;:&quot;Sarah&quot;,&quot;last_name&quot;:&quot;Al-Izki&quot;},{&quot;first_name&quot;:&quot;Lisa&quot;,&quot;last_name&quot;:&quot;Clutterbuck&quot;},{&quot;first_name&quot;:&quot;Cristina&quot;,&quot;last_name&quot;:&quot;Posada&quot;},{&quot;first_name&quot;:&quot;A.&quot;,&quot;last_name&quot;:&quot;W. Edith Chan&quot;},{&quot;first_name&quot;:&quot;Dieter&quot;,&quot;last_name&quot;:&quot;Riddall&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Garthwaite&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Baker&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;L. Selwood&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;21&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;2942-2952&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm401881q&quot;},&quot;abstract&quot;:&quot;A series of imidazol-1-ylethylindazole sodium channel ligands were developed and optimized for sodium channel inhibition and in vitro neuroprotective activity. The molecules exhibited displacement of a radiolabeled sodium channel ligand and selectivity for blockade of the inactivated state of cloned neuronal Nav channels. Metabolically stable analogue 6 was able to protect retinal ganglion cells during optic neuritis in a mouse model of multiple sclerosis.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401881q&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401881q" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401881q&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401881q" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401881q&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401881q" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm401881q&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401881q&amp;href=/doi/10.1021/jm401881q" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm401881q" /></input><a href="/doi/pdf/10.1021/jm401881q" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm401881q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm401881q%26sid%3Dliteratum%253Aachs%26pmid%3D24601592%26genre%3Darticle%26aulast%3DBrowne%26date%3D2014%26atitle%3DImidazol-1-ylethylindazole%2BVoltage-Gated%2BSodium%2BChannel%2BLigands%2BAre%2BNeuroprotective%2Bduring%2BOptic%2BNeuritis%2Bin%2Ba%2BMouse%2BModel%2Bof%2BMultiple%2BSclerosis%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D7%26spage%3D2942%26epage%3D2952%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292070" title="Neuroprotection">Neuroprotection</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291251" title="Sodium">Sodium</a>,</li><li><a href="/action/doSearch?ConceptID=290943" title="Optics">Optics</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jmcmar.2014.57.issue-7/production/jmcmar.2014.57.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/medium/jm-2013-01881q_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/large/jm-2013-01881q_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401881q&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A series of imidazol-1-ylethylindazole sodium channel ligands were developed and optimized for sodium channel inhibition and in vitro neuroprotective activity. The molecules exhibited displacement of a radiolabeled sodium channel ligand and selectivity for blockade of the inactivated state of cloned neuronal Na<sub>v</sub> channels. Metabolically stable analogue <b>6</b> was able to protect retinal ganglion cells during optic neuritis in a mouse model of multiple sclerosis.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74140" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74140" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Voltage-gated sodium (Na<sub>v</sub>) channels are the fundamental generators of electrical impulses (action potentials) in the membranes of excitable cells. A number of clinically used drugs exert their therapeutic effects through Na<sub>v</sub>. These drugs are primarily used in the treatment of central nervous system (CNS) disorders, such as epilepsy and neuropathic pain, but are increasingly being scrutinized as potential treatments for neurodegenerative conditions occurring acutely, such as in ischemic stroke, or chronically, as in multiple sclerosis (MS).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Phenytoin <b>1</b> was one of the first antiepileptics developed (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). It exerts a voltage-dependent and frequency-dependent block of Na<sup>+</sup> currents. This selectivity is suggested to be the reason for its lack of significant cognitive side effects.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Other first-generation antiepileptics that act on Na<sub>v</sub> channels include lamotrigine <b>2</b>,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and carbamazepine <b>3</b><a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Recently, lacosamide <b>4</b> was approved for use in partial-onset seizures and neuropathic pain. Lacosamide is proposed to act via an unique mechanism of state-dependent blockade of Na<sub>v</sub> channels: stabilizing channels in a slow inactivated state without effects on fast inactivation.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/medium/jm-2013-01881q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/large/jm-2013-01881q_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Compounds with sodium channel modulatory activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/large/jm-2013-01881q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401881q&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Nine Na<sub>v</sub> channel isoforms have been identified, of which, Na<sub>v</sub>1.1, 1.2, 1.3, and 1.6 are predominately found within the CNS, whereas Na<sub>v</sub>1.7, 1.8, and 1.9 are located in the peripheral nervous system. Na<sub>v</sub>1.4 is found within skeletal muscle, and Na<sub>v</sub>1.5 is found in the heart. The Na<sub>v</sub> isoforms are also expressed outside their primary tissues.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Recently, the first X-ray crystal structure of a voltage-gated sodium channel was solved: initially in the closed state and subsequently in two presumed inactivated states.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> Under normal physiological conditions, the channels interconvert between different functional states: the resting state in which the channel pore is closed, an open state in which the channel pore is open and permeable to Na<sup>+</sup>, and one or more inactivation states where the pore is open but blocked.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">Recent studies have highlighted the importance of Na<sub>v</sub>1.3, 1.7, 1.8, and 1.9 in various pain syndromes.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10-12)</a> Notably, genetically inherited pain disorders have been associated with mutation of these Na<sub>v</sub> encoding genes.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Clinically, carbamazepine, lamotrigine, and phenytoin are all used to treat neuropathic pain.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The Merck, Pfizer, AstraZeneca, and GlaxoSmithKline pharmaceutical groups have all independently reported their own series of 1.3-, 1.7-, and 1.9-selective sodium channel modulators for use in neuropathic pain,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> exemplified here by the benzazepinone compounds from Merck Pharmaceuticals, such as <b>5</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a></div><div class="NLM_p">Sodium channel blockers can exhibit significant neuroprotective effects.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Influx of sodium from the extracellular space during reperfusion plays a major role in excitotoxic neuronal death after cerebral ischemia.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Block of Na<sub>v</sub> channels can attenuate the primary events that occur in an ischemic attack, most likely by blocking Na<sup>+</sup> permeability, resulting in reduced ATP depletion and reduced ischemic-induced release of glutamate.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> A number of drugs, including lamotrigine, BW-1003C87, the local anesthetic lidocaine, and sipatrigine, have all shown neuroprotective effects in animal models of stroke.<a onclick="showRef(event, 'ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23 ref24">(21-24)</a> However, as of yet, these results have failed to translate into beneficial effects in clinical trials.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> Thus, there is a need for drugs with a better clinical efficacy and therapeutic index. Treatment of stroke is limited by the fact that administration of treatment in humans only occurs sometime after the onset of the neurodegenerative insult. In contrast, for slowly evolving neurodegenerative conditions, it is possible to treat during or even before individual neurodegenerative episodes occur. Carbamazepine (<b>3</b>) is commonly used to alleviate the symptoms of MS, such as spasms, nerve pain, and trigeminal neuralgia, and lamotrigine has been trialled in neuroprotection.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Research into the potential neuroprotective effects of these compounds is gaining increasing momentum because of a better understanding of the role of Na<sub>v</sub> channels in nerve damage.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_p last">To understand the role of individual Na<sub>v</sub> channel isoforms in neuroprotection, we need to consider their distribution. Although most of the sodium channel variants are expressed at different levels in the CNS, Na<sub>v</sub>1.6 expression is widespread<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> but is more abundant in nerves of the retina, cerebellum, and cortex tissue.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> In a mature, myelinated axon, Na<sub>v</sub>1.6 tends to cluster and is the predominant isoform at the nodes of Ranvier.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> A significant increase in Na<sub>v</sub>1.6 density can be seen subsequent to nerve fiber injury in traumatic brain injury and multiple sclerosis.<a onclick="showRef(event, 'ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34">(32-34)</a> Na<sub>v</sub>1.6 has also been implicated in secondary degeneration of neuronal cells. Mechanical, ischemic, and inflammatory insult can, over time, contribute to this degeneration. Shear and stretch forces, despite not destroying the cells or severing the axons can, nonetheless, produce secondary degeneration in brain tissues.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Rapid tetrodotoxin-sensitive calcium overload occurs in stretch-traumatized axons, which suggests that in neuropathologic conditions structural degradation of the axolemmal bilayer can foster a chronically left-shifted Na<sub>v</sub> channel operation. This points to leaky Na<sub>v</sub> channels playing an important role in determining neuronal cell survival.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Other Na<sub>v</sub> channel isoforms, namely, Na<sub>v</sub>1.1<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and Na<sub>v</sub>1.3, have also been implicated in traumatic brain injury models.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Overall, there is no clear understanding of the specific contributions of each isoform to the neuroprotective effect; we anticipate that investigations of the action of well-characterized compounds will aid in this regard. Previous work by this group designed a class of voltage-dependent sodium channel modulators based on the indazolyloxadiazolyl scaffold.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Further development of analogues around this scaffold has now identified a series of imidazolylethylindazoles with good neuroprotective effects. Following assessment of sodium channel isoform selectivity and functional activity, a candidate molecule, CFM6104, <b>6</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), was tested in an in vivo optic neuritis (inflammation of the optic nerve) mouse model of MS and found to prevent the consequent loss of retinal nerve cells.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58564" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58564" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Design</h3><div class="NLM_p last">In our previous investigations, we demonstrated that aminomethyloxadiazolylindazoles had good neuroprotective activity. If the amino group was protected as a Boc group, then the activity was generally lost. However, exploration of alternative groups to the indazole N<sub>1</sub>/N<sub>2</sub> benzyl revealed a Boc-protected intermediate (vide infra) with surprising neuroprotective activity. This molecule exhibited a different SAR profile to the previous series with lower cytochrome P450 inhibition. We therefore carried out a detailed investigation of the neuroprotective activities of this series. Key objectives were to maintain the neuroprotective activity and to improve the metabolic stability to allow evaluation in vivo.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">The synthesis of 3-[3-<i>tert</i>-butoxycarbonylaminomethyl-1,2,4-oxadiazol-5-yl]indazole <b>7</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) has been previously described.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> This compound was utilized as a key synthetic intermediate for the production of a further series of compounds. The stereoselective synthesis of alkyl N<sub>1</sub>- and N<sub>2</sub>-heteroaromatic-substituted compounds (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) was carried out using a cesium- or potassium carbonate-mediated alkylation of an alkyl halide-functionalized heteroaromatic compound (N<sub>1</sub>), <b>8</b>, or a Mitsunobu reaction with an alcohol-functionalized heteroaromatic compound (N<sub>2</sub>), <b>9</b>. Boc removal was performed using trifluoroacetic acid, triisopropylsilane, and water to yield the free amines <b>10</b> and <b>11</b>. These amines were then derivatized to provide the N<sub>1</sub><b>12</b> and N<sub>2</sub><b>13</b> analogues shown. The benzamides were formed via a coupling reaction between the free amine and R-substituted benzoic acid in the presence of DMF, HATU, and DIPEA at room temperature. This reaction occurred at various efficiencies (9–75%) across the range of substituted oxadiazolylindazoles and substituted benzoic acids. The sulfonamide analogues were formed by reaction of the free amine with R-substituted benzene sulfonyl chloride in the presence of sodium carbonate at room temperature with reaction efficiencies of 24–39%.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/medium/jm-2013-01881q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/large/jm-2013-01881q_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/large/jm-2013-01881q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401881q&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) R<sub>1</sub>-bromide/chloride, Cs<sub>2</sub>CO<sub>3</sub>, DMF; (b) TFA, TIPS, H<sub>2</sub>O, (c) ArCOOH, 2-(7-aza-1<i>H</i>-benzotriazole-1-yl)-1,1,3,3-tetramethyluroniumhexafluorophosphate (HATU); (d) ArSO<sub>2</sub>Cl, Na<sub>2</sub>CO<sub>3</sub>; (e) R<sub>1</sub>-alcohol, tributylphosphine, TMAD, PhMe.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Biological Assays</h3><div class="NLM_p">Activity against sodium channels was assessed using a radioligand binding assay using [<sup>3</sup>H]sipatrigine as the ligand<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> and by patch-clamp electrophysiology on cloned human channels. The in vitro neuroprotection assay was an adaptation of an original study by Fowler and Li.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> In this system, rat hippocampal slices are subjected to oxygen-glucose deprivation, and the subsequent progression to cell death is monitored by determining their ATP levels. This paradigm is highly sensitive to blockade of sodium channels and tetrodotoxin. The compounds were also tested for metabolic stability in rat liver microsomes. Na<sub>v</sub> channel isoform activity was determined using an automated patch-clamp system against hNa<sub>v</sub>1.1–hNa<sub>v</sub>1.8/β3 expressing cells. T-cell immunosuppressive activity was assessed using a simple contact hypersensitivity model that detects T-cell proliferation to oxazolone in lymphnodes.<a onclick="showRef(event, 'ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43">(41-43)</a> In vivo neuroprotection was evaluated in an optic neuritis model<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> using double-transgenic mice expressing both a Thy1-promoter-driven cyan fluorescent protein restricted to retinal ganglion cells and a myelin oligodendrocyte glycoprotein T-cell receptor (TCR).<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Following injection of <i>Bordetella pertussis</i> toxin, the mice develop subneurological experimental autoimmune encephalomyelitis (EAE) and optic neuritis in the optic nerve, which then leads to retinal ganglion cell loss secondary to axon damage.</div><div id="sec2_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i6" class="anchor-spacer"></div><h4 class="article-section__title" id="_i6"> Activity against Sodium Channels and Neuroprotection</h4><div class="NLM_p">Initial testing with N<sub>1</sub>- and N<sub>2</sub>-functionalized <i>tert</i>-butyl carbamate-protected analogues showed encouraging results in the [<sup>3</sup>H]sipatrigine binding and neuroprotection assays (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Lamotrigine, sipatrigine, and tetrodotoxin were included as reference molecules. Benzyl-functionalized molecules <b>14</b> and <b>15</b>, reported in previous work, are shown for comparison.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> A combination of reasonable potency (20 μM) and >30% neuroprotection identifies active compounds.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Sodium Channel Modulatory and Neuroprotective Activity of Boc-Protected Oxadiazolyindazole Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/medium/jm-2013-01881q_0007.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R (isomer)</th><th class="colsep0 rowsep0" align="center">[<sup>3</sup>H]sipatrigine binding, IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">neuroprotection at 50 <i>μ</i>M (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lamotrigine</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.8 ± 0.2<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">33<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tetrodotoxin</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">100<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">sipatrigine</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.04 ± 0.001<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">93<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>-Ph (N<sub>1</sub>)</td><td class="colsep0 rowsep0" align="left">8.3<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">19<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>-Ph (N<sub>2</sub>)</td><td class="colsep0 rowsep0" align="left">5.5<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">25<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub>-2-imidazole (N<sub>1</sub>)</td><td class="colsep0 rowsep0" align="left">7.4 ± 1.1</td><td class="colsep0 rowsep0" align="left">56 ± 5.6 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub>-2-imidazole (N<sub>2</sub>)</td><td class="colsep0 rowsep0" align="left">15.5 ± 9.2</td><td class="colsep0 rowsep0" align="left">35 ± 5.3 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">2-py (N<sub>1</sub>)</td><td class="colsep0 rowsep0" align="left">74 ± 20.4</td><td class="colsep0 rowsep0" align="left">18 ± 7.1 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>-2-py (N<sub>2</sub>)</td><td class="colsep0 rowsep0" align="left">23 ± 5.9</td><td class="colsep0 rowsep0" align="left">42 ± 3.8 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub>-2-thiophene (N<sub>2</sub>)</td><td class="colsep0 rowsep0" align="left">166 ± 49</td><td class="colsep0 rowsep0" align="left">1 ± 13.4 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>-4-(5-CH<sub>3</sub>)-isoxazole (N<sub>1</sub>)</td><td class="colsep0 rowsep0" align="left">339 ± 121</td><td class="colsep0 rowsep0" align="left">39 ± 7.8 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>-C<sub>6</sub>H<sub>4</sub>-N-pyrazole (N<sub>1</sub>)</td><td class="colsep0 rowsep0" align="left">617 ± 160</td><td class="colsep0 rowsep0" align="left">20 ± 16.4 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>-3,4-benzodioxole (N<sub>1</sub>)</td><td class="colsep0 rowsep0" align="left">6 ± 1.0</td><td class="colsep0 rowsep0" align="left">–3 ± 6.2 (4)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Values reported in literature.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Tested at 30 μM. Results are normalized to the effect of TTX and are based on the mean of at least three experiments.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">TTX tested at 1 μM.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">Tested at 3 μM.</p></div><div class="footnote" id="t1fn5"><sup>e</sup><p class="last">Reported previously.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></p></div></div></div><div class="NLM_p">Replacement of the benzyl group with substituted and nonsubstituted heteroaromatic groups showed a general decrease in the ability of the compounds to displace the radioactive ligand, with the notable exceptions of the ethylimidazole analogues <b>16</b> and <b>17</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Other side chains with weakly basic pyridyl moieties, <b>18</b> and <b>19</b>, demonstrated moderate binding and neuroprotective activity, whereas nonbasic heterocycles <b>20</b> and <b>21</b> or bulkier groups <b>22</b> and <b>23</b> displayed weak binding or low neuroprotection.</div><div class="NLM_p">In the previous series, a free amine group led to a general increase in the neuroprotection by the benzylindazole analogues (e.g., compounds <b>24</b> and <b>25</b>; Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). That trend was not observed here. The modest neuroprotection observed for the imidazole and pyridine analogues was removed with free amines such as <b>26</b> and <b>27</b>. This was also the case for the pyridyl–free amines <b>28</b> and <b>29</b>. The neutral side chains ethylthiophene <b>30</b>, methylisoxazole <b>31</b>, and substituted benzyls <b>32</b> and <b>33</b> all showed good binding and modest neuroprotection.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Sodium Channel Modulatory and Neuroprotective Activity of Oxadiazolylindazole Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/medium/jm-2013-01881q_0008.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R (isomer)</th><th class="colsep0 rowsep0" align="center">[<sup>3</sup>H]sipatrigine binding, IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">neuroprotection at 50 <i>μ</i>M (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lamotrigine</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.8 ± 0.2<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">33<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tetrodotoxin</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">100<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">sipatrigine</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.04 ± 0.001<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">93<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>-Ph (N<sub>1</sub>)</td><td class="colsep0 rowsep0" align="left">3.3 ± 0.6<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">>99,<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a> <b>35</b> ± <b>9.0</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>-Ph (N<sub>2</sub>)</td><td class="colsep0 rowsep0" align="left">7 ± 2.8<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">57 ± 15.6 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub>-2-imidazole (N<sub>1</sub>)</td><td class="colsep0 rowsep0" align="left">148 ± 120</td><td class="colsep0 rowsep0" align="left">–2 ± 1.9 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub>-2-imidazole (N<sub>2</sub>)</td><td class="colsep0 rowsep0" align="left">14 ± 1.6</td><td class="colsep0 rowsep0" align="left">8 ± 26.9 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">2-py (N<sub>1</sub>)</td><td class="colsep0 rowsep0" align="left">32 ± 8.2</td><td class="colsep0 rowsep0" align="left">–11 ± 13.8 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>-2-py (N<sub>2</sub>)</td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">25 ± 9.4 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub>-2-thiophene (N<sub>2</sub>)</td><td class="colsep0 rowsep0" align="left">0.6 ± 0.05</td><td class="colsep0 rowsep0" align="left">36 ± 5.4 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>-4-(5-CH<sub>3</sub>)- Isoxazole (N<sub>1</sub>)</td><td class="colsep0 rowsep0" align="left">15 ± 5.4</td><td class="colsep0 rowsep0" align="left">19 ± 8.6 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>-C<sub>6</sub>H<sub>4</sub>-N-pyrazole (N<sub>1</sub>)</td><td class="colsep0 rowsep0" align="left">6.2 ± 3.8</td><td class="colsep0 rowsep0" align="left">26 ± 9.0 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>-3,4-benzodioxole (N<sub>1</sub>)</td><td class="colsep0 rowsep0" align="left">2.1 ± 0.3</td><td class="colsep0 rowsep0" align="left">44 ± 2.8 (4)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Values reported in literature.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Tested at 30 μM. Results are normalized to the effect of TTX and are based on the mean of at least three experiments.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">TTX tested at 1 μM.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Tested at 3 μM.</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last">Reported previously<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> (values in bold are IC<sub>50</sub>’s in micromolar).</p></div></div></div><div class="NLM_p">These results supported the idea that the activity observed for the indazoles substituted by basic heterocycles at the N<sub>1</sub> position was not following a similar SAR pattern to the original series and required a lipophilic group at the oxadiazolylmethylamine. When the free amine analogues were functionalized with a benzamide group at the amine moiety, the neuroprotection and the radioligand-displacement ability of some of the analogues was improved, with moderate to good levels of binding observed for N<sub>1</sub> and N<sub>2</sub> imidazole analogues <b>6</b> and <b>34</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Thus, it appeared that a benzamide group could mimic the action of the <i>tert</i>-butyl carbamate. Methylpyridyl analogue <b>35</b> showed modest binding, whereas ethylthiophene <b>36</b> and methyloxazole <b>37</b> were essentially inactive.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Sodium Channel Modulatory and Neuroprotective Activity of Benzamide-Functionalized Oxadiazolylindazole Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/medium/jm-2013-01881q_0009.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R (isomer)</th><th class="colsep0 rowsep0" align="center">[<sup>3</sup>H]sipatrigine binding, IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">neuroprotection at 50 <i>μ</i>M (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lamotrigine</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.8 ± 0.2<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">33<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tetrodotoxin</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">100<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">sipatrigine</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.04 ± 0.001<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">93<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub>-N-imidazole (N<sub>1</sub>)</td><td class="colsep0 rowsep0" align="left">13 ± 9</td><td class="colsep0 rowsep0" align="left">47 ± 15.1 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>34</b><a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" rowspan="2" align="left">CH<sub>2</sub>CH<sub>2</sub>-N-imidazole (N<sub>2</sub>)</td><td class="colsep0 rowsep0" rowspan="2" align="left">4.5 ± 0.3</td><td class="colsep0 rowsep0" align="left"><b>19 ± 1.2</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">41 ± 9.4 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>-2-py (N<sub>2</sub>)</td><td class="colsep0 rowsep0" align="left">41 ± 7</td><td class="colsep0 rowsep0" align="left">58 ± 4.6 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub>-2-thiophene (N<sub>2</sub>)</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">–2 ± 6.2 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>-4-(5-CH<sub>3</sub>)-isoxazole (N<sub>1</sub>)</td><td class="colsep0 rowsep0" align="left">>2000</td><td class="colsep0 rowsep0" align="left">19 ± 20.0 (4)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Values reported in literature.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Tested at 30 μM. Results are normalized to the effect of TTX and are based on the mean of at least four experiments.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">TTX tested at 1 μM.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Tested at 3 μM. Values in bold are IC<sub>50</sub>’s in micromolar.</p></div><div class="footnote" id="t3fn5"><sup>e</sup><p class="last">Tested as a mixture of 83% N<sub>1</sub> and 17% N<sub>2</sub> isomers.</p></div></div></div><div class="NLM_p">On the basis of these encouraging effects, a new set of N<sub>1</sub> and N<sub>2</sub> imidazole analogues was designed and synthesized to see if improved binding and neuroprotective activity was achievable. The new set of N<sub>1</sub> and N<sub>2</sub> ethyl-2-imidazoles (compounds <b>38</b>–<b>64</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) showed a range of activity, with most showing good ability to displace the radioligand [<sup>3</sup>H]sipatrigine, and a range of neuroprotective activity, many with moderate to good neuroprotection. In the N<sub>1</sub>-substituted series, all but one of the 11 new analogues had a binding IC<sub>50</sub> < 13 μM, with some compounds having values as low as 1 μM. Similarly, in the N<sub>2</sub>-substituted series, all but one of the 16 new analogues had a binding IC<sub>50</sub> < 17 μM, with some as low as 0.4 μM. Neuroprotection efficacy also showed a general increase, with compound <b>50</b> reaching 88% neuroprotection. In the N<sub>1</sub> series, the most profound effect was the 2,3-dimethoxy substitution of the benzamide ring, <b>41</b>, which led to a marked increase in displacement ability (IC<sub>50</sub> 13 to 7.1 μM) and neuroprotection (46 to 71%). Interestingly, the analogous trisubstitution at the 2,3,4-positions, <b>38</b>, resulted in a decrease in neuroprotection. These aside, in the N<sub>1</sub> series, functionalization the benzamide changed little in terms of activity from the parent, <b>6</b> (IC<sub>50</sub> range of 1–13 μM and neuroprotection range of 37–52%), with the potential to add larger groups, such as a indole <b>39</b> or <i>t</i>-butyl <b>40</b>, without significant loss of binding or neuroprotection. Compared to the N<sub>1</sub> series, the N<sub>2</sub> benzamide series had a much greater range of activities, both in binding (0.4–59 μM) and neuroprotection (2–89%). The 2-, 3-, and 4-methoxybenzamides all showed good binding (IC<sub>50</sub> < 8 μM) and neuroprotection (54–63%), with the 2,3-dimethoxy-substituted benzamide once again showing the best activity with good binding (IC<sub>50</sub> = 5 μM) and excellent neuroprotection (89%, EC<sub>50</sub> = 12.3 ± 5.8). The benzamide substituted at the 3 position with OCF<sub>3</sub> showed comparable activity with binding (IC<sub>50</sub> = 0.8 μM) and neuroprotection (80%). The only other marked effect was an almost total ablation of neuroprotective effect by fluorination at the 2 and 3 positions, despite showing an IC<sub>50</sub> of 4 μM in the radioligand-displacement assay. Of all of the sulfonamide compounds in the N<sub>1</sub> series, only one improved on the neuroprotection of parent benzamide <b>6</b>, although many showed better binding. The 2- and 3-substituted sulfonamide showed good binding and modest neuroprotection, but substitution at the 4 position seemed to provide compounds with poor neuroprotective ability, if not binding, such as <b>57</b>, <b>59</b>, and <b>62</b>. In the N<sub>2</sub> series, the sulfonamide analogue of <b>34</b>, <b>63</b>, showed comparable binding and neuroprotection, but once again, a 4-substituted sulfonamide, <b>64</b>, had poorer binding and reduced neuroprotection. In fact, 4-substituted sulfonamide and benzamide analogues across the group had reduced capacity for neuroprotection in the hippocampal slice assay when compared to the 2- or 3-substituted or unsubstituted compounds, despite no significant difference in binding. The presence of unfavorable interactions at the 4 positions is indicated, and this may also account for the observation that small substituents such as Cl have a lesser detrimental effect on activity than larger groups. In the limited number of halide-functionalized benzamides and sulfonamides tested, none showed improved neuroprotection.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Sodium Channel Modulatory and Neuroprotective Activity of N<sub>1</sub>- and N<sub>2</sub>-Propylimidazole-Functionalized Oxadiazolylindazole Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/medium/jm-2013-01881q_0010.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">N<sub>1</sub>/N<sub>2</sub> functionalized</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">[<sup>3</sup>H]sipatrigine binding, IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">neuroprotection at 50 <i>μ</i>M (%) or EC<sub>50</sub> (bold)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lamotrigine</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.8 ± 0.2<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">33<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tetrodotoxin</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">100<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">sipatrigine</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.04 ± 0.001<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">93<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">N<sub>1</sub></td><td class="colsep0 rowsep0" align="left">CO-2,3,4-(OCH<sub>3</sub>)<sub>3</sub>Ph</td><td class="colsep0 rowsep0" align="left">5.3 ± 2.8</td><td class="colsep0 rowsep0" align="left">37 ± 6.4 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">N<sub>1</sub></td><td class="colsep0 rowsep0" align="left">CO-4-indole</td><td class="colsep0 rowsep0" align="left">13 ± 2.0</td><td class="colsep0 rowsep0" align="left">52 ± 9.9 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">N<sub>1</sub></td><td class="colsep0 rowsep0" align="left">CO-4-<i>t</i>-BuPh</td><td class="colsep0 rowsep0" align="left">1.2 ± 0.2</td><td class="colsep0 rowsep0" align="left">40 ± 34.2 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">N<sub>1</sub></td><td class="colsep0 rowsep0" align="left">CO-2,3-(OCH<sub>3</sub>)<sub>2</sub>Ph</td><td class="colsep0 rowsep0" align="left">7.1 ± 0.8</td><td class="colsep0 rowsep0" align="left">69 ± 7.5 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">N<sub>1</sub></td><td class="colsep0 rowsep0" align="left">CO-3-OCF<sub>3</sub>Ph</td><td class="colsep0 rowsep0" align="left">1.5 ± 0.3</td><td class="colsep0 rowsep0" align="left">37 ± 13.0 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">N<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CO-4-ClPh</td><td class="colsep0 rowsep0" align="left">2.2 ± 0.5</td><td class="colsep0 rowsep0" align="left">42 ± 3.1 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">N<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CO-2,3-F<sub>2</sub>Ph</td><td class="colsep0 rowsep0" align="left">3.6 ± 0.2</td><td class="colsep0 rowsep0" align="left">2 ± 1.4 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">N<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CO-4-OCF<sub>3</sub>Ph</td><td class="colsep0 rowsep0" align="left">0.7 ± 0.1</td><td class="colsep0 rowsep0" align="left">31 ± 8.2 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">N<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CO-2-CH<sub>3</sub>Ph</td><td class="colsep0 rowsep0" align="left">2.9 ± 0.5</td><td class="colsep0 rowsep0" align="left">62 ± 4.4 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">N<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CO-4-OCH<sub>3</sub>Ph</td><td class="colsep0 rowsep0" align="left">6.2 ± 0.7</td><td class="colsep0 rowsep0" align="left">55 ± 10.7 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">N<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CO-4-(NHCOCH<sub>3</sub>)Ph</td><td class="colsep0 rowsep0" align="left">59 ± 31</td><td class="colsep0 rowsep0" align="left">–14 ± 3.6 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">N<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CO-2-naphthalene</td><td class="colsep0 rowsep0" align="left">0.4 ± 0.2</td><td class="colsep0 rowsep0" align="left">22 ± 4.4 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>50</b></td><td class="colsep0 rowsep0" rowspan="2" align="left">N<sub>2</sub></td><td class="colsep0 rowsep0" rowspan="2" align="left">CO-2,3-(OCH<sub>3</sub>)<sub>2</sub>Ph</td><td class="colsep0 rowsep0" rowspan="2" align="left">5.8 ± 1.8</td><td class="colsep0 rowsep0" align="left"><b>12.3 ± 5.8</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">88 ± 7.7 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>51</b></td><td class="colsep0 rowsep0" rowspan="2" align="left">N<sub>2</sub></td><td class="colsep0 rowsep0" rowspan="2" align="left">CO-3-OCF<sub>3</sub>Ph</td><td class="colsep0 rowsep0" rowspan="2" align="left">0.6 ± 0.1</td><td class="colsep0 rowsep0" align="left"><b>5.15 ± 0.15</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">78 ± 4.2 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">N<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CO-(3-CH<sub>3</sub>-4-NO<sub>2</sub>)Ph</td><td class="colsep0 rowsep0" align="left">1.7 ± 0.2</td><td class="colsep0 rowsep0" align="left">43 ± 3.1 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">N<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CO-3,4-benzodioxole</td><td class="colsep0 rowsep0" align="left">5.0 ± 0.4</td><td class="colsep0 rowsep0" align="left">27 ± 4.5 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">N<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CO-3-CH<sub>3</sub>Ph</td><td class="colsep0 rowsep0" align="left">2.5 ± 0.2</td><td class="colsep0 rowsep0" align="left">41 ± 6.9 (3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="left">N<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CO-2-OCH<sub>3</sub>Ph</td><td class="colsep0 rowsep0" align="left">7.1 ± 1.2</td><td class="colsep0 rowsep0" align="left">54 ± 11.3 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="left">N<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CO-3-OCH<sub>3</sub>Ph</td><td class="colsep0 rowsep0" align="left">5.0 ± 1.1</td><td class="colsep0 rowsep0" align="left">63 ± 7.6 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57</b></td><td class="colsep0 rowsep0" align="left">N<sub>1</sub></td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>-4-ClPh</td><td class="colsep0 rowsep0" align="left">10 ± 7.1</td><td class="colsep0 rowsep0" align="left">21 ± 7.9 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" align="left">N<sub>1</sub></td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>-2,3-(OCH<sub>3</sub>)<sub>2</sub>Ph</td><td class="colsep0 rowsep0" align="left">>500</td><td class="colsep0 rowsep0" align="left">37 ± 2.5 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b></td><td class="colsep0 rowsep0" align="left">N<sub>1</sub></td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>-4-OCF<sub>3</sub>Ph</td><td class="colsep0 rowsep0" align="left">4.9 ± 6.0</td><td class="colsep0 rowsep0" align="left">0 ± 9.9 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="left">N<sub>1</sub></td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>-2-CH<sub>3</sub>Ph</td><td class="colsep0 rowsep0" align="left">4.9 ± 1.3</td><td class="colsep0 rowsep0" align="left">57 ± 10.8 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61</b></td><td class="colsep0 rowsep0" align="left">N<sub>1</sub></td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>-3-CF<sub>3</sub>Ph</td><td class="colsep0 rowsep0" align="left">2.1 ± 0.6</td><td class="colsep0 rowsep0" align="left">38 ± 12.3 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62</b></td><td class="colsep0 rowsep0" align="left">N<sub>1</sub></td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>-4-<i>t</i>-BuPh</td><td class="colsep0 rowsep0" align="left">4.4 ± 1.3</td><td class="colsep0 rowsep0" align="left">16 ± 20.2 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>63</b></td><td class="colsep0 rowsep0" rowspan="2" align="left">N<sub>2</sub></td><td class="colsep0 rowsep0" rowspan="2" align="left">SO<sub>2</sub>-Ph</td><td class="colsep0 rowsep0" rowspan="2" align="left">1.7 ± 0.5</td><td class="colsep0 rowsep0" align="left"><b>29.5 ± 3.8</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">38 ± 14 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64</b></td><td class="colsep0 rowsep0" align="left">N<sub>2</sub></td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>-4-(NHCOCH<sub>3</sub>)Ph</td><td class="colsep0 rowsep0" align="left">17 ± 6.8</td><td class="colsep0 rowsep0" align="left">25 ± 15 (4)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Values reported in literature.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Tested at 30 μM. Results are normalized to the effect of TTX and are based on the mean of at least three experiments.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">TTX tested at 1 μM.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Tested at 3 μM (values in bold are IC<sub>50</sub>’s in micromolar).</p></div></div></div></div><div id="sec2_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> Stability in Rat Liver Microsomes</h4><div class="NLM_p">The N<sub>1</sub> and N<sub>2</sub> ethyl-2-imidazole-substituted series was examined for metabolic stability in rat liver microsomes. Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> shows a select subset of the compounds screened for rate of turnover. When examined, 14 of 21 compounds tested in this series had turnovers of greater than 90% after 40 min. Boc-protected and free amine N<sub>2</sub> analogues <b>17</b> and <b>27</b> showed better metabolic resistance, with turnovers of 70 and 57 min, respectively. Functionalization of the amine with benzamide, <b>34</b>, again produced an unstable compound. However the N<sub>1</sub> analogue, <b>6</b>, showed better stability with more than half of the original compound left after 40 min. Despite this promising result, none of the further analogues managed to maintain or improve on this stability, with any substitution making the compounds significantly more labile to metabolic degradation (>90%). Five benzamide and sulphonamide analogues that were fluorine- or chlorine-substituted at the 4, 5, and 6 positions on the indazole ring were also tested to see if this modification could arrest the rate of metabolism. All showed >90% metabolism after 40 min (data not shown). The only compound with moderately increased stability was the CO-3-OCF<sub>3</sub>Ph-substituted benzamide, <b>42</b>. Similarly, substitution of the benzamide or changing to a sulfonamide did not provide much improvement in the metabolic stability of the N<sub>2</sub> analogues of benzamide <b>34</b>. Interestingly, however, substitution at the 4 position with the amide group, NHCOCH<sub>3</sub>, in both the sulfonamide <b>64</b> and benzamide <b>34</b> analogues gave significant improvement in stability, with turnovers of 54 and 45%, respectively, after 40 min. Unfortunately, these 4 position-substituted NHCOCH<sub>3</sub> compounds were also some of the most inactive compounds in the neuroprotective assay.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Metabolic Stability Measured in a Rat Liver Microsome Assay for N<sub>1</sub>- and N<sub>2</sub>-Propylimidazole-Functionalized Oxadiazolylindazole Analogues</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">turnover at 40 min (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">97</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>63</b></td><td class="colsep0 rowsep0" align="left">97</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64</b></td><td class="colsep0 rowsep0" align="left">54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">45</td></tr></tbody></table></div></div></div><div id="sec2_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Na<sub>v</sub> Channel Isoform Profiling</h4><div class="NLM_p">Compounds <b>6</b> and <b>51</b> were examined by patch-clamp electrophysiology to determine their effects on sodium channel isoforms (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a> and Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Compound <b>6</b> showed preferential activity for the inactivated state (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A) but little discrimination between subtypes. The block of Na<sub>v</sub>1.1, 1.3, and 1.6 is implicated in the pharmacological basis of neuroprotection (vide supra), and activity was noted against these isoforms consistent with the compounds’ ability to displace radiolabeled sipatrigine (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Compound <b>51</b> showed good activity in both the radioligand-displacement and neuroprotection assays, and this is reflected in its potent block across the range of isoforms. It blocks many of the isoforms at an order of magnitude lower concentration than <b>6</b>, with its most potent block against the Na<sub>v</sub>1.5 sodium channel, an isoform found primarily in cardiac muscle. There also appears to be less functional selectivity compared to <b>6</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B). The potency of <b>51</b> against Na<sub>v</sub>1.1, 1.3, and 1.6 when compared to <b>6</b> may account for the observed increase in neuroprotection seen with this compound (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>).</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/medium/jm-2013-01881q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/large/jm-2013-01881q_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Detail of activity of <b>6</b> (A) and <b>51</b> (B) against the Na<sub>v</sub>1.6 isoform. Blue triangles are block of the inactivated state, red circles are block of 10 Hz current, and black squares are block of tonic current.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/large/jm-2013-01881q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401881q&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Summary of Action of Compounds <b>6</b> and <b>51</b> on Na<sub>v</sub>1.1–1.8</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">tonic block (a)</th><th class="rowsep1 colsep0" colspan="2" align="center">10 Hz block (b)</th><th class="rowsep1 colsep0" colspan="2" align="center">inactivated-state block (c)</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub></th><th class="colsep0 rowsep0" align="center"><i>n</i><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub></th><th class="colsep0 rowsep0" align="center"><i>n</i></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub></th><th class="colsep0 rowsep0" align="center"><i>n</i></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> b/c<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> a/c</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="9" align="center"><b>Na<sub>v</sub>1.1</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">21 ± 6.29</td><td class="colsep0 rowsep0" align="left">1.71 ± 0.73</td><td class="colsep0 rowsep0" align="left">>5</td><td class="colsep0 rowsep0" align="left">>5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">15.3 ± 5.02</td><td class="colsep0 rowsep0" align="left">1.09 ± 0.24</td><td class="colsep0 rowsep0" align="left">8.54 ± 0.72</td><td class="colsep0 rowsep0" align="left">1.32 ± 0.16</td><td class="colsep0 rowsep0" align="left">2.55 ± 0.22</td><td class="colsep0 rowsep0" align="left">2.09 ± 0.32</td><td class="colsep0 rowsep0" align="left">3.3</td><td class="colsep0 rowsep0" align="left">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="9" align="center"><b>Na<sub>v</sub>1.2</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">71 ± 25</td><td class="colsep0 rowsep0" align="left">1.12 ± 0.51</td><td class="colsep0 rowsep0" align="left">46 ± 7.42</td><td class="colsep0 rowsep0" align="left">1.82 ± 0.73</td><td class="colsep0 rowsep0" align="left">29 ± 1.49</td><td class="colsep0 rowsep0" align="left">1.48 ± 0.38</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">65 ± 22</td><td class="colsep0 rowsep0" align="left">0.48 ± 0.14</td><td class="colsep0 rowsep0" align="left">24.1 ± 3.87</td><td class="colsep0 rowsep0" align="left">0.63 ± 0.14</td><td class="colsep0 rowsep0" align="left">3.54 ± 1.24</td><td class="colsep0 rowsep0" align="left">0.6 ± 0.12</td><td class="colsep0 rowsep0" align="left">6.8</td><td class="colsep0 rowsep0" align="left">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="9" align="center"><b>Na<sub>v</sub>1.3</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">22 ± 4.09</td><td class="colsep0 rowsep0" align="left">0.78 ± 0.15</td><td class="colsep0 rowsep0" align="left">>5</td><td class="colsep0 rowsep0" align="left">>5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">97 ± 72</td><td class="colsep0 rowsep0" align="left">0.35 ± 0.19</td><td class="colsep0 rowsep0" align="left">4.76 ± 0.92</td><td class="colsep0 rowsep0" align="left">0.96 ± 0.19</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">>25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="9" align="center"><b>Na<sub>v</sub>1.4</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">56 ± 16.4</td><td class="colsep0 rowsep0" align="left">1.21 ± 0.36</td><td class="colsep0 rowsep0" align="left">24 ± 2.98</td><td class="colsep0 rowsep0" align="left">1.43 ± 0.27</td><td class="colsep0 rowsep0" align="left">2.3</td><td class="colsep0 rowsep0" align="left">>5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">18.3 ± 1.65</td><td class="colsep0 rowsep0" align="left">1.23 ± 0.18</td><td class="colsep0 rowsep0" align="left">10.5 ± 0.47</td><td class="colsep0 rowsep0" align="left">1.34 ± 0.13</td><td class="colsep0 rowsep0" align="left">4.58 ± 0.25</td><td class="colsep0 rowsep0" align="left">1.75 ± 0.12</td><td class="colsep0 rowsep0" align="left">2.3</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="9" align="center"><b>Na<sub>v</sub>1.5</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">69 ± 31</td><td class="colsep0 rowsep0" align="left">1.16 ± 0.54</td><td class="colsep0 rowsep0" align="left">19 ± 3.06</td><td class="colsep0 rowsep0" align="left">0.99 ± 0.22</td><td class="colsep0 rowsep0" align="left">3.6</td><td class="colsep0 rowsep0" align="left">>5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">36 ± 19</td><td class="colsep0 rowsep0" align="left">0.76 ± 0.23</td><td class="colsep0 rowsep0" align="left">14.8 ± 7.52</td><td class="colsep0 rowsep0" align="left">0.37 ± 0.13</td><td class="colsep0 rowsep0" align="left">0.92 ± 0.89</td><td class="colsep0 rowsep0" align="left">0.49 ± 0.15</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="9" align="center"><b>Na<sub>v</sub>1.6</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">24 ± 7.3</td><td class="colsep0 rowsep0" align="left">2.45 ± 2.59</td><td class="colsep0 rowsep0" align="left">>5</td><td class="colsep0 rowsep0" align="left">>5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">32.2 ± 25.9</td><td class="colsep0 rowsep0" align="left">0.42 ± 0.19</td><td class="colsep0 rowsep0" align="left">3.32 ± 0.53</td><td class="colsep0 rowsep0" align="left">1.17 ± 0.18</td><td class="colsep0 rowsep0" align="left">9.7</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="9" align="center"><b>Na<sub>v</sub>1.7</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">37 ± 7.0</td><td class="colsep0 rowsep0" align="left">2.09 ± 1.73</td><td class="colsep0 rowsep0" align="left">28 ± 1.8</td><td class="colsep0 rowsep0" align="left">1.88 ± 0.53</td><td class="colsep0 rowsep0" align="left">14.5 ± 0.73</td><td class="colsep0 rowsep0" align="left">2.24 ± 0.17</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">2.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">5.64 ± 0.57</td><td class="colsep0 rowsep0" align="left">2.59 ± 0.41</td><td class="colsep0 rowsep0" align="left">4.82 ± 0.33</td><td class="colsep0 rowsep0" align="left">2.63 ± 0.33</td><td class="colsep0 rowsep0" align="left">3.02 ± 0.36</td><td class="colsep0 rowsep0" align="left">2.5 ± 0.1</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="9" align="center"><b>Na<sub>v</sub>1.8</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">28 ± 0.97</td><td class="colsep0 rowsep0" align="left">1.42 ± 0.1</td><td class="colsep0 rowsep0" align="left">>4</td><td class="colsep0 rowsep0" align="left">>4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">6.34 ± 1.08</td><td class="colsep0 rowsep0" align="left">2.14 ± 0.51</td><td class="colsep0 rowsep0" align="left">5.66 ± 1.47</td><td class="colsep0 rowsep0" align="left">2.62 ± 1.05</td><td class="colsep0 rowsep0" align="left">3.77 ± 0.49</td><td class="colsep0 rowsep0" align="left">2.75 ± 0.66</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">1.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last"><i>n</i> = the slope of the fit.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">The ratio of IC<sub>50</sub> a/c and b/c illustrates the degree of functional selectivity for the inactivated state.</p></div></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> In Vivo Activity in an Optic Neuritis Mouse Model of MS</h3><div class="NLM_p">Compound <b>6</b> was selected for detailed in vivo evaluation on the basis of its mix of properties: in vitro sodium channel activity, activity against the neuronal Na<sub>v</sub> isoforms, functional selectivity, and stability in rat liver microsomes. The influence of <b>6</b> was assessed in vivo in wild-type and myelin oligodendrocyte glycoprotein-specific T-cell receptor transgenic mice (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>; <b>5</b>).<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> First, <b>6</b> was examined for T-cell immunosuppressive activity, as the EAE model of MS is well-known to be T-cell-dependent.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Rather than use transgenic mice where all T-cells have the same specificity, a contact-hypersensitivity model was used because it is known to be predictive in identifying in vivo immunosuppressive doses for EAE studies.<a onclick="showRef(event, 'ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43">(41-43)</a> Doses of <b>6</b> ranging from 5–50 mg/kg were administered intraperitoneally (i.p.) from day −1 to day 2, and the in vivo induced proliferative response was assessed in the draining lymph nodes 3 days (the peak time of T-cell proliferation) after the sensitization to the contact-sensitizer oxazolone on day 0. There was no evidence suggestive of any inhibitory effect of sensitization based on cell numbers within the lymph nodes or based on a per cell proliferative response (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Importantly, this study demonstrated that the drug was well-tolerated and there was no apparent toxicity. We next sought to assess whether <b>6</b> could exert a neuroprotective effect and limit the amount of axonal and nerve loss that results as a consequence of T-cell autoimmunity within the CNS. Following the development of optic neuritis in our model mice, demyelination was augmented following injection of 250 μg of Z12 rat IgG2b demyelinating antibody on day 14.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Retinal ganglion cell survival following treatment of animals with 5 mg/kg i.p. <b>6</b> was assessed on day 21 postinduction in retinal flatmounts (Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A,B and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). It was found that <b>6</b> increased ganglion cell survival (<i>P</i> < 0.02) and reduced the mean retinal loss from 914 ± 117 to 1298 ± 77 cells/mm<sup>2</sup> compared to 1653 ± 89 cells/mm<sup>2</sup> in a group of age-matched control animals without optic neuritis (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). This study suggests that this class of compounds may have some utility in controlling the accumulation of nerve loss that occurs in diseases such as MS.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/medium/jm-2013-01881q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/large/jm-2013-01881q_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. T-cell immunosuppressive activity of <b>6</b> in vivo. Mice received epicutaneous application of 25 μL of 2.5% oxazolone (OX) in acetone olive oil (AOO) 4:1 on day 0 on the dorsum of the ear. Animals received daily intraperitoneal (i.p.) injections of either vehicle (DMSO/Cremophor/phosphate buffered saline, 1:1:18) or <b>6</b> from day −1 to day 2. On day 3, the draining auricular lymph nodes were removed from three mice and pooled, and a single-cell suspension was made. Lymph node cells were counted, and 5 × 10<sup>5</sup> cells per well, in triplicate, were cultured overnight at 37 °C. T-cell proliferation was assessed using the CellTiter 96 AQ<sub>ueous</sub> Cell Proliferation Assay, which uses a MTS tetrazolium compound that is bioreduced by live cells. The resulting formazan product absorbance is recorded at 490 nM. The results represent the mean response ± SD of triplicate assays.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/large/jm-2013-01881q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401881q&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/medium/jm-2013-01881q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/large/jm-2013-01881q_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Retinal ganglion cells in the retina of mice (A) before or (B) after the development of optic neuritis. (C) Density of RGC. The box represents the 25th and 75th percentiles. The whiskers represent the fifth and 95th percentiles. The solid line represents the median. Differences between vehicle and drug-treated controls were assessed using Student’s <i>t</i> test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/large/jm-2013-01881q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401881q&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63326" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63326" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">During MS, Na<sub>v</sub> channels are redistributed along demyelinated nerves, which can help to restore function to some extent but leaves them vulnerable to excessive sodium entry.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p">Our strategy was to develop compounds with good activity toward sodium channel inhibition, in particular against the neuronal isoforms Na<sub>v</sub>1.1, 1.3, and 1.6, but, most importantly, which could also display neuroprotective capabilities in an in vitro hippocampal slice assay system. The selection of a candidate molecule for in vivo studies was based on a balanced assessment of properties, principally sodium channel activity, neuroprotection, and in vitro stability. The use of the hippocampal slice model, measuring ATP levels and tuned for sodium channel blockade, was key in ensuring an appropriate functional effect. In general, the series was found to exhibit poor stability in rat liver microsomes in vitro, with <b>6</b> being a notable exception that allowed us to test this paradigm in vivo. There are reports on the metabolism of 1,2,4-oxadiazoles,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> and this may be the site of the metabolic fragility. Studies detailing the pharmacokinetics and localization of <b>6</b> to brain and spinal cord lesions in other EAE models are published elsewhere.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><div class="NLM_p">Sodium channel blockade with <b>6</b> in vivo was found to be neuroprotective, preventing retinal ganglion cell loss in optic neuritis in this refined EAE model.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> In this case, the mechanism of neuroprotection is unlikely to be due to peripheral immunosuppression that prevents disease from developing.<a onclick="showRef(event, 'ref18 ref51'); return false;" href="javascript:void(0);" class="ref ref18 ref51">(18, 51)</a> There was no evidence of T-cell immunosuppression seen here in a paradigm that can detect immunosuppressive doses of drugs even following a single dose. Furthermore, in our hands, overt immunosuppression does not affect the development of disease in conventional EAE using a similar delivery of sodium channel-blocking compounds including phenytoin, sipatrigine, carbamazepine, and oxcarbazepine,<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> which is in contrast to some studies where immunosuppression of sodium channel blockers delivered in the drinking water was noted.<a onclick="showRef(event, 'ref18 ref51'); return false;" href="javascript:void(0);" class="ref ref18 ref51">(18, 51)</a> This class of agents has consistently been found to be neuroprotective.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Neuroprotection with <b>6</b> is most likely to occur at the level of the axon or nerve and perhaps through inhibition of microglial activity, which are probably central to the pathogenesis of progressive MS.<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45, 46)</a></div><div class="NLM_p">Furthermore, some microglial responses are mediated via Na<sub>v</sub> channel activity. Therefore, blockade of sodium channels could result in neuroprotective effects on immune and nonimmune components that may drive progressive nerve loss in MS.<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45, 46)</a> Neurodegeneration accumulates slowly over time and therefore allows a larger time window for treatment onset compared to acute conditions such as stroke. Lesions in MS can develop throughout the neuroaxis but are common within the optic nerve, where optic neuritis is often an initial sign of disease. The visual pathway is the most accessible part of the human nervous system, and optic neuritis in MS is considered to be an ideal tissue to study the effect of neuroprotective treatments in MS and is being targeted in a number of studies.<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47, 48)</a> Amiloride and phenytoin are currently in phase II clinical trials for the treatment of optic neuritis in MS (NCT01802489, NCT01451593).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> We chose to utilize an optic neuritis model for in vivo evaluation of neuroprotection in this study.</div><div class="NLM_p last">Recently, lamotrigine was examined in progressive MS, but it did not appear to inhibit the development of brain atrophy, which was the primary outcome measure, although significant effects of slowing of walking deterioration were noted.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> There is a clear need to evaluate better tolerated and more effective neuroprotective agents. The chemical series described here may provide a platform for the development of pharmaceutical agents for the treatment of MS and other neurological diseases.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88536" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88536" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All compounds were at least 95% pure as assayed by LCMS (electrospray positive). The preparations of analogues <b>6</b> and <b>51</b> are shown below, and the preparation of the remainder of the analogues is provided in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Procedure for the Synthesis of Benzamide Analogues</h3><div class="NLM_p last">To a solution of R-substituted benzoic acid (0.10 g, 0.82 mmol) in DMF (5 mL) were added HATU (0.34 g, 0.9 mmol, 1.1 equiv) and diisopropylethylamine (0.23 g, 0.31 mL, 1.8 mmol, 2.2 equiv), and the solution allowed to stir for half of an hour at room temperature under nitrogen. The amine (0.9 mmol, 1.1 equiv) was then added, and the brown solution was allowed to stir overnight. The DMF was removed in vacuo, and the resulting crude oil was dissolved in ethyl acetate and washed with water, 1 N HCl, 1 N NaHCO<sub>3</sub>, and brine. The organic phase was then dried over magnesium sulfate, and the solvent was removed in vacuo. The crude oil was purified using flash chromatography, eluting with 10% methanol in dichloromethane.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Procedure for the Synthesis of Sulfonamide N<sub>1</sub> Analogues</h3><div class="NLM_p last">To a solution of the appropriate amine (0.22 g, 0.71 mmol, 1 equiv) in water (10 mL) was added R-substituted benzene sulfonyl chloride (0.78 mmol, 1.1 equiv). The solution was allowed to stir, and saturated sodium carbonate(aq) was added gradually to adjust the acidic pH to 8. The solution was then allowed to stir overnight at room temperature. The white precipitate was filtered off, washed with diethyl ether, and dried in vacuo.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> <i>N</i>-[[5-[1-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]benzamide (<b>6</b>)</h3><div class="NLM_p last">Orange crystals (18% yield, 98% purity). <sup>1</sup>H NMR (300 MHz, DMSO) δ 9.27 (t, <i>J</i> = 5.7 Hz, 1H, NH), 8.13 (d, <i>J</i> = 8.1 Hz, 1H, ArH), 7.92 (d, <i>J</i> = 6.7 Hz, 2H, ArH), 7.64 (d, <i>J</i> = 8.5 Hz, 1H, ArH), 7.61–7.41 (m, 4H, ArH), 7.41–7.27 (m, 2H, ArH), 7.02 (s, 1H, ArH), 6.71 (s, 1H, ArH), 4.96 (t, <i>J</i> = 5.8 Hz, 2H, CH<sub>2</sub>), 4.73 (d, <i>J</i> = 5.7 Hz, 2H, CH<sub>2</sub>), 4.55 (t, <i>J</i> = 5.8 Hz, 2H, CH<sub>2</sub>). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 170.1, 168.9, 166.5, 140.8, 137.2, 133.7, 131.5, 129.3, 128.4, 127.7, 127.4, 127.3, 123.7, 121.5, 120.3, 119.6, 110.5, 49.7, 45.7, 35.3. HRMS (TOF MS ES<sup>+</sup>) calcd for C<sub>22</sub>H<sub>20</sub>N<sub>7</sub>O<sub>2</sub> (MH<sup>+</sup>), 414.1678; found, 414.1668.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> <i>N</i>-[[5-[2-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]-2-(trifluoromethoxy)benzamide (<b>51</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.18 (s, 1H, NH), 8.09 (d, <i>J</i> = 8.4 Hz, 1H, ArH), 7.99 (d, <i>J</i> = 7.7 Hz, 1H, ArH), 7.95 (s, 1H, ArH), 7.81 (d, <i>J</i> = 8.6 Hz, 1H, ArH), 7.54–7.30 (m, 5H, ArH), 6.69 (s, 1H, ArH), 6.30 (s, 1H, ArH), 5.37 (t, <i>J</i> = 5.5 Hz, 2H, CH<sub>2</sub>), 4.82 (d, <i>J</i> = 5.1 Hz, 2H, CH<sub>2</sub>), 4.55 (t, <i>J</i> = 5.5 Hz, 2H, CH<sub>2</sub>).<sup>13</sup>C NMR (75 MHz, DMSO) δ 237.95, 168.13, 167.26, 164.96, 151.20, 148.34, 147.35, 137.33, 135.81, 130.68, 128.25, 127.08, 126.41, 125.70, 124.15, 122.28, 119.96, 119.79, 119.23, 118.23, 53.29, 45.60, 35.20. HRMS (TOF MS ES<sup>+</sup>) calcd for C<sub>25</sub>H<sub>30</sub>N<sub>10</sub>O<sub>5</sub> (MH<sup>+</sup>), 498.1501; found, 498.1500.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> In Vivo</h3><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Animals</h4><div class="NLM_p last">Six to eight week old male and female wild-type and double-transgenic C57BL/6-Cg-Tg(Thy1-CFP)23Jrs.Tg (Tcra2D2,Tcrb2D2)1Kuch/J mice<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> were used from stock bred at Queen Mary University of London. Founder mice were originally obtained from Jackson Laboratories, Bar Habor, ME, USA). These transgenic mice express both a H-2A<sup>b</sup>-restricted T-cell receptor (Vα3, Vβ11) specific for myelin oligodendrocyte glycoprotein residues 35–55 and a neuronally restricted Thy1 (CD90)-promoter-driven expression of cyan fluorescent protein, which is only present in the retinal ganglion cells within the retina.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Mice were maintained on a 12 h light/dark cycle with controlled humidity and temperature and housed as described previously.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The reporting of most aspects of the experimental design, which conform with the ARRIVE guidelines, has been described previously.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Animals were fed RM-1E diet and water ad libitum. All animal studies were approved by the Queen Mary ethical review panel and the United Kingdom Government Home Office Inspectorate. These studies conformed to the United Kingdom Animals (Scientific Procedures) Act 1986 for the use of animals in research.</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> In Vivo Local Lymph Node Assay</h4><div class="NLM_p last">Mice (<i>n</i> = 3–4/group) received epicutaneous application of 25 μL of acetone/olive oil (4:1, AOO) or 25 μL of 2.5% oxazolone (OX, Sigma-Aldrich, Poole, UK) on day 0 on the dorsum of the ear. On day 3, the draining auricular lymph nodes were removed, and a single-cell suspension was made. Lymph node cells were counted, and 5 × 10<sup>5</sup> cells/well, in triplicate, were cultured overnight at 37 °C/5% CO<sub>2</sub> in 200 μL of RPMI-1640 medium supplemented with 10% heat-inactivated fetal calf serum, <span class="smallcaps smallerCapital">l</span>-glutamine, sodium-pyruvate, and antibiotics as described previously.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> T-cell proliferation was assessed using the CellTiter 96 AQ<sub>ueous</sub> Non-Radioactive Cell Proliferation Assay according to the manufacturer’s instructions (Promega, Southhampton, UK). Animals received daily intraperitoneal (i.p.) injections of either DMSO/Cremophor/phosphate buffered saline (1:1:18) or <b>6</b> from day −1 to 2.</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Optic Neuritis Multiple Sclerosis Mouse Model</h4><div class="NLM_p last">Optic neuritis was induced in C57BL/6-Cg-Tg(Thy1-CFP)23Jrs.Tg(Tcra2D2, Tcrb2D2)1Kuch/J transgenic mice. Subclinical EAE in the absence of paralytic disease was induced following administration of 150 ng of <i>Bordetella pertussis</i> toxin (Sigma-Aldrich) in phosphate-buffered saline.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Optic neuritis within the optic nerve was augmented following the injection of 250 μg of Z12 rat IgG2b mouse myelin oligodendrocyte-specific demyelinating antibody on day 14.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Animals were injected daily from day 0–21 of the experiment with 5 mg/kg i.p. Animals were killed on day 21 postinduction, and eyes were enucleated and immersed in 4% paraformaldehyde (Sigma-Aldrich) in PBS (pH 7.4) overnight. The retinae were dissected, and the cornea, sclera, lens, hyaloid vasculature, and connective tissue were removed in 2× normal-strength PBS. Four radial incisions were cut around the retina, and flatmounts were mounted onto slides and coverslipped with antifade glycerol (CitiFluor Ltd., London, UK). The retinal flatmounts were imaged by fluorescent microscopy, retinal ganglion cell density was calculated by counting cyan fluorescent protein-expressing retinal ganglion cells using stereology software with a fractionator probe, and the number cells in the four quadrants around the optic nerve head was counted.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> The parametric data was assessed using Student’s <i>t</i> test, incorporating tests for equality of variance using SigmaStat software (Systat Software, Inc., San Jose, CA, USA).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26"><a href="/doi/suppl/10.1021/jm401881q">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56262" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56262" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Additional biological methods and experimental details for synthesized compounds. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401881q/suppl_file/jm401881q_si_001.pdf">jm401881q_si_001.pdf (287.84 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm401881q" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48884" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48884" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David L. Selwood</span> - <span class="hlFld-Affiliation affiliation">Biological
and Medicinal Chemistry, Wolfson Institute for Biomedical Science, University College London, Gower Street, London WC1E 6BT, United Kingdom</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#56327825333a213939321623353a78373578233d"><span class="__cf_email__" data-cfemail="23470d50464f544c4c476356404f0d42400d5648">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lorcan Browne</span> - <span class="hlFld-Affiliation affiliation">Biological
and Medicinal Chemistry, Wolfson Institute for Biomedical Science, University College London, Gower Street, London WC1E 6BT, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katie Lidster</span> - <span class="hlFld-Affiliation affiliation">Neuroimmunology,
Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, London E1 2AT, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sarah Al-Izki</span> - <span class="hlFld-Affiliation affiliation">Neuroimmunology,
Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, London E1 2AT, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lisa Clutterbuck</span> - <span class="hlFld-Affiliation affiliation">Biological
and Medicinal Chemistry, Wolfson Institute for Biomedical Science, University College London, Gower Street, London WC1E 6BT, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cristina Posada</span> - <span class="hlFld-Affiliation affiliation">Biological
and Medicinal Chemistry, Wolfson Institute for Biomedical Science, University College London, Gower Street, London WC1E 6BT, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">A. W. Edith Chan</span> - <span class="hlFld-Affiliation affiliation">Biological
and Medicinal Chemistry, Wolfson Institute for Biomedical Science, University College London, Gower Street, London WC1E 6BT, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dieter Riddall</span> - <span class="hlFld-Affiliation affiliation">Biological
and Medicinal Chemistry, Wolfson Institute for Biomedical Science, University College London, Gower Street, London WC1E 6BT, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Garthwaite</span> - <span class="hlFld-Affiliation affiliation">Biological
and Medicinal Chemistry, Wolfson Institute for Biomedical Science, University College London, Gower Street, London WC1E 6BT, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Baker</span> - <span class="hlFld-Affiliation affiliation">Neuroimmunology,
Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, London E1 2AT, United Kingdom</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d3017e4012-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82724" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82724" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the National Multiple Sclerosis Society (USA), the Wellcome Trust, and the National Centre for the Replacement, Refinement & Reduction of Animals in Research as well as the MRC through a studentship to L.B.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i28" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i28"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i29" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i29"> Abbreviations Used</h2><tr><td class="NLM_term">AOO</td><td class="NLM_def"><p class="first last">acetone olive oil</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">EAE</td><td class="NLM_def"><p class="first last">experimental autoimmune encephalomyelitis</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last"><i>N</i>-[(dimethylamino)-1<i>H</i>-1,2,3-triazolo-[4,5-<i>b</i>]pyridin-1-ylmethylene]-<i>N</i>-methylmethanaminium hexafluorophosphate <i>N</i>-oxide</p></td></tr><tr><td class="NLM_term">MS</td><td class="NLM_def"><p class="first last">multiple sclerosis</p></td></tr><tr><td class="NLM_term">Na<sub>v</sub></td><td class="NLM_def"><p class="first last">voltage-gated sodium</p></td></tr><tr><td class="NLM_term">OX</td><td class="NLM_def"><p class="first last">oxazalone</p></td></tr><tr><td class="NLM_term">TCR</td><td class="NLM_def"><p class="first last">T-cell receptor</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01520" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01520" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 52 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Tarnawa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolcskei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kocsis, P.</span><span> </span><span class="NLM_article-title">Blockers of voltage-gated sodium channels for the treatment of central nervous system diseases</span> <span class="citation_source-journal">Recent Pat. CNS Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.2174%2F157488907779561754" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=18221218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVWiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=57-78&author=I.+Tarnawaauthor=H.+Bolcskeiauthor=P.+Kocsis&title=Blockers+of+voltage-gated+sodium+channels+for+the+treatment+of+central+nervous+system+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Blockers of voltage-gated sodium channels for the treatment of central nervous system diseases</span></div><div class="casAuthors">Tarnawa, Istvan; Bolcskei, Hedvig; Kocsis, Pal</div><div class="citationInfo"><span class="NLM_cas:title">Recent Patents on CNS Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-78</span>CODEN:
                <span class="NLM_cas:coden">RPCDC9</span>;
        ISSN:<span class="NLM_cas:issn">1574-8898</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Voltage gated sodium channels play important roles both in vital physiol. functions and several pathol. processes of the central nervous system.  Epilepsy, chronic pain, neurodegenerative diseases, and spasticity are all characterized by an over-excited state of specific groups of central neurons that is accompanied by an abnormally increased activity of sodium channels.  An efficient strategy of controlling such diseases is to use blockers that preferentially act on these over-excited cells.  State dependently acting agents, such as phenytoin, or lamotrigine, leave normal physiol. functions relatively intact, resulting in a favorable therapeutic window.  Nine isoforms of the channel forming alpha subunit are known, which show distinct expression patterns in different tissues.  Another possible way to decrease the chance of adverse effects is to develop agents selectively inhibiting the channel subtype involved in the pathomechanism of the disease to be treated.  Many recent patents claim sodium channel blockers with improved characteristics regarding state dependency or subtype selectivity.  Such agents may offer a breakthrough in the treatment of a variety of central nervous system diseases.  This review focuses on the current trends in sodium channel research, surveying the traditional and newly emerging therapeutic fields, and the diverse medicinal chem. of sodium channel blockers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGNCqTFvaSNLVg90H21EOLACvtfcHk0liBYCRFKjQrpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVWiurs%253D&md5=f2c492f5b77911ffbdc0213c2311dc7c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F157488907779561754&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157488907779561754%26sid%3Dliteratum%253Aachs%26aulast%3DTarnawa%26aufirst%3DI.%26aulast%3DBolcskei%26aufirst%3DH.%26aulast%3DKocsis%26aufirst%3DP.%26atitle%3DBlockers%2520of%2520voltage-gated%2520sodium%2520channels%2520for%2520the%2520treatment%2520of%2520central%2520nervous%2520system%2520diseases%26jtitle%3DRecent%2520Pat.%2520CNS%2520Drug%2520Discovery%26date%3D2007%26volume%3D2%26spage%3D57%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Mantegazza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biagini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ragsdale, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avoli, M.</span><span> </span><span class="NLM_article-title">Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1016%2FS1474-4422%2810%2970059-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=20298965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltF2ktLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=413-424&author=M.+Mantegazzaauthor=G.+Curiaauthor=G.+Biaginiauthor=D.+S.+Ragsdaleauthor=M.+Avoli&title=Voltage-gated+sodium+channels+as+therapeutic+targets+in+epilepsy+and+other+neurological+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders</span></div><div class="casAuthors">Mantegazza, Massimo; Curia, Giulia; Biagini, Giuseppe; Ragsdale, David S.; Avoli, Massimo</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">413-424</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Voltage-gated sodium channels (VGSCs) are key mediators of intrinsic neuronal and muscle excitability.  Abnormal VGSC activity is central to the pathophysiol. of epileptic seizures, and many of the most widely used antiepileptic drugs, including phenytoin, carbamazepine, and lamotrigine, are inhibitors of VGSC function.  These antiepileptic drugs might also be efficacious in the treatment of other nervous system disorders, such as migraine, multiple sclerosis, neurodegenerative diseases, and neuropathic pain.  In this Review, we summarise the structure and function of VGSCs and their involvement in the pathophysiol. of several neurol. disorders.  We also describe the biophys. and mol. bases for the mechanisms of action of antiepileptic VGSC blockers and discuss the efficacy of these drugs in the treatment of epileptic and non-epileptic disorders.  Overall, clin. and exptl. data indicate that these drugs are efficacious for a range of diseases, and that the development of drugs with enhanced selectivity for specific VGSC isoforms might be an effective and novel approach for the treatment of several neurol. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZU7nzgvD1tLVg90H21EOLACvtfcHk0liBYCRFKjQrpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltF2ktLw%253D&md5=5c5768f89cc6157665ad45a3f680dfa5</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2810%2970059-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252810%252970059-4%26sid%3Dliteratum%253Aachs%26aulast%3DMantegazza%26aufirst%3DM.%26aulast%3DCuria%26aufirst%3DG.%26aulast%3DBiagini%26aufirst%3DG.%26aulast%3DRagsdale%26aufirst%3DD.%2BS.%26aulast%3DAvoli%26aufirst%3DM.%26atitle%3DVoltage-gated%2520sodium%2520channels%2520as%2520therapeutic%2520targets%2520in%2520epilepsy%2520and%2520other%2520neurological%2520disorders%26jtitle%3DLancet%2520Neurol.%26date%3D2010%26volume%3D9%26spage%3D413%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Choi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrell, M. J.</span><span> </span><span class="NLM_article-title">Review of lamotrigine and its clinical applications in epilepsy</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">251</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1517%2F14656566.4.2.243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=12562315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsV2ltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=243-251&author=H.+Choiauthor=M.+J.+Morrell&title=Review+of+lamotrigine+and+its+clinical+applications+in+epilepsy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Review of lamotrigine and its clinical applications in epilepsy</span></div><div class="casAuthors">Choi, Hyunmi; Morrell, Martha J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">243-251</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  Lamotrigine is an anti-epileptic agent with broad efficacy.  Lamotrigine works at voltage-sensitive sodium channels, thereby stabilizing the neuronal membrane and inhibiting the release of excitatory neurotransmitters such as glutamate and aspartate.  Early preclin. animal studies indicate its broad-spectrum efficacy, which was later confirmed in clin. trials.  Multiple randomized, placebo-controlled and comparative trials demonstrate its efficacy against partial and secondarily generalized seizures.  Open-label trials show its efficacy against generalised seizures, esp. absence seizures of childhood absence epilepsy and generalised seizures of juvenile myoclonic epilepsy.  Lamotrigine has a wide clin. dose range and possesses favorable pharmacokinetic properties.  It has a good tolerability and safety profile, which enhance compliance.  Its small risk of serious skin rash should be weighed against its potential benefits when choosing lamotrigine on an individual basis.  Lamotrigine is an excellent therapeutic option in epilepsy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD70P_UpvzerVg90H21EOLACvtfcHk0lgH-fIRhlbN-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsV2ltL0%253D&md5=60f1b236f51d87332ca1de23e5b2bfe8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1517%2F14656566.4.2.243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.4.2.243%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DMorrell%26aufirst%3DM.%2BJ.%26atitle%3DReview%2520of%2520lamotrigine%2520and%2520its%2520clinical%2520applications%2520in%2520epilepsy%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2003%26volume%3D4%26spage%3D243%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Ambrosio, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-Da-Silva, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvalho, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvalho, A. P.</span><span> </span><span class="NLM_article-title">Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2002&pages=121-130&author=A.+F.+Ambrosioauthor=P.+Soares-Da-Silvaauthor=C.+M.+Carvalhoauthor=A.+P.+Carvalho&title=Mechanisms+of+action+of+carbamazepine+and+its+derivatives%2C+oxcarbazepine%2C+BIA+2-093%2C+and+BIA+2-024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmbrosio%26aufirst%3DA.%2BF.%26aulast%3DSoares-Da-Silva%26aufirst%3DP.%26aulast%3DCarvalho%26aufirst%3DC.%2BM.%26aulast%3DCarvalho%26aufirst%3DA.%2BP.%26atitle%3DMechanisms%2520of%2520action%2520of%2520carbamazepine%2520and%2520its%2520derivatives%252C%2520oxcarbazepine%252C%2520BIA%25202-093%252C%2520and%2520BIA%25202-024%26jtitle%3DNeurochem.%2520Res.%26date%3D2002%26volume%3D27%26spage%3D121%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Errington, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stohr, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lees, G.</span><span> </span><span class="NLM_article-title">The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=157-169&author=A.+C.+Erringtonauthor=T.+Stohrauthor=C.+Heersauthor=G.+Lees&title=The+investigational+anticonvulsant+lacosamide+selectively+enhances+slow+inactivation+of+voltage-gated+sodium+channels"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DErrington%26aufirst%3DA.%2BC.%26aulast%3DStohr%26aufirst%3DT.%26aulast%3DHeers%26aufirst%3DC.%26aulast%3DLees%26aufirst%3DG.%26atitle%3DThe%2520investigational%2520anticonvulsant%2520lacosamide%2520selectively%2520enhances%2520slow%2520inactivation%2520of%2520voltage-gated%2520sodium%2520channels%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D73%26spage%3D157%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Catterall, W. A.</span><span> </span><span class="NLM_article-title">Voltage-gated sodium channels at 60: Structure, function and pathophysiology</span> <span class="citation_source-journal">J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">590</span><span class="NLM_x">, </span> <span class="NLM_fpage">2577</span><span class="NLM_x">–</span> <span class="NLM_lpage">2589</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1113%2Fjphysiol.2011.224204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=22473783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFGrs7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=590&publication_year=2012&pages=2577-2589&author=W.+A.+Catterall&title=Voltage-gated+sodium+channels+at+60%3A+Structure%2C+function+and+pathophysiology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage-gated sodium channels at 60: Structure, function and pathophysiology</span></div><div class="casAuthors">Catterall, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">590</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2577-2589</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Voltage-gated sodium channels initiate action potentials in nerve, muscle and other excitable cells.  The sodium current that initiates the nerve action potential was discovered by Hodgkin and Huxley using the voltage clamp technique in their landmark series of papers in The Journal of Physiol. in 1952.  They described sodium selectivity, voltage-dependent activation and fast inactivation, and they developed a quant. model for action potential generation that has endured for many decades.  This article gives an overview of the legacy that has evolved from their work, including development of conceptual models of sodium channel function, discovery of the sodium channel protein, anal. of its structure and function, detn. of its structure at high resoln., definition of the mechanism and structural basis for drug block, and exploration of the role of the sodium channel as a target for disease mutations.  Structural models for sodium selectivity and conductance, voltage-dependent activation, fast inactivation and drug block are discussed.  A perspective for the future envisions new advances in understanding the structural basis for sodium channel function, the role of sodium channels in disease and the opportunity for discovery of novel therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlKg4VZCpUSLVg90H21EOLACvtfcHk0lgH-fIRhlbN-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFGrs7fP&md5=483245655ea96e64c6c84ca7b086eaaa</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1113%2Fjphysiol.2011.224204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252Fjphysiol.2011.224204%26sid%3Dliteratum%253Aachs%26aulast%3DCatterall%26aufirst%3DW.%2BA.%26atitle%3DVoltage-gated%2520sodium%2520channels%2520at%252060%253A%2520Structure%252C%2520function%2520and%2520pathophysiology%26jtitle%3DJ.%2520Physiol.%26date%3D2012%26volume%3D590%26spage%3D2577%26epage%3D2589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Payandeh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamal El-Din, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheuer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catterall, W. A.</span><span> </span><span class="NLM_article-title">Crystal structure of a voltage-gated sodium channel in two potentially inactivated states</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">486</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1038%2Fnature11077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=22678296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BC38Xot1Cnurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=486&publication_year=2012&pages=135-139&author=J.+Payandehauthor=T.+M.+Gamal+El-Dinauthor=T.+Scheuerauthor=N.+Zhengauthor=W.+A.+Catterall&title=Crystal+structure+of+a+voltage-gated+sodium+channel+in+two+potentially+inactivated+states"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of a voltage-gated sodium channel in two potentially inactivated states</span></div><div class="casAuthors">Payandeh, Jian; Gamal El-Din, Tamer M.; Scheuer, Todd; Zheng, Ning; Catterall, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">486</span>
        (<span class="NLM_cas:issue">7401</span>),
    <span class="NLM_cas:pages">135-139</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In excitable cells, voltage-gated sodium (NaV) channels activate to initiate action potentials and then undergo fast and slow inactivation processes that terminate their ionic conductance.  Inactivation is a hallmark of NaV channel function and is crit. for control of membrane excitability, but the structural basis for this process has remained elusive.  Here we report crystallog. snapshots of the wild-type NaVAb channel from Arcobacter butzleri captured in two potentially inactivated states at 3.2 Å resoln.  Compared to previous structures of NaVAb channels with cysteine mutations in the pore-lining S6 helixes, the S6 helixes and the intracellular activation gate have undergone significant rearrangements: one pair of S6 helixes has collapsed towards the central pore axis and the other S6 pair has moved outward to produce a striking dimer-of-dimers configuration.  An increase in global structural asymmetry is obsd. throughout our wild-type NaVAb models, reshaping the ion selectivity filter at the extracellular end of the pore, the central cavity and its residues that are analogous to the mammalian drug receptor site, and the lateral pore fenestrations.  The voltage-sensing domains have also shifted around the perimeter of the pore module in wild-type NaVAb, compared to the mutant channel, and local structural changes identify a conserved interaction network that connects distant mol. determinants involved in NaV channel gating and inactivation.  These potential inactivated-state structures provide new insights into NaV channel gating and novel avenues to drug development and therapy for a range of debilitating NaV channelopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk0RF98ffBHLVg90H21EOLACvtfcHk0lj2AeJMXSgTCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xot1Cnurc%253D&md5=2cbb80a554fac794c973e6f9097c878d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature11077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11077%26sid%3Dliteratum%253Aachs%26aulast%3DPayandeh%26aufirst%3DJ.%26aulast%3DGamal%2BEl-Din%26aufirst%3DT.%2BM.%26aulast%3DScheuer%26aufirst%3DT.%26aulast%3DZheng%26aufirst%3DN.%26aulast%3DCatterall%26aufirst%3DW.%2BA.%26atitle%3DCrystal%2520structure%2520of%2520a%2520voltage-gated%2520sodium%2520channel%2520in%2520two%2520potentially%2520inactivated%2520states%26jtitle%3DNature%26date%3D2012%26volume%3D486%26spage%3D135%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Payandeh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheuer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catterall, W. A.</span><span> </span><span class="NLM_article-title">The crystal structure of a voltage-gated sodium channel</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">475</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1038%2Fnature10238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=21743477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1OmsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=475&publication_year=2011&pages=353-358&author=J.+Payandehauthor=T.+Scheuerauthor=N.+Zhengauthor=W.+A.+Catterall&title=The+crystal+structure+of+a+voltage-gated+sodium+channel"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The crystal structure of a voltage-gated sodium channel</span></div><div class="casAuthors">Payandeh, Jian; Scheuer, Todd; Zheng, Ning; Catterall, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">475</span>
        (<span class="NLM_cas:issue">7356</span>),
    <span class="NLM_cas:pages">353-358</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Voltage-gated sodium (NaV) channels initiate elec. signalling in excitable cells and are the mol. targets for drugs and disease mutations, but the structural basis for their voltage-dependent activation, ion selectivity and drug block is unknown.  Here, we report the crystal structure of a voltage-gated Na+ channel from Arcobacter butzleri (NavAb) captured in a closed-pore conformation with four activated voltage sensors at 2.7 Å resoln.  The arginine gating charges make multiple hydrophilic interactions within the voltage sensor, including unanticipated hydrogen bonds to the protein backbone.  Comparisons to previous open-pore potassium channel structures indicate that the voltage-sensor domains and the S4-S5 linkers dilate the central pore by pivoting together around a hinge at the base of the pore module.  The NavAb selectivity filter is short, ∼4.6 Å wide, and water filled, with four acidic side chains surrounding the narrowest part of the ion conduction pathway.  This unique structure presents a high-field-strength anionic coordination site, which confers Na+ selectivity through partial dehydration via direct interaction with glutamate side chains.  Fenestrations in the sides of the pore module are unexpectedly penetrated by fatty acyl chains that extend into the central cavity, and these portals are large enough for the entry of small, hydrophobic pore-blocking drugs.  This structure provides the template for understanding elec. signalling in excitable cells and the actions of drugs used for pain, epilepsy and cardiac arrhythmia at the at. level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWTPZUI8wqg7Vg90H21EOLACvtfcHk0lj2AeJMXSgTCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1OmsLs%253D&md5=b24b729f516809e422a526b9b7727ee7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature10238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10238%26sid%3Dliteratum%253Aachs%26aulast%3DPayandeh%26aufirst%3DJ.%26aulast%3DScheuer%26aufirst%3DT.%26aulast%3DZheng%26aufirst%3DN.%26aulast%3DCatterall%26aufirst%3DW.%2BA.%26atitle%3DThe%2520crystal%2520structure%2520of%2520a%2520voltage-gated%2520sodium%2520channel%26jtitle%3DNature%26date%3D2011%26volume%3D475%26spage%3D353%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Ulbricht, W.</span><span> </span><span class="NLM_article-title">Sodium channel inactivation: Molecular determinants and modulation</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">1271</span><span class="NLM_x">–</span> <span class="NLM_lpage">1301</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2005&pages=1271-1301&author=W.+Ulbricht&title=Sodium+channel+inactivation%3A+Molecular+determinants+and+modulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUlbricht%26aufirst%3DW.%26atitle%3DSodium%2520channel%2520inactivation%253A%2520Molecular%2520determinants%2520and%2520modulation%26jtitle%3DPhysiol.%2520Rev.%26date%3D2005%26volume%3D85%26spage%3D1271%26epage%3D1301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Lai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span> </span><span class="NLM_article-title">The role of voltage-gated sodium channels in neuropathic pain</span> <span class="citation_source-journal">Curr. Opin. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=291-297&author=J.+Laiauthor=J.+C.+Hunterauthor=F.+Porreca&title=The+role+of+voltage-gated+sodium+channels+in+neuropathic+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DJ.%26aulast%3DHunter%26aufirst%3DJ.%2BC.%26aulast%3DPorreca%26aufirst%3DF.%26atitle%3DThe%2520role%2520of%2520voltage-gated%2520sodium%2520channels%2520in%2520neuropathic%2520pain%26jtitle%3DCurr.%2520Opin.%2520Neurobiol.%26date%3D2003%26volume%3D13%26spage%3D291%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Wood, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boorman, J.</span><span> </span><span class="NLM_article-title">Voltage-gated sodium channel blockers; target validation and therapeutic potential</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">529</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.2174%2F1568026054367584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=16022675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsVKltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=529-537&author=J.+N.+Woodauthor=J.+Boorman&title=Voltage-gated+sodium+channel+blockers%3B+target+validation+and+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage-gated sodium channel blockers; target validation and therapeutic potential</span></div><div class="casAuthors">Wood, John N.; Boorman, James</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">529-537</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Voltage-gated sodium channels are encoded by a family of 10 structurally-related genes that are expressed in spatially and temporally distinct patterns, mainly in excitable tissues.  They underlie elec. signalling in nerve and muscle.  It has long been known that sodium channel blockers are anesthetics as well as powerful analgesics when delivered at low concns.  In addn., cardiac arrhythmias and epileptic activity can be treated with sodium channel blockers.  As we have learned more about the subtypes of sodium channels and their distribution, new therapeutic opportunities have suggested themselves.  There are indications that sodium channel blockers may also be useful in affective disorders and schizophrenia.  The prodn. of tissue-specific and eventually inducible knock out mice as well as genetic studies has proved useful in understanding the specialized role of individual types of sodium channels.  The development of subtype-specific blockers has proved slower than anticipated, although the properties of naturally occurring toxin blockers suggest that subtype-specific blockers of sodium channels could be very useful clin. in the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro0_4sFMQybrVg90H21EOLACvtfcHk0lj2AeJMXSgTCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsVKltro%253D&md5=1ed688405bc9f975b23d61fc2ada387c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F1568026054367584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054367584%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DJ.%2BN.%26aulast%3DBoorman%26aufirst%3DJ.%26atitle%3DVoltage-gated%2520sodium%2520channel%2520blockers%253B%2520target%2520validation%2520and%2520therapeutic%2520potential%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D529%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Costigan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolf, C. J.</span><span> </span><span class="NLM_article-title">Neuropathic pain: A maladaptive response of the nervous system to damage</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1146%2Fannurev.neuro.051508.135531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=19400724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsV2nur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2009&pages=1-32&author=M.+Costiganauthor=J.+Scholzauthor=C.+J.+Woolf&title=Neuropathic+pain%3A+A+maladaptive+response+of+the+nervous+system+to+damage"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropathic pain: a maladaptive response of the nervous system to damage</span></div><div class="casAuthors">Costigan, Michael; Scholz, Joachim; Woolf, Clifford J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-32</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Neuropathic pain is triggered by lesions to the somatosensory nervous system that alter its structure and function so that pain occurs spontaneously and responses to noxious and innocuous stimuli are pathol. amplified.  The pain is an expression of maladaptive plasticity within the nociceptive system, a series of changes that constitute a neural disease state.  Multiple alterations distributed widely across the nervous system contribute to complex pain phenotypes.  These alterations include ectopic generation of action potentials, facilitation and disinhibition of synaptic transmission, loss of synaptic connectivity and formation of new synaptic circuits, and neuroimmune interactions.  Although neural lesions are necessary, they are not sufficient to generate neuropathic pain; genetic polymorphisms, gender, and age all influence the risk of developing persistent pain.  Treatment needs to move from merely suppressing symptoms to a disease-modifying strategy aimed at both preventing maladaptive plasticity and reducing intrinsic risk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodJvh-ROUpD7Vg90H21EOLACvtfcHk0lgMbYwFlQnEVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsV2nur8%253D&md5=7869abfea9d20587dd6894eba3669cd2</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.051508.135531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.051508.135531%26sid%3Dliteratum%253Aachs%26aulast%3DCostigan%26aufirst%3DM.%26aulast%3DScholz%26aufirst%3DJ.%26aulast%3DWoolf%26aufirst%3DC.%2BJ.%26atitle%3DNeuropathic%2520pain%253A%2520A%2520maladaptive%2520response%2520of%2520the%2520nervous%2520system%2520to%2520damage%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D2009%26volume%3D32%26spage%3D1%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Dib-Hajj, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waxman, S. G.</span><span> </span><span class="NLM_article-title">Voltage-gated sodium channels: Therapeutic targets for pain</span> <span class="citation_source-journal">Pain Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1260</span><span class="NLM_x">–</span> <span class="NLM_lpage">1269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1111%2Fj.1526-4637.2009.00719.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=19818036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A280%3ADC%252BD1MnosVGguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=1260-1269&author=S.+D.+Dib-Hajjauthor=J.+A.+Blackauthor=S.+G.+Waxman&title=Voltage-gated+sodium+channels%3A+Therapeutic+targets+for+pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage-gated sodium channels: therapeutic targets for pain</span></div><div class="casAuthors">Dib-Hajj Sulayman D; Black Joel A; Waxman Stephen G</div><div class="citationInfo"><span class="NLM_cas:title">Pain medicine (Malden, Mass.)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1260-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To provide an overview of the role of voltage-gated sodium channels in pathophysiology of acquired and inherited pain states, and of recent developments that validate these channels as therapeutic targets for treating chronic pain.  BACKGROUND:  Neuropathic and inflammatory pain conditions are major medical needs worldwide with only partial or low efficacy treatment options currently available.  An important role of voltage-gated sodium channels in many different pain states has been established in animal models and, empirically, in humans, where sodium channel blockers partially ameliorate pain.  Animal studies have causally linked changes in sodium channel expression and modulation that alter channel gating properties or current density in nociceptor neurons to different pain states.  Biophysical and pharmacological studies have identified the sodium channel isoforms Na(v)1.3, Na(v)1.7, Na(v)1.8, and Na(v)1.9 as particularly important in the pathophysiology of different pain syndromes.  Recently, gain-of-function mutations in SCN9A, the gene which encodes Na(v)1.7, have been linked to two human-inherited pain syndromes, inherited erythromelalgia and paroxysmal extreme pain disorder, while loss-of-function mutations in SCN9A have been linked to complete insensitivity to pain.  Studies on firing properties of sensory neurons of dorsal root ganglia demonstrate that the effects of gain-of-function mutations in Na(v)1.7 on the excitability of these neurons depend on the presence of Na(v)1.8, which suggests a similar physiological interaction of these two channels in humans carrying the Na(v)1.7 pain mutation.  CONCLUSIONS:  These studies suggest that isoform-specific blockers of these channels or targeting of their modulators may provide novel approaches to treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS28A9K4ifO7potVjB3IRIyfW6udTcc2eZQqPPBdvL6Rrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MnosVGguw%253D%253D&md5=9c25c528ab8a56e4132a85969196f372</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1111%2Fj.1526-4637.2009.00719.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1526-4637.2009.00719.x%26sid%3Dliteratum%253Aachs%26aulast%3DDib-Hajj%26aufirst%3DS.%2BD.%26aulast%3DBlack%26aufirst%3DJ.%2BA.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DVoltage-gated%2520sodium%2520channels%253A%2520Therapeutic%2520targets%2520for%2520pain%26jtitle%3DPain%2520Med.%26date%3D2009%26volume%3D10%26spage%3D1260%26epage%3D1269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Theile, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummins, T. R.</span><span> </span><span class="NLM_article-title">Recent developments regarding voltage-gated sodium channel blockers for the treatment of inherited and acquired neuropathic pain syndromes</span> <span class="citation_source-journal">Front. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.3389%2Ffphar.2011.00054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BC38Xis1ahsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=54&author=J.+W.+Theileauthor=T.+R.+Cummins&title=Recent+developments+regarding+voltage-gated+sodium+channel+blockers+for+the+treatment+of+inherited+and+acquired+neuropathic+pain+syndromes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments regarding voltage-gated sodium channel blockers for the treatment of inherited and acquired neuropathic pain syndromes</span></div><div class="casAuthors">Theile, Jonathan W.; Cummins, Theodore R.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology of Ion Channels and Channelopathies</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">Oct.</span>),
    <span class="NLM_cas:pages">54</span>CODEN:
                <span class="NLM_cas:coden">FPICA4</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  Chronic and neuropathic pain constitute significant health problems affecting millions of individuals each year.  Pain sensations typically originate in sensory neurons of the peripheral nervous system which relay information to the central nervous system (CNS).  Pathol. pain sensations can arise as result of changes in excitability of these peripheral sensory neurons.  Voltage-gated sodium channels are key determinants regulating action potential generation and propagation; thus, changes in sodium channel function can have profound effects on neuronal excitability and pain signaling.  At present, most of the clin. available sodium channel blockers used to treat pain are non-selective across sodium channel isoforms and can contribute to cardio-toxicity, motor impairments, and CNS side effects.  Numerous strides have been made over the last decade in an effort to develop more selective and efficacious sodium channel blockers to treat pain.  The purpose of this review is to highlight some of the more recent developments put forth by research universities and pharmaceutical companies alike in the pursuit of developing more targeted sodium channel therapies for the treatment of a variety of neuropathic pain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXOR22u6_qp7Vg90H21EOLACvtfcHk0lgMbYwFlQnEVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xis1ahsQ%253D%253D&md5=5bdb937ce99cf54a253439f9bf03861b</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2011.00054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2011.00054%26sid%3Dliteratum%253Aachs%26aulast%3DTheile%26aufirst%3DJ.%2BW.%26aulast%3DCummins%26aufirst%3DT.%2BR.%26atitle%3DRecent%2520developments%2520regarding%2520voltage-gated%2520sodium%2520channel%2520blockers%2520for%2520the%2520treatment%2520of%2520inherited%2520and%2520acquired%2520neuropathic%2520pain%2520syndromes%26jtitle%3DFront.%2520Pharmacol.%26date%3D2011%26volume%3D2%26spage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Zuliani, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costantino, G.</span><span> </span><span class="NLM_article-title">Sodium channel blockers for neuropathic pain</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">755</span><span class="NLM_x">–</span> <span class="NLM_lpage">779</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1517%2F13543771003774118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=20384535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFWqtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=755-779&author=V.+Zulianiauthor=M.+Rivaraauthor=M.+Fantiniauthor=G.+Costantino&title=Sodium+channel+blockers+for+neuropathic+pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Sodium channel blockers for neuropathic pain</span></div><div class="casAuthors">Zuliani, Valentina; Rivara, Mirko; Fantini, Marco; Costantino, Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">755-779</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The voltage-gated sodium channels (VGSCs) play a fundamental role in controlling cellular excitability and their abnormal activity is related to several pathol. processes, including cardiac arrhythmias, epilepsy, neurodegenerative diseases, spasticity, chronic and neuropathic pain.  In particular, neuropathic pain (e.g., postherpetic and trigeminal neuralgia, diabetic neuropathy and spinal cord injury) is a serious clin. problem that affects a high percentage of the world population.  Because an altered sodium channel isoform expression profile has been considered one reason for the changes in neuronal excitability, there is a continuous quest for new selective mols. targeting sodium channels for the treatment of chronic pain.  Areas covered in this review: PubMed, , SciFinder Scholar and were used as sources for this review and patents between 2007 and Sept. 2009 were taken into account for the sodium channel blockers mol. classes reviewed and discussed herein.What the reader will gain: The sodium channel blockers reported in this review have been categorized into different mol. classes on the basis of their wide structural diversity.  This classification, somewhat arbitrary, does not necessarily reflect the presence of pharmacophoric elements but offers a useful way to discuss and comment on structurally homogenous classes of chemotypes recently patented.  Take home message: The continuous discoveries in the field of sodium channel blockers, highlighted by the increasing nos. of patent applications published in the last few years and by the nos. of compds. currently in clin. development, underline the importance of this target for the treatment of neuropathic pain.  The great difficulty in the design of new selective and active structures, not obtained from old VGSC blockers that are often assocd. with high risk of adverse effects, is a strong challenge for medicinal chem. research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7kOVgiikYPrVg90H21EOLACvtfcHk0lgMbYwFlQnEVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFWqtrs%253D&md5=375ee344a170ee1418c2e4f65e3fa7d2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1517%2F13543771003774118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543771003774118%26sid%3Dliteratum%253Aachs%26aulast%3DZuliani%26aufirst%3DV.%26aulast%3DRivara%26aufirst%3DM.%26aulast%3DFantini%26aufirst%3DM.%26aulast%3DCostantino%26aufirst%3DG.%26atitle%3DSodium%2520channel%2520blockers%2520for%2520neuropathic%2520pain%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D755%26epage%3D779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Hoyt, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">London, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyvratt, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbadie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felix, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priest, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaczorowski, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, W. H.</span><span> </span><span class="NLM_article-title">Discovery of a novel class of benzazepinone Na<sub>v</sub>1.7 blockers: Potential treatments for neuropathic pain</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4630</span><span class="NLM_x">–</span> <span class="NLM_lpage">4634</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4630-4634&author=S.+B.+Hoytauthor=C.+Londonauthor=D.+Gorinauthor=M.+J.+Wyvrattauthor=M.+H.+Fisherauthor=C.+Abbadieauthor=J.+P.+Felixauthor=M.+L.+Garciaauthor=X.+Liauthor=K.+A.+Lyonsauthor=E.+McGowanauthor=D.+E.+MacIntyreauthor=W.+J.+Martinauthor=B.+T.+Priestauthor=A.+Ritterauthor=M.+M.+Smithauthor=V.+A.+Warrenauthor=B.+S.+Williamsauthor=G.+J.+Kaczorowskiauthor=W.+H.+Parsons&title=Discovery+of+a+novel+class+of+benzazepinone+Nav1.7+blockers%3A+Potential+treatments+for+neuropathic+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoyt%26aufirst%3DS.%2BB.%26aulast%3DLondon%26aufirst%3DC.%26aulast%3DGorin%26aufirst%3DD.%26aulast%3DWyvratt%26aufirst%3DM.%2BJ.%26aulast%3DFisher%26aufirst%3DM.%2BH.%26aulast%3DAbbadie%26aufirst%3DC.%26aulast%3DFelix%26aufirst%3DJ.%2BP.%26aulast%3DGarcia%26aufirst%3DM.%2BL.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DMcGowan%26aufirst%3DE.%26aulast%3DMacIntyre%26aufirst%3DD.%2BE.%26aulast%3DMartin%26aufirst%3DW.%2BJ.%26aulast%3DPriest%26aufirst%3DB.%2BT.%26aulast%3DRitter%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DM.%2BM.%26aulast%3DWarren%26aufirst%3DV.%2BA.%26aulast%3DWilliams%26aufirst%3DB.%2BS.%26aulast%3DKaczorowski%26aufirst%3DG.%2BJ.%26aulast%3DParsons%26aufirst%3DW.%2BH.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520class%2520of%2520benzazepinone%2520Nav1.7%2520blockers%253A%2520Potential%2520treatments%2520for%2520neuropathic%2520pain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4630%26epage%3D4634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Hoyt, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">London, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbadie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felix, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jochnowitz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karanam, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priest, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas-Fowlkes, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaczorowski, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffy, J. L.</span><span> </span><span class="NLM_article-title">A novel benzazepinone sodium channel blocker with oral efficacy in a rat model of neuropathic pain</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3640</span><span class="NLM_x">–</span> <span class="NLM_lpage">3645</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=3640-3645&author=S.+B.+Hoytauthor=C.+Londonauthor=C.+Abbadieauthor=J.+P.+Felixauthor=M.+L.+Garciaauthor=N.+Jochnowitzauthor=B.+V.+Karanamauthor=X.+Liauthor=K.+A.+Lyonsauthor=E.+McGowanauthor=B.+T.+Priestauthor=M.+M.+Smithauthor=V.+A.+Warrenauthor=B.+S.+Thomas-Fowlkesauthor=G.+J.+Kaczorowskiauthor=J.+L.+Duffy&title=A+novel+benzazepinone+sodium+channel+blocker+with+oral+efficacy+in+a+rat+model+of+neuropathic+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoyt%26aufirst%3DS.%2BB.%26aulast%3DLondon%26aufirst%3DC.%26aulast%3DAbbadie%26aufirst%3DC.%26aulast%3DFelix%26aufirst%3DJ.%2BP.%26aulast%3DGarcia%26aufirst%3DM.%2BL.%26aulast%3DJochnowitz%26aufirst%3DN.%26aulast%3DKaranam%26aufirst%3DB.%2BV.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DMcGowan%26aufirst%3DE.%26aulast%3DPriest%26aufirst%3DB.%2BT.%26aulast%3DSmith%26aufirst%3DM.%2BM.%26aulast%3DWarren%26aufirst%3DV.%2BA.%26aulast%3DThomas-Fowlkes%26aufirst%3DB.%2BS.%26aulast%3DKaczorowski%26aufirst%3DG.%2BJ.%26aulast%3DDuffy%26aufirst%3DJ.%2BL.%26atitle%3DA%2520novel%2520benzazepinone%2520sodium%2520channel%2520blocker%2520with%2520oral%2520efficacy%2520in%2520a%2520rat%2520model%2520of%2520neuropathic%2520pain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D3640%26epage%3D3645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Waxman, S. G.</span><span> </span><span class="NLM_article-title">Mechanisms of disease: Sodium channels and neuroprotection in multiple sclerosis-current status</span> <span class="citation_source-journal">Nat. Clin. Pract. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1038%2Fncpneuro0735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=18227822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivVyjt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=159-169&author=S.+G.+Waxman&title=Mechanisms+of+disease%3A+Sodium+channels+and+neuroprotection+in+multiple+sclerosis-current+status"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of Disease: sodium channels and neuroprotection in multiple sclerosis-current status</span></div><div class="casAuthors">Waxman, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Clinical Practice Neurology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">159-169</span>CODEN:
                <span class="NLM_cas:coden">NCPND4</span>;
        ISSN:<span class="NLM_cas:issn">1745-834X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Axon degeneration is a major contributor to disability in multiple sclerosis, and sodium channels have been shown to have a crucial role in this process.  In this article, Waxman reviews the development of the concept of sodium channel blockers as neuroprotectants in multiple sclerosis, and discusses recent attempts to translate this approach from the lab. to the clinic.  Sodium channels can provide a route for a persistent influx of sodium ions into neurons.  Over the past decade, it has emerged that sustained sodium influx can, in turn, trigger calcium ion influx, which produces axonal injury in neuroinflammatory disorders such as multiple sclerosis (MS).  The development of sodium channel blockers as potential neuroprotectants in MS has proceeded rapidly, and two clin. trials are currently ongoing.  The route from the lab. to the clinic includes some complex turns, however, and a third trial was recently put on hold because of new data that suggested that sodium channel blockers might have multiple, complex actions.  This article reviews the development of the concept of sodium channel blockers as neuroprotectants in MS, the path from lab. to clinic, and the current status of research in this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzVatshdLc57Vg90H21EOLACvtfcHk0lgVk7AV4FKXiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivVyjt7c%253D&md5=79a934e9b60a4732a88f03054fdc1507</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fncpneuro0735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncpneuro0735%26sid%3Dliteratum%253Aachs%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DMechanisms%2520of%2520disease%253A%2520Sodium%2520channels%2520and%2520neuroprotection%2520in%2520multiple%2520sclerosis-current%2520status%26jtitle%3DNat.%2520Clin.%2520Pract.%2520Neurol.%26date%3D2008%26volume%3D4%26spage%3D159%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Mongin, A. A.</span><span> </span><span class="NLM_article-title">Disruption of ionic and cell volume homeostasis in cerebral ischemia: The perfect storm</span> <span class="citation_source-journal">Pathophysiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1016%2Fj.pathophys.2007.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=17961999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSnsrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=183-193&author=A.+A.+Mongin&title=Disruption+of+ionic+and+cell+volume+homeostasis+in+cerebral+ischemia%3A+The+perfect+storm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Disruption of ionic and cell volume homeostasis in cerebral ischemia: The perfect storm</span></div><div class="casAuthors">Mongin, Alexander A.</div><div class="citationInfo"><span class="NLM_cas:title">Pathophysiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">183-193</span>CODEN:
                <span class="NLM_cas:coden">PTHOE7</span>;
        ISSN:<span class="NLM_cas:issn">0928-4680</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The mechanisms of brain tissue damage in stroke are strongly linked to the phenomenon of excitotoxicity, which is defined as damage or death of neural cells due to excessive activation of receptors for the excitatory neurotransmitters glutamate and aspartate.  Under physiol. conditions, ionotropic glutamate receptors mediate the processes of excitatory neurotransmission and synaptic plasticity.  In ischemia, sustained pathol. release of glutamate from neurons and glial cells causes prolonged activation of these receptors, resulting in massive depolarization and cytoplasmic Ca2+ overload.  High cytoplasmic levels of Ca2+ activate many degradative processes that, depending on the metabolic status, cause immediate or delayed death of neural cells.  This traditional view has been expanded by a no. of observations that implicate Cl- channels and several types of non-channel transporter proteins, such as the Na+,K+,2Cl- cotransporter, Na+/H+ exchanger, and Na+/Ca2+ exchanger, in the development of glutamate toxicity.  Some of these ion transporters increase tissue damage by promoting pathol. cell swelling and necrotic cell death, while others contribute to a long-term accumulation of cytoplasmic Ca2+.  This brief review is aimed at illustrating how the dysregulation of various ion transport processes combine in a perfect storm' that disrupts neural ionic homeostasis and culminates in the irreversible damage and death of neural cells.  The clin. relevance of individual transporters as targets for therapeutic intervention in stroke is also briefly discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1-1rnjhWuULVg90H21EOLACvtfcHk0lgVk7AV4FKXiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSnsrbO&md5=2c7d2872b7f9996a4041b0504dd39a57</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.pathophys.2007.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pathophys.2007.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DMongin%26aufirst%3DA.%2BA.%26atitle%3DDisruption%2520of%2520ionic%2520and%2520cell%2520volume%2520homeostasis%2520in%2520cerebral%2520ischemia%253A%2520The%2520perfect%2520storm%26jtitle%3DPathophysiology%26date%3D2007%26volume%3D14%26spage%3D183%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Stankowski, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, R.</span><span> </span><span class="NLM_article-title">Therapeutic targets for neuroprotection in acute ischemic stroke: Lost in translation?</span> <span class="citation_source-journal">Antioxid. Redox Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1841</span><span class="NLM_x">–</span> <span class="NLM_lpage">1851</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1089%2Fars.2010.3292" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=20626319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVSqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=1841-1851&author=J.+N.+Stankowskiauthor=R.+Gupta&title=Therapeutic+targets+for+neuroprotection+in+acute+ischemic+stroke%3A+Lost+in+translation%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Targets for Neuroprotection in Acute Ischemic Stroke: Lost in Translation?</span></div><div class="casAuthors">Stankowski, Jeannette N.; Gupta, Rishi</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1841-1851</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  The development of a suitable neuroprotective agent to treat ischemic stroke has failed when transitioned to the clin. setting.  An understanding of the mol. mechanisms involved in neuronal injury during ischemic stroke is important, but must be placed in the clin. context.  Current therapeutic targets have focused on the preservation of the ischemic penumbra in the hope of improving clin. outcomes.  Unfortunately, most patients in the ultra-early time windows harbor penumbra but have tremendous variability in the size of the core infarct, the ultimate predictor of prognosis.  Understanding this variability may allow for proper patient selection that may better correlate to bench models.  Reperfusion therapies are rapidly evolving and have been shown to improve clin. outcomes.  The use of neuroprotective agents to prolong time windows prior to reperfusion or to prevent reperfusion injury may present future therapeutic targets for the treatment of ischemic stroke.  We review the mol. pathways and the clin. context from which future targets may be identified.  Antioxid. Redox Signal. 14, 1841-1851.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuCxAoHY0FY7Vg90H21EOLACvtfcHk0lj3Pgxgm-N9Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVSqsrk%253D&md5=d73db001d0ca7c944d11e0f086724acf</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1089%2Fars.2010.3292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2010.3292%26sid%3Dliteratum%253Aachs%26aulast%3DStankowski%26aufirst%3DJ.%2BN.%26aulast%3DGupta%26aufirst%3DR.%26atitle%3DTherapeutic%2520targets%2520for%2520neuroprotection%2520in%2520acute%2520ischemic%2520stroke%253A%2520Lost%2520in%2520translation%253F%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2011%26volume%3D14%26spage%3D1841%26epage%3D1851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Crumrine, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrand, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faison, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, B. R.</span><span> </span><span class="NLM_article-title">Lamotrigine protects hippocampal CA1 neurons from ischemic damage after cardiac arrest</span> <span class="citation_source-journal">Stroke</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">2230</span><span class="NLM_x">–</span> <span class="NLM_lpage">2236</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1997&pages=2230-2236&author=R.+C.+Crumrineauthor=K.+Bergstrandauthor=A.+T.+Cooperauthor=W.+L.+Faisonauthor=B.+R.+Cooper&title=Lamotrigine+protects+hippocampal+CA1+neurons+from+ischemic+damage+after+cardiac+arrest"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrumrine%26aufirst%3DR.%2BC.%26aulast%3DBergstrand%26aufirst%3DK.%26aulast%3DCooper%26aufirst%3DA.%2BT.%26aulast%3DFaison%26aufirst%3DW.%2BL.%26aulast%3DCooper%26aufirst%3DB.%2BR.%26atitle%3DLamotrigine%2520protects%2520hippocampal%2520CA1%2520neurons%2520from%2520ischemic%2520damage%2520after%2520cardiac%2520arrest%26jtitle%3DStroke%26date%3D1997%26volume%3D28%26spage%3D2230%26epage%3D2236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Fujitani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kataoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, T.</span><span> </span><span class="NLM_article-title">Lidocaine protects hippocampal neurons against ischemic damage by preventing increase of extracellular excitatory amino acids: A microdialysis study in Mongolian gerbils</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=1994&pages=91-94&author=T.+Fujitaniauthor=N.+Adachiauthor=H.+Miyazakiauthor=K.+Liuauthor=Y.+Nakamuraauthor=K.+Kataokaauthor=T.+Arai&title=Lidocaine+protects+hippocampal+neurons+against+ischemic+damage+by+preventing+increase+of+extracellular+excitatory+amino+acids%3A+A+microdialysis+study+in+Mongolian+gerbils"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFujitani%26aufirst%3DT.%26aulast%3DAdachi%26aufirst%3DN.%26aulast%3DMiyazaki%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DKataoka%26aufirst%3DK.%26aulast%3DArai%26aufirst%3DT.%26atitle%3DLidocaine%2520protects%2520hippocampal%2520neurons%2520against%2520ischemic%2520damage%2520by%2520preventing%2520increase%2520of%2520extracellular%2520excitatory%2520amino%2520acids%253A%2520A%2520microdialysis%2520study%2520in%2520Mongolian%2520gerbils%26jtitle%3DNeurosci.%2520Lett.%26date%3D1994%26volume%3D179%26spage%3D91%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Graham, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, R. P.</span><span> </span><span class="NLM_article-title">Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">854</span><span class="NLM_x">–</span> <span class="NLM_lpage">859</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=7910213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADyaK2cXkt1KmtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=854-859&author=S.+H.+Grahamauthor=J.+Chenauthor=J.+Lanauthor=M.+J.+Leachauthor=R.+P.+Simon&title=Neuroprotective+effects+of+a+use-dependent+blocker+of+voltage-dependent+sodium+channels%2C+BW619C89%2C+in+rat+middle+cerebral+artery+occlusion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion</span></div><div class="casAuthors">Graham, Steven H.; Chen, Jun; Lan, Jingquan; Leach, Michael J.; Simon, Roger P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">269</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">854-9</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">BW619C89 [4-amino-2-(4-methyl-1-piperazinyl)-5-(2,3,5-trichlorophenyl)pyrimidine] is a use-dependent blocker of voltage-dependent sodium channels that blocks veratrine-induced glutamate release in vitro.  The aim of this study is to det. if BW619C89 inhibits glutamate release and is neuroprotective in cerebral ischemia produced by proximal middle cerebral artery (MCA) occlusion in rats.  Infarct vol. was detd. at 24 h after permanent MCA occlusion from 2,3,5-triphenyltetrazolim hydrochloride-stained sections.  Pretreatment with BW619C89 (10, 20, 30 and 50 mg/kg i.v. of mesylate salt) decreased infarct vol. in a dose-dependent fashion maximal at 30 mg/kg compared to saline controls.  Treatment with 30 mg/kg up to 45 min after MCA occlusion also was effective.  Microdialyzate glutamate in rats treated with 30 mg/kg of drug before MCA occlusion was decreased in both caudate (ischemic core) and rostral cortex (penumbra) compared to controls.  BW619C89 did not induce significant arterial hypotension, except when it was administered by rapid bolus administration.  In this case, the hypotension was transient and did not reduce efficacy or superficial cortical blood flow.  BW619C89 did not induce the 72 kDa heat shock protein in cingulate gyrus or retrospleniald cortex as did MK801, suggesting that BW619C89 does not injure neurons in these regions as do N-methyl-D-aspartate antagonists.  These results suggest that inhibition of glutamate release by BW619C89 may be an effective and nontoxic treatment for stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAYi7iB3fv5rVg90H21EOLACvtfcHk0lj3Pgxgm-N9Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkt1KmtL0%253D&md5=d98f5ba882a388e8ccf1b54e79ee91d8</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGraham%26aufirst%3DS.%2BH.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DLeach%26aufirst%3DM.%2BJ.%26aulast%3DSimon%26aufirst%3DR.%2BP.%26atitle%3DNeuroprotective%2520effects%2520of%2520a%2520use-dependent%2520blocker%2520of%2520voltage-dependent%2520sodium%2520channels%252C%2520BW619C89%252C%2520in%2520rat%2520middle%2520cerebral%2520artery%2520occlusion%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1994%26volume%3D269%26spage%3D854%26epage%3D859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Lekieffre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meldrum, B. S.</span><span> </span><span class="NLM_article-title">The pyrimidine-derivative, BW1003C87, protects CA1 and striatal neurons following transient severe forebrain ischaemia in rats. A microdialysis and histological study</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1993&pages=93-99&author=D.+Lekieffreauthor=B.+S.+Meldrum&title=The+pyrimidine-derivative%2C+BW1003C87%2C+protects+CA1+and+striatal+neurons+following+transient+severe+forebrain+ischaemia+in+rats.+A+microdialysis+and+histological+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLekieffre%26aufirst%3DD.%26aulast%3DMeldrum%26aufirst%3DB.%2BS.%26atitle%3DThe%2520pyrimidine-derivative%252C%2520BW1003C87%252C%2520protects%2520CA1%2520and%2520striatal%2520neurons%2520following%2520transient%2520severe%2520forebrain%2520ischaemia%2520in%2520rats.%2520A%2520microdialysis%2520and%2520histological%2520study%26jtitle%3DNeuroscience%26date%3D1993%26volume%3D56%26spage%3D93%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Cheng, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Khoury, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zivin, J. A.</span><span> </span><span class="NLM_article-title">Neuroprotection for ischemic stroke: Two decades of success and failure</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=36-45&author=Y.+D.+Chengauthor=L.+Al-Khouryauthor=J.+A.+Zivin&title=Neuroprotection+for+ischemic+stroke%3A+Two+decades+of+success+and+failure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%2BD.%26aulast%3DAl-Khoury%26aufirst%3DL.%26aulast%3DZivin%26aufirst%3DJ.%2BA.%26atitle%3DNeuroprotection%2520for%2520ischemic%2520stroke%253A%2520Two%2520decades%2520of%2520success%2520and%2520failure%26jtitle%3DNeuroRx%26date%3D2004%26volume%3D1%26spage%3D36%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Onteniente, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasika, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benchoua, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guegan, C.</span><span> </span><span class="NLM_article-title">Molecular pathways in cerebral ischemia: Cues to novel therapeutic strategies</span> <span class="citation_source-journal">Mol. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1385%2FMN%3A27%3A1%3A33" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=12668901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtl2gtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2003&pages=33-72&author=B.+Ontenienteauthor=S.+Rasikaauthor=A.+Benchouaauthor=C.+Guegan&title=Molecular+pathways+in+cerebral+ischemia%3A+Cues+to+novel+therapeutic+strategies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular pathways in cerebral ischemia: Cues to novel therapeutic strategies</span></div><div class="casAuthors">Onteniente, Brigitte; Rasika, Sowmyalakshmi; Benchoua, Alexandra; Guegan, Christelle</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-72</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review with refs.  Stroke is one of the leading causes of death and severe disability in most industrialized countries.  Despite the extensive research efforts of both academic and industrial labs. during the last few decades, no changes have been brought about by the design of neuroprotective therapies.  The progressive decrease of stroke-induced death and disability is entirely attributable to improvements in the identification and redn. of risk factors.  Over the past few years, exptl. research has led to the emergence of a wealth of information regarding the complex and interrelated processes of neuronal degeneration and death triggered by ischemia.  This unprecedented insight has led to new theories on the mechanisms of ischemic damage, and has suggested new targets and strategies for therapeutic intervention designed to reduce the clin. consequences of stroke.  Among current developments, three strategies seem particularly appealing-namely, the limitation of initial or secondary neuronal death by inhibition of apoptotic mechanisms, the enhancement of the endogenous capacity of nervous structures to restore lost function, and the replacement of lost cells by transplantation therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGormEwCCnRR3bVg90H21EOLACvtfcHk0ljnM5aec3vAGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtl2gtb0%253D&md5=b3561d41a729509ca59a53d7438f5ad4</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1385%2FMN%3A27%3A1%3A33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FMN%253A27%253A1%253A33%26sid%3Dliteratum%253Aachs%26aulast%3DOnteniente%26aufirst%3DB.%26aulast%3DRasika%26aufirst%3DS.%26aulast%3DBenchoua%26aufirst%3DA.%26aulast%3DGuegan%26aufirst%3DC.%26atitle%3DMolecular%2520pathways%2520in%2520cerebral%2520ischemia%253A%2520Cues%2520to%2520novel%2520therapeutic%2520strategies%26jtitle%3DMol.%2520Neurobiol.%26date%3D2003%26volume%3D27%26spage%3D33%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Kapoor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altmann, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chataway, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. H.</span><span> </span><span class="NLM_article-title">Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: A randomised, double-blind, placebo-controlled, parallel-group trial</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">681</span><span class="NLM_x">–</span> <span class="NLM_lpage">688</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1016%2FS1474-4422%2810%2970131-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=20621711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsFajur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=681-688&author=R.+Kapoorauthor=J.+Furbyauthor=T.+Haytonauthor=K.+J.+Smithauthor=D.+R.+Altmannauthor=R.+Brennerauthor=J.+Chatawayauthor=R.+A.+Hughesauthor=D.+H.+Miller&title=Lamotrigine+for+neuroprotection+in+secondary+progressive+multiple+sclerosis%3A+A+randomised%2C+double-blind%2C+placebo-controlled%2C+parallel-group+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial</span></div><div class="casAuthors">Kapoor, Raju; Furby, Julian; Hayton, Thomas; Smith, Kenneth J.; Altmann, Daniel R.; Brenner, Robert; Chataway, Jeremy; Hughes, Richard A. C.; Miller, David H.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">681-688</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Partial blockade of voltage-gated sodium channels is neuroprotective in exptl. models of inflammatory demyelinating disease.  In this phase 2 trial, we aimed to assess whether the sodium-channel blocker lamotrigine is also neuroprotective in patients with secondary progressive multiple sclerosis.  Patients with secondary progressive multiple sclerosis who attended the National Hospital for Neurol. and Neurosurgery or the Royal Free Hospital, London, UK, were eligible for inclusion in this double-blind, parallel-group trial.  Patients were randomly assigned via a website by minimisation to receive lamotrigine (target dose 400 mg/day) or placebo for 2 years.  Treating physicians, evaluating physicians, and patients were masked to treatment allocation.  The primary outcome was the rate of change of partial (central) cerebral vol. over 24 mo.  All patients who were randomly assigned were included in the primary anal.  This trial is registered with ClinicalTrials.gov, NCT00257855.  120 patients were randomly assigned to treatment (87 women and 33 men): 61 to lamotrigine and 59 to placebo.  108 Patients were analyzed for the primary endpoint: 52 in the lamotrigine group and 56 in the placebo group.  The mean change in partial (central) cerebral vol. per yr was -3.18 mL (SD -1.25) in the lamotrigine group and -2.48 mL (-0.97) in the placebo group (difference -0.71 mL, 95% CI -2.56 to 1.15; p = 0.40).  However, in an exploratory modeling anal., lamotrigine treatment seemed to be assocd. with greater partial (central) cerebral vol. loss than was placebo in the first year (p = 0.04), and vol. increased partially after treatment stopped (p = 0.04).  Lamotrigine treatment reduced the deterioration of the timed 25-ft walk (p = 0.02) but did not affect other secondary clin. outcome measures.  Rash and dose-related deterioration of gait and balance were experienced more by patients in the lamotrigine group than the placebo group.  The effect of lamotrigine on cerebral vol. of patients with secondary progressive multiple sclerosis did not differ from that of placebo over 24 mo, but lamotrigine seemed to cause early vol. loss that reversed partially on discontinuation of treatment.  Future trials of neuroprotection in multiple sclerosis should include investigation of complex early vol. changes in different compartments of the CNS, effects unrelated to neurodegeneration, and targeting of earlier and more inflammatory disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4qviTFXv17bVg90H21EOLACvtfcHk0ljnM5aec3vAGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsFajur4%253D&md5=eb768255a842df2b97899df819f34b5c</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2810%2970131-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252810%252970131-9%26sid%3Dliteratum%253Aachs%26aulast%3DKapoor%26aufirst%3DR.%26aulast%3DFurby%26aufirst%3DJ.%26aulast%3DHayton%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DAltmann%26aufirst%3DD.%2BR.%26aulast%3DBrenner%26aufirst%3DR.%26aulast%3DChataway%26aufirst%3DJ.%26aulast%3DHughes%26aufirst%3DR.%2BA.%26aulast%3DMiller%26aufirst%3DD.%2BH.%26atitle%3DLamotrigine%2520for%2520neuroprotection%2520in%2520secondary%2520progressive%2520multiple%2520sclerosis%253A%2520A%2520randomised%252C%2520double-blind%252C%2520placebo-controlled%252C%2520parallel-group%2520trial%26jtitle%3DLancet%2520Neurol.%26date%3D2010%26volume%3D9%26spage%3D681%26epage%3D688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Van der Walt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butzkueven, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolbe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marriott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexandrou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gresle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilpatrick, T.</span><span> </span><span class="NLM_article-title">Neuroprotection in multiple sclerosis: A therapeutic challenge for the next decade</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">82</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1016%2Fj.pharmthera.2010.01.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=20122960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjt1KgsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2010&pages=82-93&author=A.+Van+der+Waltauthor=H.+Butzkuevenauthor=S.+Kolbeauthor=M.+Marriottauthor=E.+Alexandrouauthor=M.+Gresleauthor=G.+Eganauthor=T.+Kilpatrick&title=Neuroprotection+in+multiple+sclerosis%3A+A+therapeutic+challenge+for+the+next+decade"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotection in multiple sclerosis: A therapeutic challenge for the next decade</span></div><div class="casAuthors">Van der Walt, Anneke; Butzkueven, Helmut; Kolbe, Scott; Marriott, Mark; Alexandrou, Estella; Gresle, Melissa; Egan, Gary; Kilpatrick, Trevor</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">82-93</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Multiple sclerosis (MS) is the commonest cause of progressive neurol. disability amongst young, Caucasian adults.  MS is considered to be an auto-immune disease that results from an attack against myelin, the layer which surrounds axons.  The pathophysiol. of MS is complex, with both demyelination and axonal degeneration contributing to what is essentially an inflammatory neurodegenerative disease.  Axonal loss is increasingly being accepted as the histopathol. correlate of neurol. disability.  Currently, the underpinnings of neurodegeneration in MS, and how to promote neuroprotection are only partly understood.  No established treatments that directly reduce nervous system damage or enhance its repair are currently available.  Moreover, the ability of currently available immunomodulatory therapies used to treat MS, such as interferon-β, to prevent long-term disability is uncertain.  Results from short-term randomized-controlled trials suggest a partial benefit with regards to disability outcomes, but this is yet to be established in long-term studies.  Novel neuroprotective agents have been identified in preclin. studies but their development is being hampered by the absence of appropriate clin. platforms to test them.  In this article, we will discuss some of the principal therapeutic candidates that could provide neuroprotection in MS and emerging methodologies by which to test them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof51fBmuweUbVg90H21EOLACvtfcHk0ljnM5aec3vAGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjt1KgsL4%253D&md5=306d97851cf31315df8ad0d4515ade97</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2010.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2010.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bder%2BWalt%26aufirst%3DA.%26aulast%3DButzkueven%26aufirst%3DH.%26aulast%3DKolbe%26aufirst%3DS.%26aulast%3DMarriott%26aufirst%3DM.%26aulast%3DAlexandrou%26aufirst%3DE.%26aulast%3DGresle%26aufirst%3DM.%26aulast%3DEgan%26aufirst%3DG.%26aulast%3DKilpatrick%26aufirst%3DT.%26atitle%3DNeuroprotection%2520in%2520multiple%2520sclerosis%253A%2520A%2520therapeutic%2520challenge%2520for%2520the%2520next%2520decade%26jtitle%3DPharmacol.%2520Ther.%26date%3D2010%26volume%3D126%26spage%3D82%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Yu, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catterall, W. A.</span><span> </span><span class="NLM_article-title">Overview of the voltage-gated sodium channel family</span> <span class="citation_source-journal">Genome Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1186%2Fgb-2003-4-3-207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=12620097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A280%3ADC%252BD3s7gvVWrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=207&author=F.+H.+Yuauthor=W.+A.+Catterall&title=Overview+of+the+voltage-gated+sodium+channel+family"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the voltage-gated sodium channel family</span></div><div class="casAuthors">Yu Frank H; Catterall William A</div><div class="citationInfo"><span class="NLM_cas:title">Genome biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">207</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Selective permeation of sodium ions through voltage-dependent sodium channels is fundamental to the generation of action potentials in excitable cells such as neurons.  These channels are large integral membrane proteins and are encoded by at least ten genes in mammals.  The different sodium channels have remarkably similar functional properties, but small changes in sodium-channel function are biologically relevant, as underscored by mutations that cause several human diseases of hyperexcitability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTuC-dT5iHA1skU0YCbOU3EfW6udTcc2eYk__-KpxMq1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s7gvVWrsw%253D%253D&md5=0c86fe051b76e03ccb9fe9f5d85cc35b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1186%2Fgb-2003-4-3-207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fgb-2003-4-3-207%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DF.%2BH.%26aulast%3DCatterall%26aufirst%3DW.%2BA.%26atitle%3DOverview%2520of%2520the%2520voltage-gated%2520sodium%2520channel%2520family%26jtitle%3DGenome%2520Biol.%26date%3D2003%26volume%3D4%26spage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Whitaker, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faull, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldvogel, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plumpton, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emson, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clare, J. J.</span><span> </span><span class="NLM_article-title">Comparative distribution of voltage-gated sodium channel proteins in human brain</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1016%2FS0169-328X%2800%2900289-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BD3MXisVWgsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2001&pages=37-53&author=W.+R.+Whitakerauthor=R.+L.+Faullauthor=H.+J.+Waldvogelauthor=C.+J.+Plumptonauthor=P.+C.+Emsonauthor=J.+J.+Clare&title=Comparative+distribution+of+voltage-gated+sodium+channel+proteins+in+human+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative distribution of voltage-gated sodium channel proteins in human brain</span></div><div class="casAuthors">Whitaker, W. R. J.; Faull, R. L. M.; Waldvogel, H. J.; Plumpton, C. J.; Emson, P. C.; Clare, J. J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">37-53</span>CODEN:
                <span class="NLM_cas:coden">MBREE4</span>;
        ISSN:<span class="NLM_cas:issn">0169-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Antisera directed against unique peptide regions from each of the human brain voltage-gated Na+ channel α subunits were generated.  In immunoblots, these were found to be highly specific for the corresponding recombinant polypeptides and to recognize the native holoprotein in human brain membrane prepns.  These antisera were used to perform a comparative immunohistochem. distribution anal. of all 4 brain Na+ channel subtypes in selected human CNS regions.  Distinct but heterogeneous distribution patterns were obsd. for each of the α subunits.  In general, these were complementary to that previously shown for the corresponding human mRNAs.  A high degree of conservation with respect to the distribution found in rat was also evident.  The human α subunit proteins exhibited distinct subcellular localization patterns.  Type I, III, and VI immunoreactivity was found predominantly in neuronal cell bodies and proximal processes, whereas type II was concd. along axons.  This was similar to rat brain and suggested that the different Na+ channel subtypes have distinct functions which are highly conserved between human and rodents.  A notable difference was that the type III protein was detected in all human brain regions examd., unlike in rat brain where its expression in adults was very restricted.  Also, in contrast to rat brain, the human type VI protein was not detected in axons of unmyelinated neurons.  These differences may reflect true species variations and could have important implications for understanding the function of the Na+ channel subtypes and their roles in human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou-pZXdakIcLVg90H21EOLACvtfcHk0lhI-Ts6h661XA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXisVWgsr8%253D&md5=e4929e3820b60dd8ebd83713f6d700d1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0169-328X%2800%2900289-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-328X%252800%252900289-8%26sid%3Dliteratum%253Aachs%26aulast%3DWhitaker%26aufirst%3DW.%2BR.%26aulast%3DFaull%26aufirst%3DR.%2BL.%26aulast%3DWaldvogel%26aufirst%3DH.%2BJ.%26aulast%3DPlumpton%26aufirst%3DC.%2BJ.%26aulast%3DEmson%26aufirst%3DP.%2BC.%26aulast%3DClare%26aufirst%3DJ.%2BJ.%26atitle%3DComparative%2520distribution%2520of%2520voltage-gated%2520sodium%2520channel%2520proteins%2520in%2520human%2520brain%26jtitle%3DBrain%2520Res.%26date%3D2001%26volume%3D88%26spage%3D37%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Kaplan, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullian, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isom, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levinson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barres, B. A.</span><span> </span><span class="NLM_article-title">Differential control of clustering of the sodium channels Na(v)1.2 and Na(v)1.6 at developing CNS nodes of Ranvier</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">119</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2001&pages=105-119&author=M.+R.+Kaplanauthor=M.+H.+Choauthor=E.+M.+Ullianauthor=L.+L.+Isomauthor=S.+R.+Levinsonauthor=B.+A.+Barres&title=Differential+control+of+clustering+of+the+sodium+channels+Na%28v%291.2+and+Na%28v%291.6+at+developing+CNS+nodes+of+Ranvier"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKaplan%26aufirst%3DM.%2BR.%26aulast%3DCho%26aufirst%3DM.%2BH.%26aulast%3DUllian%26aufirst%3DE.%2BM.%26aulast%3DIsom%26aufirst%3DL.%2BL.%26aulast%3DLevinson%26aufirst%3DS.%2BR.%26aulast%3DBarres%26aufirst%3DB.%2BA.%26atitle%3DDifferential%2520control%2520of%2520clustering%2520of%2520the%2520sodium%2520channels%2520Na%2528v%25291.2%2520and%2520Na%2528v%25291.6%2520at%2520developing%2520CNS%2520nodes%2520of%2520Ranvier%26jtitle%3DNeuron%26date%3D2001%26volume%3D30%26spage%3D105%26epage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Mao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Q. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J. Y.</span><span> </span><span class="NLM_article-title">The up-regulation of voltage-gated sodium channel Nav1.6 expression following fluid percussion traumatic brain injury in rats</span> <span class="citation_source-journal">Neurosurgery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1134</span><span class="NLM_x">–</span> <span class="NLM_lpage">1139</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=1134-1139&author=Q.+Maoauthor=F.+Jiaauthor=X.+H.+Zhangauthor=Y.+M.+Qiuauthor=J.+W.+Geauthor=W.+J.+Baoauthor=Q.+Z.+Luoauthor=J.+Y.+Jiang&title=The+up-regulation+of+voltage-gated+sodium+channel+Nav1.6+expression+following+fluid+percussion+traumatic+brain+injury+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DQ.%26aulast%3DJia%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DX.%2BH.%26aulast%3DQiu%26aufirst%3DY.%2BM.%26aulast%3DGe%26aufirst%3DJ.%2BW.%26aulast%3DBao%26aufirst%3DW.%2BJ.%26aulast%3DLuo%26aufirst%3DQ.%2BZ.%26aulast%3DJiang%26aufirst%3DJ.%2BY.%26atitle%3DThe%2520up-regulation%2520of%2520voltage-gated%2520sodium%2520channel%2520Nav1.6%2520expression%2520following%2520fluid%2520percussion%2520traumatic%2520brain%2520injury%2520in%2520rats%26jtitle%3DNeurosurgery%26date%3D2010%26volume%3D66%26spage%3D1134%26epage%3D1139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Waxman, S. G.</span><span> </span><span class="NLM_article-title">Axonal conduction and injury in multiple sclerosis: The role of sodium channels</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">932</span><span class="NLM_x">–</span> <span class="NLM_lpage">941</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1038%2Fnrn2023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=17115075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1WqurzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=932-941&author=S.+G.+Waxman&title=Axonal+conduction+and+injury+in+multiple+sclerosis%3A+The+role+of+sodium+channels"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Axonal conduction and injury in multiple sclerosis: the role of sodium channels</span></div><div class="casAuthors">Waxman, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">932-941</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Multiple sclerosis (MS) is the most common cause of neurol. disability in young adults.  Recent studies have implicated specific sodium channel isoforms as having an important role in several aspects of the pathophysiol. of MS, including the restoration of impulse conduction after demyelination, axonal degeneration and the mistuning of Purkinje neurons that leads to cerebellar dysfunction.  By manipulating the activity of these channels or their expression, it might be possible to develop new therapeutic approaches that will prevent or limit disability in MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomSCSd9htT3bVg90H21EOLACvtfcHk0lhI-Ts6h661XA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1WqurzM&md5=cee2cf0db2e3eeed25230256e1a0b42b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnrn2023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2023%26sid%3Dliteratum%253Aachs%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DAxonal%2520conduction%2520and%2520injury%2520in%2520multiple%2520sclerosis%253A%2520The%2520role%2520of%2520sodium%2520channels%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2006%26volume%3D7%26spage%3D932%26epage%3D941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Yuen, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browne, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. H.</span><span> </span><span class="NLM_article-title">Sodium channelopathy induced by mild axonal trauma worsens outcome after a repeat injury</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">3620</span><span class="NLM_x">–</span> <span class="NLM_lpage">3625</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1002%2Fjnr.22161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=19565655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1yrsLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2009&pages=3620-3625&author=T.+J.+Yuenauthor=K.+D.+Browneauthor=A.+Iwataauthor=D.+H.+Smith&title=Sodium+channelopathy+induced+by+mild+axonal+trauma+worsens+outcome+after+a+repeat+injury"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Sodium channelopathy induced by mild axonal trauma worsens outcome after a repeat injury</span></div><div class="casAuthors">Yuen, Tracy J.; Browne, Kevin D.; Iwata, Akira; Smith, Douglas H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3620-3625</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">There is great concern that one mild traumatic brain injury (mTBI) predisposes individuals to an exacerbated response with a subsequent mTBI.  Although no mechanism has been identified, mounting evidence suggests traumatic axonal injury (TAI) plays a role in this process.  By using a cell culture system, a threshold of mild TAI was found where dynamic stretch of cortical axons at strains lower than 5% induced no overt pathol. changes.  However, the axons were found to display an increased expression of sodium channels (NaChs) by 24 h.  After a second, identical mild injury, pathol. increases in [Ca2+]i were obsd., leading to axon degeneration.  The central role of NaChs in this response was demonstrated by blocking NaChs with tetrodotoxin prior to the second injury, which completely abolished postinjury increases in [Ca2+]i.  These data suggest that mild TAI induces a form of sodium channelopathy on axons that greatly exaggerates the pathophysiol. response to subsequent mild injuries. © 2009 Wiley-Liss, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvbi-ixIDWdbVg90H21EOLACvtfcHk0lg0ylYd1dR9LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1yrsLvK&md5=ac06eefea4846df397460441a2131493</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fjnr.22161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.22161%26sid%3Dliteratum%253Aachs%26aulast%3DYuen%26aufirst%3DT.%2BJ.%26aulast%3DBrowne%26aufirst%3DK.%2BD.%26aulast%3DIwata%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DD.%2BH.%26atitle%3DSodium%2520channelopathy%2520induced%2520by%2520mild%2520axonal%2520trauma%2520worsens%2520outcome%2520after%2520a%2520repeat%2520injury%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2009%26volume%3D87%26spage%3D3620%26epage%3D3625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Wang, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banderali, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juranka, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, C. E.</span><span> </span><span class="NLM_article-title">Membrane trauma and Na<sup>+</sup> leak from Nav1.6 channels</span> <span class="citation_source-journal">Am. J. Physiol.: Cell Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">C823</span><span class="NLM_x">–</span> <span class="NLM_lpage">C834</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2009&pages=C823-C834&author=J.+A.+Wangauthor=W.+Linauthor=T.+Morrisauthor=U.+Banderaliauthor=P.+F.+Jurankaauthor=C.+E.+Morris&title=Membrane+trauma+and+Na%2B+leak+from+Nav1.6+channels"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%2BA.%26aulast%3DLin%26aufirst%3DW.%26aulast%3DMorris%26aufirst%3DT.%26aulast%3DBanderali%26aufirst%3DU.%26aulast%3DJuranka%26aufirst%3DP.%2BF.%26aulast%3DMorris%26aufirst%3DC.%2BE.%26atitle%3DMembrane%2520trauma%2520and%2520Na%252B%2520leak%2520from%2520Nav1.6%2520channels%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Cell%2520Physiol.%26date%3D2009%26volume%3D297%26spage%3DC823%26epage%3DC834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Boucher, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, C. E.</span><span> </span><span class="NLM_article-title">Coupled left-shift of Nav channels: Modeling the Na<sup>+</sup>-loading and dysfunctional excitability of damaged axons</span> <span class="citation_source-journal">J. Comput. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">319</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1007%2Fs10827-012-0387-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=22476614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A280%3ADC%252BC38ritlyguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=301-319&author=P.+A.+Boucherauthor=B.+Joosauthor=C.+E.+Morris&title=Coupled+left-shift+of+Nav+channels%3A+Modeling+the+Na%2B-loading+and+dysfunctional+excitability+of+damaged+axons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Coupled left-shift of Nav channels: modeling the Na -loading and dysfunctional excitability of damaged axons</span></div><div class="casAuthors">Boucher Pierre-Alexandre; Joos Bela; Morris Catherine E</div><div class="citationInfo"><span class="NLM_cas:title">Journal of computational neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">301-19</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Injury to neural tissue renders voltage-gated Na  (Nav) channels leaky.  Even mild axonal trauma initiates Na -loading, leading to secondary Ca2 -loading and white matter degeneration.  The nodal isoform is Nav1.6 and for Nav1.6-expressing HEK-cells, traumatic whole cell stretch causes an immediate tetrodotoxin-sensitive Na -leak.  In stretch-damaged oocyte patches, Nav1.6 current undergoes damage-intensity dependent hyperpolarizing- (left-) shifts, but whether left-shift underlies injured-axon Nav-leak is uncertain.  Nav1.6 inactivation (availability) is kinetically limited by (coupled to) Nav activation, yielding coupled left-shift (CLS) of the two processes: CLS should move the steady-state Nav1.6 "window conductance" closer to typical firing thresholds.  Here we simulated excitability and ion homeostasis in free-running nodes of Ranvier to assess if hallmark injured-axon behaviors--Na -loading, ectopic excitation, propagation block--would occur with Nav-CLS.  Intact/traumatized axolemma ratios were varied, and for some simulations Na/K pumps were included, with varied in/outside volumes.  We simulated saltatory propagation with one mid-axon node variously traumatized.  While dissipating the [Na ] gradient and hyperactivating the Na/K pump, Nav-CLS generated neuropathic pain-like ectopic bursts.  Depending on CLS magnitude, fraction of Nav channels affected, and pump intensity, tonic or burst firing or nodal inexcitability occurred, with [Na ] and [K ] fluctuating.  Severe CLS-induced inexcitability did not preclude Na -loading; in fact, the steady-state Na -leaks elicited large pump currents.  At a mid-axon node, mild CLS perturbed normal anterograde propagation, and severe CLS blocked saltatory propagation.  These results suggest that in damaged excitable cells, Nav-CLS could initiate cellular deterioration with attendant hyper- or hypo-excitability.  Healthy-cell versions of Nav-CLS, however, could contribute to physiological rhythmic firing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ5iPox2COc83T4ugvCDgnZfW6udTcc2eaE_Jx4GxWrGbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38ritlyguw%253D%253D&md5=9b6f6ba2eefe0788ed4002ad04fcff90</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1007%2Fs10827-012-0387-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10827-012-0387-7%26sid%3Dliteratum%253Aachs%26aulast%3DBoucher%26aufirst%3DP.%2BA.%26aulast%3DJoos%26aufirst%3DB.%26aulast%3DMorris%26aufirst%3DC.%2BE.%26atitle%3DCoupled%2520left-shift%2520of%2520Nav%2520channels%253A%2520Modeling%2520the%2520Na%252B-loading%2520and%2520dysfunctional%2520excitability%2520of%2520damaged%2520axons%26jtitle%3DJ.%2520Comput.%2520Neurosci.%26date%3D2012%26volume%3D33%26spage%3D301%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Yao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortella, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dave, J. R.</span><span> </span><span class="NLM_article-title">Differential pattern of expression of voltage-gated sodium channel genes following ischemic brain injury in rats</span> <span class="citation_source-journal">Neurotoxic. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1080%2F10298420290007646" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=12826495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BD38Xmsl2jur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=67-75&author=C.+Yaoauthor=A.+J.+Williamsauthor=P.+Cuiauthor=R.+Bertiauthor=J.+C.+Hunterauthor=F.+C.+Tortellaauthor=J.+R.+Dave&title=Differential+pattern+of+expression+of+voltage-gated+sodium+channel+genes+following+ischemic+brain+injury+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Differential pattern of expression of voltage-gated sodium channel genes following ischemic brain injury in rats</span></div><div class="casAuthors">Yao, C.; Williams, A. J.; Cui, P.; Berti, R.; Hunter, J. C.; Tortella, E. C.; Dave, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Neurotoxicity Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-75</span>CODEN:
                <span class="NLM_cas:coden">NURRFI</span>;
        ISSN:<span class="NLM_cas:issn">1029-8428</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">This study investigated the effects of brain ischemia on sodium channel gene (NaCh) expression in rats.  Using quant. RT-PCR, our findings demonstrated the expression ratio of NaCh genes in normal rat brain to be Nav1.1 > Nav1.8 > Nav1.3 > Nav1.7 (rBI > PN3 > rBIII > PN1).  In contrast, brain injury caused by middle cerebral artery occlusion (MCAo) for 2 h followed by reperfusion significantly down-regulated Nav1.3 and Nav1.7 genes in both injured and contralateral hemispheres; whereas the Nav1.8 gene was down regulated in only the injured hemisphere (though only acutely at 2 or 2-6 h post-MCAo).  However, the time-course of NaCh gene expression revealed a significant down-regulation of Nav1.1 only in the ischemic hemisphere beginning 6 h post-MCAo and measured out to 48 h post-MCAo.  In a sep. preliminary study Nav1.2 (rBII) gene was found be expressed at levels greater than that of Nav1.1 in normal rats and was significantly down regulated at 24 h post-MCAo.  Our findings document, for the first time, quant. and relative changes in the expression of various NaCh genes following ischemic brain injury and suggest that the Nav1.1 sodium channel gene may play a key role in ischemic injury/recovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE-uu8eYxzVLVg90H21EOLACvtfcHk0lhdPvPV_HmgRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xmsl2jur8%253D&md5=67bf3163d08349d635b6a2e10eb04508</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1080%2F10298420290007646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10298420290007646%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DC.%26aulast%3DWilliams%26aufirst%3DA.%2BJ.%26aulast%3DCui%26aufirst%3DP.%26aulast%3DBerti%26aufirst%3DR.%26aulast%3DHunter%26aufirst%3DJ.%2BC.%26aulast%3DTortella%26aufirst%3DF.%2BC.%26aulast%3DDave%26aufirst%3DJ.%2BR.%26atitle%3DDifferential%2520pattern%2520of%2520expression%2520of%2520voltage-gated%2520sodium%2520channel%2520genes%2520following%2520ischemic%2520brain%2520injury%2520in%2520rats%26jtitle%3DNeurotoxic.%2520Res.%26date%3D2002%26volume%3D4%26spage%3D67%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Huang, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J. Y.</span><span> </span><span class="NLM_article-title">Expression of voltage-gated sodium channel Nav1.3 is associated with severity of traumatic brain injury in adult rats</span> <span class="citation_source-journal">J. Neurotrauma</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1089%2Fneu.2012.2508" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=22928478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A280%3ADC%252BC38bhvFagtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2013&pages=39-46&author=X.+J.+Huangauthor=Q.+Maoauthor=Y.+Linauthor=J.+F.+Fengauthor=J.+Y.+Jiang&title=Expression+of+voltage-gated+sodium+channel+Nav1.3+is+associated+with+severity+of+traumatic+brain+injury+in+adult+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of voltage-gated sodium channel Nav1.3 is associated with severity of traumatic brain injury in adult rats</span></div><div class="casAuthors">Huang Xian-jian; Mao Qing; Lin Yong; Feng Jun-feng; Jiang Ji-yao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurotrauma</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-46</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">During the secondary injury period after traumatic brain injury (TBI), depolarization of neurons mediated by voltage-gated sodium channels (VGSCs) leads to cellular abnormalities and neurological dysfunction.  Alterations in expression of different α subunits of VGSCs can affect early brain pathology following TBI.  This study detected the expression of Nav1.3 mRNA and protein in the rat cortex post-TBI.  Adult male Sprague-Dawley rats were randomly assigned to sham-TBI, mild-TBI (mTBI), or severe-TBI (sTBI) groups.  TBI was induced using a fluid percussion device at magnitudes of 1.5-1.6 atm (mTBI) and 2.9-3.0 atm (sTBI).  Nav1.3 mRNA and protein levels in the ipsilateral-injured cortex were examined at 2 h, 12 h, 24 h, and 72 h post-TBI by real-time reverse transcriptase quantitative polymerase chain reaction and Western blot.  Brains were collected at 24 h, 72 h, and 7 days post-TBI for TUNEL staining and cell count analysis.  Immunofluorescence was performed to localize expression of Nav1.3 protein in the ipsilateral-injured cortex.  Expression of Nav1.3 mRNA and protein were significantly upregulated in mTBI and sTBI groups when compared with the sham-TBI group at 2 h and 12 h post-TBI.  Nav1.3 mRNA and protein levels in the sTBI group were much higher than in the mTBI group at 12 h post-TBI.  TUNEL-positive cell numbers were significantly higher in the sTBI group than in the mTBI at 24 h, 72 h, and 7 days post-TBI.  Expression of Nav1.3 was observed predominantly in neurons of the cortex.  These findings indicated significant upregulation in the expression of Nav1.3 mRNA and protein in the rat ipsilateral-injured cortex at the very early stage post-TBI, and were also correlated with TBI severity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQKCZelbcW2ylw2ofyr07jXfW6udTcc2ebdOxbJXuQriLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38bhvFagtQ%253D%253D&md5=c794fffb9f218b411cc95095acdcc521</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1089%2Fneu.2012.2508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fneu.2012.2508%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%2BJ.%26aulast%3DMao%26aufirst%3DQ.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DFeng%26aufirst%3DJ.%2BF.%26aulast%3DJiang%26aufirst%3DJ.%2BY.%26atitle%3DExpression%2520of%2520voltage-gated%2520sodium%2520channel%2520Nav1.3%2520is%2520associated%2520with%2520severity%2520of%2520traumatic%2520brain%2520injury%2520in%2520adult%2520rats%26jtitle%3DJ.%2520Neurotrauma%26date%3D2013%26volume%3D30%26spage%3D39%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Clutterbuck, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posada, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visintin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddall, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancaster, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gane, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garthwaite, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selwood, D. L.</span><span> </span><span class="NLM_article-title">Oxadiazolylindazole sodium channel modulators are neuroprotective toward hippocampal neurones</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2694</span><span class="NLM_x">–</span> <span class="NLM_lpage">2707</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801180p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvF2gsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2694-2707&author=L.+A.+Clutterbuckauthor=C.+G.+Posadaauthor=C.+Visintinauthor=D.+R.+Riddallauthor=B.+Lancasterauthor=P.+J.+Ganeauthor=J.+Garthwaiteauthor=D.+L.+Selwood&title=Oxadiazolylindazole+sodium+channel+modulators+are+neuroprotective+toward+hippocampal+neurones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Oxadiazolylindazole Sodium Channel Modulators are Neuroprotective toward Hippocampal Neurones</span></div><div class="casAuthors">Clutterbuck, Lisa A.; Garcia Posada, Cristina; Visintin, Cristina; Riddall, Dieter R.; Lancaster, Barrie; Gane, Paul J.; Garthwaite, John; Selwood, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2694-2707</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the discovery of a new class of neuroprotective voltage-dependent sodium channel modulators exemplified by (5-(1-benzyl-1H-indazol-3-yl)-1,2,4-oxadiazol-3-yl)methanamine 11 (CFM1178).  The compds. were inhibitors of [14C]guanidinium ion flux in rat forebrain synaptosomes and displaced binding of the sodium channel ligand [3H]BW202W92.  11 And the corresponding N2-benzyl isomer, 38 (CFM6058), demonstrated neuroprotective activity in hippocampal slices comparable to sipatrigine.  CYP450 enzyme inhibition obsd. with 11 was reduced with 38.  In electrophysiol. expts. on dissocd. hippocampal neurons, these two compds. caused use- and voltage-dependent block of sodium currents.  Sodium channel isoform profiling against Nav1.1-1.8 demonstrated that the std. sodium channel blocker lamotrigine had modest activity against Nav1.1, while sipatrigine was generally more potent and less selective.  11 And 38 showed potent activity against Nav1.6, pointing to pharmacol. block of this isoform being consistent with the neuroprotective effect.  38 Also showed use dependent block of Nav1.6 in HEK cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzQfFV_-fwe7Vg90H21EOLACvtfcHk0lj523GlNe4MrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvF2gsrs%253D&md5=706c835492da40e1b684431b6fdaa3eb</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm801180p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801180p%26sid%3Dliteratum%253Aachs%26aulast%3DClutterbuck%26aufirst%3DL.%2BA.%26aulast%3DPosada%26aufirst%3DC.%2BG.%26aulast%3DVisintin%26aufirst%3DC.%26aulast%3DRiddall%26aufirst%3DD.%2BR.%26aulast%3DLancaster%26aufirst%3DB.%26aulast%3DGane%26aufirst%3DP.%2BJ.%26aulast%3DGarthwaite%26aufirst%3DJ.%26aulast%3DSelwood%26aufirst%3DD.%2BL.%26atitle%3DOxadiazolylindazole%2520sodium%2520channel%2520modulators%2520are%2520neuroprotective%2520toward%2520hippocampal%2520neurones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2694%26epage%3D2707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Fowler, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span> </span><span class="NLM_article-title">Contributions of Na<sup>+</sup> flux and the anoxic depolarization to adenosine 5′-triphosphate levels in hypoxic/hypoglycemic rat hippocampal slices</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">722</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1998&pages=717-722&author=J.+C.+Fowlerauthor=Y.+Li&title=Contributions+of+Na%2B+flux+and+the+anoxic+depolarization+to+adenosine+5%E2%80%B2-triphosphate+levels+in+hypoxic%2Fhypoglycemic+rat+hippocampal+slices"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DJ.%2BC.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DContributions%2520of%2520Na%252B%2520flux%2520and%2520the%2520anoxic%2520depolarization%2520to%2520adenosine%25205%25E2%2580%25B2-triphosphate%2520levels%2520in%2520hypoxic%252Fhypoglycemic%2520rat%2520hippocampal%2520slices%26jtitle%3DNeuroscience%26date%3D1998%26volume%3D83%26spage%3D717%26epage%3D722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Watson, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davison, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, J. L.</span><span> </span><span class="NLM_article-title">Suppression of demyelination by mitoxantrone</span> <span class="citation_source-journal">Int. J. Immunopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">930</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1016%2F0192-0561%2891%2990045-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=1761358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADyaK38XktV0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1991&pages=923-930&author=C.+M.+Watsonauthor=A.+N.+Davisonauthor=D.+Bakerauthor=J.+K.+O%E2%80%99Neillauthor=J.+L.+Turk&title=Suppression+of+demyelination+by+mitoxantrone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of demyelination by mitoxantrone</span></div><div class="casAuthors">Watson, Carolyn M.; Davison, Alan N.; Baker, David; O'Neill, Janet K.; Turk, John L.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Immunopharmacology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">923-30</span>CODEN:
                <span class="NLM_cas:coden">IJIMDS</span>;
        ISSN:<span class="NLM_cas:issn">0192-0561</span>.
    </div><div class="casAbstract">The mode of action of the immunosuppressant mitoxantrone was examd. in murine models of demyelinating disease.  The drug has been shown to block antigen-induced proliferative activity and to inhibit myelin degrdn. by leukocytes from paralyzed mice.  Mitoxantrone blocked myelin breakdown by macrophages although phagocytosis was not affected.  Further evidence was obtained to indicate that mitoxantrone acts therapeutically in reducing, or at high dose, preventing signs of exptl. allergic encephalomyclitis developing in mice immunized with spinal cord homogenate and Freund's complete adjuvant.  Mitoxanthrone also significantly inhibited the incidence of relapse when treatment was initiated during the post-acute remission period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNqr4Nmo5hDrVg90H21EOLACvtfcHk0lj523GlNe4MrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XktV0%253D&md5=9f80efe4ad305127f399458db8cd93b5</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2F0192-0561%2891%2990045-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0192-0561%252891%252990045-9%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DC.%2BM.%26aulast%3DDavison%26aufirst%3DA.%2BN.%26aulast%3DBaker%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DJ.%2BK.%26aulast%3DTurk%26aufirst%3DJ.%2BL.%26atitle%3DSuppression%2520of%2520demyelination%2520by%2520mitoxantrone%26jtitle%3DInt.%2520J.%2520Immunopharmacol.%26date%3D1991%26volume%3D13%26spage%3D923%26epage%3D930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">O’Neill, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davison, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggon, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffee, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, J. L.</span><span> </span><span class="NLM_article-title">Therapy of chronic relapsing experimental allergic encephalomyelitis and the role of the blood-brain barrier: Elucidation by the action of Brequinar sodium</span> <span class="citation_source-journal">J. Neuroimmunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1016%2F0165-5728%2892%2990090-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=1577953" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADyaK38Xks1amtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1992&pages=53-62&author=J.+K.+O%E2%80%99Neillauthor=D.+Bakerauthor=A.+N.+Davisonauthor=K.+K.+Maggonauthor=B.+D.+Jaffeeauthor=J.+L.+Turk&title=Therapy+of+chronic+relapsing+experimental+allergic+encephalomyelitis+and+the+role+of+the+blood-brain+barrier%3A+Elucidation+by+the+action+of+Brequinar+sodium"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Therapy of chronic relapsing experimental allergic encephalomyelitis and the role of the blood-brain barrier:  elucidation by the action of Brequinar sodium</span></div><div class="casAuthors">O'Neill, J. K.; Baker, D.; Davison, A. N.; Maggon, K. K.; Jaffee, B. D.; Turk, J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroimmunology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">53-62</span>CODEN:
                <span class="NLM_cas:coden">JNRIDW</span>;
        ISSN:<span class="NLM_cas:issn">0165-5728</span>.
    </div><div class="casAbstract">The immunosuppressive effect of the novel 4-quinoline carboxylic acid deriv. Brequinar sodium on the chronic relapsing exptl. allergic encephalomyelitis CREAE model in the Biozzi AB/H mouse was investigated.  Although Brequinar sodium actively inhibited peripheral immune responses, it showed a limited potential to control an ongoing disease of the central nervous system (CNS).  Doses of 25 mg/kg inhibited in vivo induced proliferative response and prevented EAE when treated from day 9 post-inoculation (p.i.).  However, when administered from day 12 p.i. or during the post-acute remission phase-limited effects on the course of disease were obsd.  By comparison, treatment with a single high dose of cyclophosphamide (200 mg/kg) at these time points was significantly effective in controlling disease.  As a possible explanation of the obsd. results it is suggested that for a compd. to be effective in treating an ongoing immune response in the CNS, it must be capable of crossing the blood-brain barrier and act on the disease-inducing cells activated within the CNS.  This hypothesis is supported by the finding that intracerebral injections of Brequinar sodium on day 12 p.i. significantly inhibited disease progression.  This suggests that strategies aimed at controlling immune-mediated disease of the CNS require therapeutic doses of the compds. to be delivered into the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC_V4nOdzsJ7Vg90H21EOLACvtfcHk0lgM2ncOyGezyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xks1amtrc%253D&md5=acd8d837f1529e5fbb02ec4798c045b9</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2F0165-5728%2892%2990090-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-5728%252892%252990090-8%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DJ.%2BK.%26aulast%3DBaker%26aufirst%3DD.%26aulast%3DDavison%26aufirst%3DA.%2BN.%26aulast%3DMaggon%26aufirst%3DK.%2BK.%26aulast%3DJaffee%26aufirst%3DB.%2BD.%26aulast%3DTurk%26aufirst%3DJ.%2BL.%26atitle%3DTherapy%2520of%2520chronic%2520relapsing%2520experimental%2520allergic%2520encephalomyelitis%2520and%2520the%2520role%2520of%2520the%2520blood-brain%2520barrier%253A%2520Elucidation%2520by%2520the%2520action%2520of%2520Brequinar%2520sodium%26jtitle%3DJ.%2520Neuroimmunol.%26date%3D1992%26volume%3D38%26spage%3D53%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Baker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davison, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, J. L.</span><span> </span><span class="NLM_article-title">Control of immune-mediated disease of the central nervous system requires the use of a neuroactive agent: Elucidation by the action of mitoxantrone</span> <span class="citation_source-journal">Clin. Exp. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">128</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1111%2Fj.1365-2249.1992.tb05843.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=1395092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADyaK38Xmt1Gqtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1992&pages=124-128&author=D.+Bakerauthor=J.+K.+O%E2%80%99Neillauthor=A.+N.+Davisonauthor=J.+L.+Turk&title=Control+of+immune-mediated+disease+of+the+central+nervous+system+requires+the+use+of+a+neuroactive+agent%3A+Elucidation+by+the+action+of+mitoxantrone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Control of immune-mediated disease of the central nervous system requires the use of a neuroactive agent:  elucidation by the action of mitoxantrone</span></div><div class="casAuthors">Baker, D.; O'Neill, J. K.; Davison, A. N.; Turk, J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Immunology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">124-8</span>CODEN:
                <span class="NLM_cas:coden">CEXIAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-9104</span>.
    </div><div class="casAbstract">Mitoxantrone was used as an immunosuppressive probe to elucidate a means for the control of exptl. allergic encephalomyelitis (EAE) induced in Biozzi AB/H mice following injection of spinal cord homogenate emulsified in Freund's adjuvant.  A single i.p. injection of 2.5 mg/kg of mitoxantrone, 1-2 days before the anticipated onset of EAE, failed to prevent the majority of animals from developing clin. disease, whereas when the compd. was injected directly into the central nervous system (CNS), at this time point, significantly increased therapeutic benefit was evident, with most animals failing to develop clin. EAE.  Although the clin. use of intrathecal mitoxantrone is strongly contraindicated, these data suggest that increased therapeutic benefit may be achieved in immune-mediated disease of the CNS by targeting immunosuppressive doses of suitable agents, on lymphocyte activation within the CNS.  In addn., direct administration of immunosuppressive doses into the CNS may reduce potentially unwanted (side) effects in the periphery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGbEYOuumIOrVg90H21EOLACvtfcHk0lgM2ncOyGezyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xmt1Gqtrg%253D&md5=7003bc5cfc390adb2869be12322f910a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2249.1992.tb05843.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2249.1992.tb05843.x%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DJ.%2BK.%26aulast%3DDavison%26aufirst%3DA.%2BN.%26aulast%3DTurk%26aufirst%3DJ.%2BL.%26atitle%3DControl%2520of%2520immune-mediated%2520disease%2520of%2520the%2520central%2520nervous%2520system%2520requires%2520the%2520use%2520of%2520a%2520neuroactive%2520agent%253A%2520Elucidation%2520by%2520the%2520action%2520of%2520mitoxantrone%26jtitle%3DClin.%2520Exp.%2520Immunol.%26date%3D1992%26volume%3D90%26spage%3D124%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Lidster, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munro, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giovannoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D.</span><span> </span><span class="NLM_article-title">Neuroprotection in a novel mouse model of multiple sclerosis</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e79188-1</span><span class="NLM_x">–</span> <span class="NLM_lpage">e79188-15</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e79188-1-e79188-15&author=K.+Lidsterauthor=S.+J.+Jacksonauthor=Z.+Ahmedauthor=P.+Munroauthor=P.+Coffeyauthor=G.+Giovannoniauthor=M.+D.+Bakerauthor=D.+Baker&title=Neuroprotection+in+a+novel+mouse+model+of+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLidster%26aufirst%3DK.%26aulast%3DJackson%26aufirst%3DS.%2BJ.%26aulast%3DAhmed%26aufirst%3DZ.%26aulast%3DMunro%26aufirst%3DP.%26aulast%3DCoffey%26aufirst%3DP.%26aulast%3DGiovannoni%26aufirst%3DG.%26aulast%3DBaker%26aufirst%3DM.%2BD.%26aulast%3DBaker%26aufirst%3DD.%26atitle%3DNeuroprotection%2520in%2520a%2520novel%2520mouse%2520model%2520of%2520multiple%2520sclerosis%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De79188-1%26epage%3De79188-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Black, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waxman, S. G.</span><span> </span><span class="NLM_article-title">Sodium channels and microglial function</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">234</span><span class="NLM_x">, </span> <span class="NLM_fpage">302</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1016%2Fj.expneurol.2011.09.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=21985863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Gru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=234&publication_year=2012&pages=302-315&author=J.+A.+Blackauthor=S.+G.+Waxman&title=Sodium+channels+and+microglial+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Sodium channels and microglial function</span></div><div class="casAuthors">Black, Joel A.; Waxman, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">234</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">302-315</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Microglia are resident immune cells that provide continuous surveillance within the central nervous system (CNS) and respond to perturbations of brain and spinal cord parenchyma with an array of effector functions, including proliferation, migration, phagocytosis, secretions of multiple cytokines/chemokines and promotion of repair.  To sense alterations within their environment, microglia express a large no. of cell surface receptors, ion channels and adhesion mols., which activate complex and dynamic signaling pathways.  In the present chapter, we review studies that demonstrate that microglia in vivo and in vitro express specific voltage-gated sodium channel isoforms, and that blockade of sodium channel activity can attenuate several effector functions of microglia.  These studies also provide strong evidence that Nav1.6 is the predominant sodium channel isoform expressed in microglia and that its activity contributes to the response of microglia to multiple activating signals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru0wXJlR3gGLVg90H21EOLACvtfcHk0lgM2ncOyGezyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Gru78%253D&md5=37bd14b08226ec15d3a1c9de76703fc2</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2011.09.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2011.09.030%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DJ.%2BA.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DSodium%2520channels%2520and%2520microglial%2520function%26jtitle%3DExp.%2520Neurol.%26date%3D2012%26volume%3D234%26spage%3D302%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Morsali, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bechtold, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauhdry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palchaudhuri, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassoon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snell, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malpass, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pocock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. J.</span><span> </span><span class="NLM_article-title">Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">1067</span><span class="NLM_x">–</span> <span class="NLM_lpage">1082</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2013&pages=1067-1082&author=D.+Morsaliauthor=D.+Bechtoldauthor=W.+Leeauthor=S.+Chauhdryauthor=U.+Palchaudhuriauthor=P.+Hassoonauthor=D.+M.+Snellauthor=K.+Malpassauthor=T.+Piersauthor=J.+Pocockauthor=A.+Roachauthor=K.+J.+Smith&title=Safinamide+and+flecainide+protect+axons+and+reduce+microglial+activation+in+models+of+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorsali%26aufirst%3DD.%26aulast%3DBechtold%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DW.%26aulast%3DChauhdry%26aufirst%3DS.%26aulast%3DPalchaudhuri%26aufirst%3DU.%26aulast%3DHassoon%26aufirst%3DP.%26aulast%3DSnell%26aufirst%3DD.%2BM.%26aulast%3DMalpass%26aufirst%3DK.%26aulast%3DPiers%26aufirst%3DT.%26aulast%3DPocock%26aufirst%3DJ.%26aulast%3DRoach%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26atitle%3DSafinamide%2520and%2520flecainide%2520protect%2520axons%2520and%2520reduce%2520microglial%2520activation%2520in%2520models%2520of%2520multiple%2520sclerosis%26jtitle%3DBrain%26date%3D2013%26volume%3D136%26spage%3D1067%26epage%3D1082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Lidster, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D.</span><span> </span><span class="NLM_article-title">Optical coherence tomography detection of neurodegeneration in multiple sclerosis</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">518</span><span class="NLM_x">–</span> <span class="NLM_lpage">527</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.2174%2F187152712801661185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=22583437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtF2jur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=518-527&author=K.+Lidsterauthor=D.+Baker&title=Optical+coherence+tomography+detection+of+neurodegeneration+in+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Optical coherence tomography detection of neurodegeneration in multiple sclerosis</span></div><div class="casAuthors">Lidster, Katie; Baker, David</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">518-527</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The pathophysiol. of multiple sclerosis (MS) is typically characterised by inflammation and demyelination leading to neurodegeneration, which is assocd. with disability and the progressive stages of MS.  The visual system is a valuable tool for studying neurodegeneration and potential neuroprotection in the central nervous system due to its ease of accessibility.  Optical coherence tomog. (OCT) is a non-invasive tool, which can be used to measure the thickness of the retinal nerve fiber layer (RNFL).  The thickness of RNFL is reduced following the development of MS and optic neuritis and can therefore be used as a correlate of global axonal loss.  OCT is currently being investigated as a structural outcome measure for neuroprotective clin. trials of MS.  This review describes the relationship between MS and optic neuritis and the assocd. RNFL thinning, the technol. and advancements of OCT, the role of OCT in clin. trials for new neuroprotective therapies in MS and the future role of OCT in MS research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBSGFfTx-ZlrVg90H21EOLACvtfcHk0liYO9Jmvy0UHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtF2jur3I&md5=1c1107d25c810b4ecdcea8002d5cc633</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.2174%2F187152712801661185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152712801661185%26sid%3Dliteratum%253Aachs%26aulast%3DLidster%26aufirst%3DK.%26aulast%3DBaker%26aufirst%3DD.%26atitle%3DOptical%2520coherence%2520tomography%2520detection%2520of%2520neurodegeneration%2520in%2520multiple%2520sclerosis%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2012%26volume%3D11%26spage%3D518%26epage%3D527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Raftopoulos, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapoor, R.</span><span> </span><span class="NLM_article-title">Neuroprotection for acute optic neuritis—Can it work?</span> <span class="citation_source-journal">Mult. Scler. Relat. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">311</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1016%2Fj.msard.2013.02.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=307-311&author=R.+E.+Raftopoulosauthor=R.+Kapoor&title=Neuroprotection+for+acute+optic+neuritis%E2%80%94Can+it+work%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.msard.2013.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.msard.2013.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DRaftopoulos%26aufirst%3DR.%2BE.%26aulast%3DKapoor%26aufirst%3DR.%26atitle%3DNeuroprotection%2520for%2520acute%2520optic%2520neuritis%25E2%2580%2594Can%2520it%2520work%253F%26jtitle%3DMult.%2520Scler.%2520Relat.%2520Disord.%26date%3D2013%26volume%3D2%26spage%3D307%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Bostrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plowright, A. T.</span><span> </span><span class="NLM_article-title">Oxadiazoles in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1817</span><span class="NLM_x">–</span> <span class="NLM_lpage">1830</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2013248" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A280%3ADC%252BC383pt1Oisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1817-1830&author=J.+Bostromauthor=A.+Hognerauthor=A.+Llinasauthor=E.+Wellnerauthor=A.+T.+Plowright&title=Oxadiazoles+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Oxadiazoles in medicinal chemistry</span></div><div class="casAuthors">Bostrom Jonas; Hogner Anders; Llinas Antonio; Wellner Eric; Plowright Alleyn T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1817-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Oxadiazoles are five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom, and they exist in different regioisomeric forms.  Oxadiazoles are frequently occurring motifs in druglike molecules, and they are often used with the intention of being bioisosteric replacements for ester and amide functionalities.  The current study presents a systematic comparison of 1,2,4- and 1,3,4-oxadiazole matched pairs in the AstraZeneca compound collection.  In virtually all cases, the 1,3,4-oxadiazole isomer shows an order of magnitude lower lipophilicity (log D), as compared to its isomeric partner.  Significant differences are also observed with respect to metabolic stability, hERG inhibition, and aqueous solubility, favoring the 1,3,4-oxadiazole isomers.  The difference in profile between the 1,2,4 and 1,3,4 regioisomers can be rationalized by their intrinsically different charge distributions (e.g., dipole moments).  To facilitate the use of these heteroaromatic rings, novel synthetic routes for ready access of a broad spectrum of 1,3,4-oxadiazoles, under mild conditions, are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSO9RQiG9xFS2Zyxfu64m4ffW6udTcc2eYtK-MIwRqvd7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC383pt1Oisw%253D%253D&md5=b934995431ced1be297e6f126262f3cb</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm2013248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2013248%26sid%3Dliteratum%253Aachs%26aulast%3DBostrom%26aufirst%3DJ.%26aulast%3DHogner%26aufirst%3DA.%26aulast%3DLlinas%26aufirst%3DA.%26aulast%3DWellner%26aufirst%3DE.%26aulast%3DPlowright%26aufirst%3DA.%2BT.%26atitle%3DOxadiazoles%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1817%26epage%3D1830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Al-Izki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pryce, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hankey, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lidster, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Kutzleben, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browne, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clutterbuck, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posada, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edith Chan, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerritsen, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ummenthum, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peferoen-Baert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Valk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montoya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joel, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garthwaite, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giovannoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selwood, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D.</span><span> </span><span class="NLM_article-title">Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">92</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2013&pages=92-98&author=S.+Al-Izkiauthor=G.+Pryceauthor=D.+J.+Hankeyauthor=K.+Lidsterauthor=S.+M.+von+Kutzlebenauthor=L.+Browneauthor=L.+Clutterbuckauthor=C.+Posadaauthor=A.+W.+Edith+Chanauthor=S.+Amorauthor=V.+Perkinsauthor=W.+H.+Gerritsenauthor=K.+Ummenthumauthor=R.+Peferoen-Baertauthor=P.+van+der+Valkauthor=A.+Montoyaauthor=S.+P.+Joelauthor=J.+Garthwaiteauthor=G.+Giovannoniauthor=D.+L.+Selwoodauthor=D.+Baker&title=Lesional-targeting+of+neuroprotection+to+the+inflammatory+penumbra+in+experimental+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Izki%26aufirst%3DS.%26aulast%3DPryce%26aufirst%3DG.%26aulast%3DHankey%26aufirst%3DD.%2BJ.%26aulast%3DLidster%26aufirst%3DK.%26aulast%3Dvon%2BKutzleben%26aufirst%3DS.%2BM.%26aulast%3DBrowne%26aufirst%3DL.%26aulast%3DClutterbuck%26aufirst%3DL.%26aulast%3DPosada%26aufirst%3DC.%26aulast%3DEdith%2BChan%26aufirst%3DA.%2BW.%26aulast%3DAmor%26aufirst%3DS.%26aulast%3DPerkins%26aufirst%3DV.%26aulast%3DGerritsen%26aufirst%3DW.%2BH.%26aulast%3DUmmenthum%26aufirst%3DK.%26aulast%3DPeferoen-Baert%26aufirst%3DR.%26aulast%3Dvan%2Bder%2BValk%26aufirst%3DP.%26aulast%3DMontoya%26aufirst%3DA.%26aulast%3DJoel%26aufirst%3DS.%2BP.%26aulast%3DGarthwaite%26aufirst%3DJ.%26aulast%3DGiovannoni%26aufirst%3DG.%26aulast%3DSelwood%26aufirst%3DD.%2BL.%26aulast%3DBaker%26aufirst%3DD.%26atitle%3DLesional-targeting%2520of%2520neuroprotection%2520to%2520the%2520inflammatory%2520penumbra%2520in%2520experimental%2520multiple%2520sclerosis%26jtitle%3DBrain%26date%3D2013%26volume%3D137%26spage%3D92%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Black, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hains, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saab, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waxman, S. G.</span><span> </span><span class="NLM_article-title">Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">3196</span><span class="NLM_x">–</span> <span class="NLM_lpage">3208</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2006&pages=3196-3208&author=J.+A.+Blackauthor=S.+Liuauthor=B.+C.+Hainsauthor=C.+Y.+Saabauthor=S.+G.+Waxman&title=Long-term+protection+of+central+axons+with+phenytoin+in+monophasic+and+chronic-relapsing+EAE"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DJ.%2BA.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DHains%26aufirst%3DB.%2BC.%26aulast%3DSaab%26aufirst%3DC.%2BY.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DLong-term%2520protection%2520of%2520central%2520axons%2520with%2520phenytoin%2520in%2520monophasic%2520and%2520chronic-relapsing%2520EAE%26jtitle%3DBrain%26date%3D2006%26volume%3D129%26spage%3D3196%26epage%3D3208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Al-Izki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pryce, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giovannoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D.</span><span> </span><span class="NLM_article-title">Practical guide to the induction of relapsing progressive experimental autoimmune encephalomyelitis in the Biozzi ABH mouse</span> <span class="citation_source-journal">Mult. Scler. Relat. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1016%2Fj.msard.2011.09.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2012&pages=29-38&author=S.+Al-Izkiauthor=G.+Pryceauthor=J.+K.+O%E2%80%99Neillauthor=C.+Butterauthor=G.+Giovannoniauthor=S.+Amorauthor=D.+Baker&title=Practical+guide+to+the+induction+of+relapsing+progressive+experimental+autoimmune+encephalomyelitis+in+the+Biozzi+ABH+mouse"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.msard.2011.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.msard.2011.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Izki%26aufirst%3DS.%26aulast%3DPryce%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DJ.%2BK.%26aulast%3DButter%26aufirst%3DC.%26aulast%3DGiovannoni%26aufirst%3DG.%26aulast%3DAmor%26aufirst%3DS.%26aulast%3DBaker%26aufirst%3DD.%26atitle%3DPractical%2520guide%2520to%2520the%2520induction%2520of%2520relapsing%2520progressive%2520experimental%2520autoimmune%2520encephalomyelitis%2520in%2520the%2520Biozzi%2520ABH%2520mouse%26jtitle%3DMult.%2520Scler.%2520Relat.%2520Disord.%26date%3D2012%26volume%3D1%26spage%3D29%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 6 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Andreas Stumpf, Zhigang Ken Cheng, Danial Beaudry, Remy Angelaud, <span class="NLM_string-name hlFld-ContribAuthor">Francis Gosselin</span>. </span><span class="cited-content_cbyCitation_article-title">Improved Synthesis of the Nav1.7 Inhibitor GDC-0276 via a Highly Regioselective SNAr Reaction. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2019,</strong> <em>23 </em>
                                    (9)
                                     , 1829-1840. <a href="https://doi.org/10.1021/acs.oprd.9b00082" title="DOI URL">https://doi.org/10.1021/acs.oprd.9b00082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.9b00082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.9b00082%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DImproved%252BSynthesis%252Bof%252Bthe%252BNav1.7%252BInhibitor%252BGDC-0276%252Bvia%252Ba%252BHighly%252BRegioselective%252BSNAr%252BReaction%26aulast%3DStumpf%26aufirst%3DAndreas%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D18022019%26date%3D16082019%26date%3D31072019%26volume%3D23%26issue%3D9%26spage%3D1829%26epage%3D1840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Cheng Zhang, Sailan Chang, Shanliang Dong, Lihua Qiu, <span class="NLM_string-name hlFld-ContribAuthor">Xinfang Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Acid-Promoted Bicyclization of Diaryl Alkynes: Synthesis of 2H-Indazoles with in Situ Generated Diazonium Salt as Nitrogen Source. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (16)
                                     , 9125-9136. <a href="https://doi.org/10.1021/acs.joc.8b01199" title="DOI URL">https://doi.org/10.1021/acs.joc.8b01199</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b01199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b01199%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAcid-Promoted%252BBicyclization%252Bof%252BDiaryl%252BAlkynes%25253A%252BSynthesis%252Bof%252B2H-Indazoles%252Bwith%252Bin%252BSitu%252BGenerated%252BDiazonium%252BSalt%252Bas%252BNitrogen%252BSource%26aulast%3DZhang%26aufirst%3DCheng%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D10052018%26date%3D21062018%26date%3D08062018%26volume%3D83%26issue%3D16%26spage%3D9125%26epage%3D9136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patrizia  LoPresti</span>. </span><span class="cited-content_cbyCitation_article-title">Silent Free Fall at Disease Onset: A Perspective on Therapeutics for Progressive Multiple Sclerosis. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Neurology</span><span> <strong>2018,</strong> <em>9 </em><a href="https://doi.org/10.3389/fneur.2018.00973" title="DOI URL">https://doi.org/10.3389/fneur.2018.00973</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fneur.2018.00973&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffneur.2018.00973%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Neurology%26atitle%3DSilent%252BFree%252BFall%252Bat%252BDisease%252BOnset%25253A%252BA%252BPerspective%252Bon%252BTherapeutics%252Bfor%252BProgressive%252BMultiple%252BSclerosis%26aulast%3DLoPresti%26aufirst%3DPatrizia%26date%3D2018%26date%3D2018%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Minghong  Lan</span>, <span class="hlFld-ContribAuthor ">Xiaoyi  Tang</span>, <span class="hlFld-ContribAuthor ">Jie  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhongxiang  Yao</span>. </span><span class="cited-content_cbyCitation_article-title">Insights in pathogenesis of multiple sclerosis: nitric oxide may induce mitochondrial dysfunction of oligodendrocytes. </span><span class="cited-content_cbyCitation_journal-name">Reviews in the Neurosciences</span><span> <strong>2017,</strong> <em>29 </em>
                                    (1)
                                     , 39-53. <a href="https://doi.org/10.1515/revneuro-2017-0033" title="DOI URL">https://doi.org/10.1515/revneuro-2017-0033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/revneuro-2017-0033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Frevneuro-2017-0033%26sid%3Dliteratum%253Aachs%26jtitle%3DReviews%2520in%2520the%2520Neurosciences%26atitle%3DInsights%252Bin%252Bpathogenesis%252Bof%252Bmultiple%252Bsclerosis%25253A%252Bnitric%252Boxide%252Bmay%252Binduce%252Bmitochondrial%252Bdysfunction%252Bof%252Boligodendrocytes%26aulast%3DLan%26aufirst%3DMinghong%26date%3D2017%26volume%3D29%26issue%3D1%26spage%3D39%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guanghao  Shi</span>, <span class="hlFld-ContribAuthor ">Xinwei  He</span>, <span class="hlFld-ContribAuthor ">Yongjia  Shang</span>, <span class="hlFld-ContribAuthor ">Liwei  Xiang</span>, <span class="hlFld-ContribAuthor ">Cheng  Yang</span>, <span class="hlFld-ContribAuthor ">Guang  Han</span>, <span class="hlFld-ContribAuthor ">Bing  Du</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 3′,4′-Diaryl-4′
              H
              -spiro[indoline-3,5′-[1′,2′,4′]oxadiazol]-2-ones
              via
              DMAP-catalyzed Domino Reactions and Their Antibacterial Activity. </span><span class="cited-content_cbyCitation_journal-name">Chinese Journal of Chemistry</span><span> <strong>2016,</strong> <em>34 </em>
                                    (9)
                                     , 901-909. <a href="https://doi.org/10.1002/cjoc.201600285" title="DOI URL">https://doi.org/10.1002/cjoc.201600285</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cjoc.201600285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcjoc.201600285%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Journal%2520of%2520Chemistry%26atitle%3DSynthesis%252Bof%252B3%2525E2%252580%2525B2%25252C4%2525E2%252580%2525B2-Diaryl-4%2525E2%252580%2525B2%252BH%252B-spiro%25255Bindoline-3%25252C5%2525E2%252580%2525B2-%25255B1%2525E2%252580%2525B2%25252C2%2525E2%252580%2525B2%25252C4%2525E2%252580%2525B2%25255Doxadiazol%25255D-2-ones%252Bvia%252BDMAP-catalyzed%252BDomino%252BReactions%252Band%252BTheir%252BAntibacterial%252BActivity%26aulast%3DShi%26aufirst%3DGuanghao%26date%3D2016%26date%3D2016%26volume%3D34%26issue%3D9%26spage%3D901%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jae Young  Lee</span>, <span class="hlFld-ContribAuthor ">Kasra  Taghian</span>, <span class="hlFld-ContribAuthor ">Steven  Petratos</span>. </span><span class="cited-content_cbyCitation_article-title">Axonal degeneration in multiple sclerosis: can we predict and prevent permanent disability?. </span><span class="cited-content_cbyCitation_journal-name">Acta Neuropathologica Communications</span><span> <strong>2014,</strong> <em>2 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s40478-014-0097-7" title="DOI URL">https://doi.org/10.1186/s40478-014-0097-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s40478-014-0097-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs40478-014-0097-7%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Neuropathologica%2520Communications%26atitle%3DAxonal%252Bdegeneration%252Bin%252Bmultiple%252Bsclerosis%25253A%252Bcan%252Bwe%252Bpredict%252Band%252Bprevent%252Bpermanent%252Bdisability%25253F%26aulast%3DLee%26aufirst%3DJae%2BYoung%26date%3D2014%26date%3D2014%26volume%3D2%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/medium/jm-2013-01881q_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/large/jm-2013-01881q_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401881q&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/medium/jm-2013-01881q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/large/jm-2013-01881q_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Compounds with sodium channel modulatory activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/large/jm-2013-01881q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401881q&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/medium/jm-2013-01881q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/large/jm-2013-01881q_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/large/jm-2013-01881q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401881q&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) R<sub>1</sub>-bromide/chloride, Cs<sub>2</sub>CO<sub>3</sub>, DMF; (b) TFA, TIPS, H<sub>2</sub>O, (c) ArCOOH, 2-(7-aza-1<i>H</i>-benzotriazole-1-yl)-1,1,3,3-tetramethyluroniumhexafluorophosphate (HATU); (d) ArSO<sub>2</sub>Cl, Na<sub>2</sub>CO<sub>3</sub>; (e) R<sub>1</sub>-alcohol, tributylphosphine, TMAD, PhMe.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/medium/jm-2013-01881q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/large/jm-2013-01881q_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Detail of activity of <b>6</b> (A) and <b>51</b> (B) against the Na<sub>v</sub>1.6 isoform. Blue triangles are block of the inactivated state, red circles are block of 10 Hz current, and black squares are block of tonic current.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/large/jm-2013-01881q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401881q&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/medium/jm-2013-01881q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/large/jm-2013-01881q_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. T-cell immunosuppressive activity of <b>6</b> in vivo. Mice received epicutaneous application of 25 μL of 2.5% oxazolone (OX) in acetone olive oil (AOO) 4:1 on day 0 on the dorsum of the ear. Animals received daily intraperitoneal (i.p.) injections of either vehicle (DMSO/Cremophor/phosphate buffered saline, 1:1:18) or <b>6</b> from day −1 to day 2. On day 3, the draining auricular lymph nodes were removed from three mice and pooled, and a single-cell suspension was made. Lymph node cells were counted, and 5 × 10<sup>5</sup> cells per well, in triplicate, were cultured overnight at 37 °C. T-cell proliferation was assessed using the CellTiter 96 AQ<sub>ueous</sub> Cell Proliferation Assay, which uses a MTS tetrazolium compound that is bioreduced by live cells. The resulting formazan product absorbance is recorded at 490 nM. The results represent the mean response ± SD of triplicate assays.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/large/jm-2013-01881q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401881q&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/medium/jm-2013-01881q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/large/jm-2013-01881q_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Retinal ganglion cells in the retina of mice (A) before or (B) after the development of optic neuritis. (C) Density of RGC. The box represents the 25th and 75th percentiles. The whiskers represent the fifth and 95th percentiles. The solid line represents the median. Differences between vehicle and drug-treated controls were assessed using Student’s <i>t</i> test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm401881q/production/images/large/jm-2013-01881q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401881q&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45786" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45786" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 52 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Tarnawa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolcskei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kocsis, P.</span><span> </span><span class="NLM_article-title">Blockers of voltage-gated sodium channels for the treatment of central nervous system diseases</span> <span class="citation_source-journal">Recent Pat. CNS Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.2174%2F157488907779561754" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=18221218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVWiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=57-78&author=I.+Tarnawaauthor=H.+Bolcskeiauthor=P.+Kocsis&title=Blockers+of+voltage-gated+sodium+channels+for+the+treatment+of+central+nervous+system+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Blockers of voltage-gated sodium channels for the treatment of central nervous system diseases</span></div><div class="casAuthors">Tarnawa, Istvan; Bolcskei, Hedvig; Kocsis, Pal</div><div class="citationInfo"><span class="NLM_cas:title">Recent Patents on CNS Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-78</span>CODEN:
                <span class="NLM_cas:coden">RPCDC9</span>;
        ISSN:<span class="NLM_cas:issn">1574-8898</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Voltage gated sodium channels play important roles both in vital physiol. functions and several pathol. processes of the central nervous system.  Epilepsy, chronic pain, neurodegenerative diseases, and spasticity are all characterized by an over-excited state of specific groups of central neurons that is accompanied by an abnormally increased activity of sodium channels.  An efficient strategy of controlling such diseases is to use blockers that preferentially act on these over-excited cells.  State dependently acting agents, such as phenytoin, or lamotrigine, leave normal physiol. functions relatively intact, resulting in a favorable therapeutic window.  Nine isoforms of the channel forming alpha subunit are known, which show distinct expression patterns in different tissues.  Another possible way to decrease the chance of adverse effects is to develop agents selectively inhibiting the channel subtype involved in the pathomechanism of the disease to be treated.  Many recent patents claim sodium channel blockers with improved characteristics regarding state dependency or subtype selectivity.  Such agents may offer a breakthrough in the treatment of a variety of central nervous system diseases.  This review focuses on the current trends in sodium channel research, surveying the traditional and newly emerging therapeutic fields, and the diverse medicinal chem. of sodium channel blockers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGNCqTFvaSNLVg90H21EOLACvtfcHk0lig-aQllMbHkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVWiurs%253D&md5=f2c492f5b77911ffbdc0213c2311dc7c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F157488907779561754&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157488907779561754%26sid%3Dliteratum%253Aachs%26aulast%3DTarnawa%26aufirst%3DI.%26aulast%3DBolcskei%26aufirst%3DH.%26aulast%3DKocsis%26aufirst%3DP.%26atitle%3DBlockers%2520of%2520voltage-gated%2520sodium%2520channels%2520for%2520the%2520treatment%2520of%2520central%2520nervous%2520system%2520diseases%26jtitle%3DRecent%2520Pat.%2520CNS%2520Drug%2520Discovery%26date%3D2007%26volume%3D2%26spage%3D57%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Mantegazza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biagini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ragsdale, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avoli, M.</span><span> </span><span class="NLM_article-title">Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1016%2FS1474-4422%2810%2970059-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=20298965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltF2ktLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=413-424&author=M.+Mantegazzaauthor=G.+Curiaauthor=G.+Biaginiauthor=D.+S.+Ragsdaleauthor=M.+Avoli&title=Voltage-gated+sodium+channels+as+therapeutic+targets+in+epilepsy+and+other+neurological+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders</span></div><div class="casAuthors">Mantegazza, Massimo; Curia, Giulia; Biagini, Giuseppe; Ragsdale, David S.; Avoli, Massimo</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">413-424</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Voltage-gated sodium channels (VGSCs) are key mediators of intrinsic neuronal and muscle excitability.  Abnormal VGSC activity is central to the pathophysiol. of epileptic seizures, and many of the most widely used antiepileptic drugs, including phenytoin, carbamazepine, and lamotrigine, are inhibitors of VGSC function.  These antiepileptic drugs might also be efficacious in the treatment of other nervous system disorders, such as migraine, multiple sclerosis, neurodegenerative diseases, and neuropathic pain.  In this Review, we summarise the structure and function of VGSCs and their involvement in the pathophysiol. of several neurol. disorders.  We also describe the biophys. and mol. bases for the mechanisms of action of antiepileptic VGSC blockers and discuss the efficacy of these drugs in the treatment of epileptic and non-epileptic disorders.  Overall, clin. and exptl. data indicate that these drugs are efficacious for a range of diseases, and that the development of drugs with enhanced selectivity for specific VGSC isoforms might be an effective and novel approach for the treatment of several neurol. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZU7nzgvD1tLVg90H21EOLACvtfcHk0lig-aQllMbHkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltF2ktLw%253D&md5=5c5768f89cc6157665ad45a3f680dfa5</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2810%2970059-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252810%252970059-4%26sid%3Dliteratum%253Aachs%26aulast%3DMantegazza%26aufirst%3DM.%26aulast%3DCuria%26aufirst%3DG.%26aulast%3DBiagini%26aufirst%3DG.%26aulast%3DRagsdale%26aufirst%3DD.%2BS.%26aulast%3DAvoli%26aufirst%3DM.%26atitle%3DVoltage-gated%2520sodium%2520channels%2520as%2520therapeutic%2520targets%2520in%2520epilepsy%2520and%2520other%2520neurological%2520disorders%26jtitle%3DLancet%2520Neurol.%26date%3D2010%26volume%3D9%26spage%3D413%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Choi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrell, M. J.</span><span> </span><span class="NLM_article-title">Review of lamotrigine and its clinical applications in epilepsy</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">251</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1517%2F14656566.4.2.243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=12562315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsV2ltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=243-251&author=H.+Choiauthor=M.+J.+Morrell&title=Review+of+lamotrigine+and+its+clinical+applications+in+epilepsy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Review of lamotrigine and its clinical applications in epilepsy</span></div><div class="casAuthors">Choi, Hyunmi; Morrell, Martha J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">243-251</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  Lamotrigine is an anti-epileptic agent with broad efficacy.  Lamotrigine works at voltage-sensitive sodium channels, thereby stabilizing the neuronal membrane and inhibiting the release of excitatory neurotransmitters such as glutamate and aspartate.  Early preclin. animal studies indicate its broad-spectrum efficacy, which was later confirmed in clin. trials.  Multiple randomized, placebo-controlled and comparative trials demonstrate its efficacy against partial and secondarily generalized seizures.  Open-label trials show its efficacy against generalised seizures, esp. absence seizures of childhood absence epilepsy and generalised seizures of juvenile myoclonic epilepsy.  Lamotrigine has a wide clin. dose range and possesses favorable pharmacokinetic properties.  It has a good tolerability and safety profile, which enhance compliance.  Its small risk of serious skin rash should be weighed against its potential benefits when choosing lamotrigine on an individual basis.  Lamotrigine is an excellent therapeutic option in epilepsy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD70P_UpvzerVg90H21EOLACvtfcHk0lig-aQllMbHkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsV2ltL0%253D&md5=60f1b236f51d87332ca1de23e5b2bfe8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1517%2F14656566.4.2.243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.4.2.243%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DMorrell%26aufirst%3DM.%2BJ.%26atitle%3DReview%2520of%2520lamotrigine%2520and%2520its%2520clinical%2520applications%2520in%2520epilepsy%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2003%26volume%3D4%26spage%3D243%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Ambrosio, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-Da-Silva, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvalho, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvalho, A. P.</span><span> </span><span class="NLM_article-title">Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2002&pages=121-130&author=A.+F.+Ambrosioauthor=P.+Soares-Da-Silvaauthor=C.+M.+Carvalhoauthor=A.+P.+Carvalho&title=Mechanisms+of+action+of+carbamazepine+and+its+derivatives%2C+oxcarbazepine%2C+BIA+2-093%2C+and+BIA+2-024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmbrosio%26aufirst%3DA.%2BF.%26aulast%3DSoares-Da-Silva%26aufirst%3DP.%26aulast%3DCarvalho%26aufirst%3DC.%2BM.%26aulast%3DCarvalho%26aufirst%3DA.%2BP.%26atitle%3DMechanisms%2520of%2520action%2520of%2520carbamazepine%2520and%2520its%2520derivatives%252C%2520oxcarbazepine%252C%2520BIA%25202-093%252C%2520and%2520BIA%25202-024%26jtitle%3DNeurochem.%2520Res.%26date%3D2002%26volume%3D27%26spage%3D121%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Errington, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stohr, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lees, G.</span><span> </span><span class="NLM_article-title">The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=157-169&author=A.+C.+Erringtonauthor=T.+Stohrauthor=C.+Heersauthor=G.+Lees&title=The+investigational+anticonvulsant+lacosamide+selectively+enhances+slow+inactivation+of+voltage-gated+sodium+channels"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DErrington%26aufirst%3DA.%2BC.%26aulast%3DStohr%26aufirst%3DT.%26aulast%3DHeers%26aufirst%3DC.%26aulast%3DLees%26aufirst%3DG.%26atitle%3DThe%2520investigational%2520anticonvulsant%2520lacosamide%2520selectively%2520enhances%2520slow%2520inactivation%2520of%2520voltage-gated%2520sodium%2520channels%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D73%26spage%3D157%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Catterall, W. A.</span><span> </span><span class="NLM_article-title">Voltage-gated sodium channels at 60: Structure, function and pathophysiology</span> <span class="citation_source-journal">J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">590</span><span class="NLM_x">, </span> <span class="NLM_fpage">2577</span><span class="NLM_x">–</span> <span class="NLM_lpage">2589</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1113%2Fjphysiol.2011.224204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=22473783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFGrs7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=590&publication_year=2012&pages=2577-2589&author=W.+A.+Catterall&title=Voltage-gated+sodium+channels+at+60%3A+Structure%2C+function+and+pathophysiology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage-gated sodium channels at 60: Structure, function and pathophysiology</span></div><div class="casAuthors">Catterall, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">590</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2577-2589</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Voltage-gated sodium channels initiate action potentials in nerve, muscle and other excitable cells.  The sodium current that initiates the nerve action potential was discovered by Hodgkin and Huxley using the voltage clamp technique in their landmark series of papers in The Journal of Physiol. in 1952.  They described sodium selectivity, voltage-dependent activation and fast inactivation, and they developed a quant. model for action potential generation that has endured for many decades.  This article gives an overview of the legacy that has evolved from their work, including development of conceptual models of sodium channel function, discovery of the sodium channel protein, anal. of its structure and function, detn. of its structure at high resoln., definition of the mechanism and structural basis for drug block, and exploration of the role of the sodium channel as a target for disease mutations.  Structural models for sodium selectivity and conductance, voltage-dependent activation, fast inactivation and drug block are discussed.  A perspective for the future envisions new advances in understanding the structural basis for sodium channel function, the role of sodium channels in disease and the opportunity for discovery of novel therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlKg4VZCpUSLVg90H21EOLACvtfcHk0ljbYUIZZjXgCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFGrs7fP&md5=483245655ea96e64c6c84ca7b086eaaa</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1113%2Fjphysiol.2011.224204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252Fjphysiol.2011.224204%26sid%3Dliteratum%253Aachs%26aulast%3DCatterall%26aufirst%3DW.%2BA.%26atitle%3DVoltage-gated%2520sodium%2520channels%2520at%252060%253A%2520Structure%252C%2520function%2520and%2520pathophysiology%26jtitle%3DJ.%2520Physiol.%26date%3D2012%26volume%3D590%26spage%3D2577%26epage%3D2589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Payandeh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamal El-Din, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheuer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catterall, W. A.</span><span> </span><span class="NLM_article-title">Crystal structure of a voltage-gated sodium channel in two potentially inactivated states</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">486</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1038%2Fnature11077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=22678296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BC38Xot1Cnurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=486&publication_year=2012&pages=135-139&author=J.+Payandehauthor=T.+M.+Gamal+El-Dinauthor=T.+Scheuerauthor=N.+Zhengauthor=W.+A.+Catterall&title=Crystal+structure+of+a+voltage-gated+sodium+channel+in+two+potentially+inactivated+states"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of a voltage-gated sodium channel in two potentially inactivated states</span></div><div class="casAuthors">Payandeh, Jian; Gamal El-Din, Tamer M.; Scheuer, Todd; Zheng, Ning; Catterall, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">486</span>
        (<span class="NLM_cas:issue">7401</span>),
    <span class="NLM_cas:pages">135-139</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In excitable cells, voltage-gated sodium (NaV) channels activate to initiate action potentials and then undergo fast and slow inactivation processes that terminate their ionic conductance.  Inactivation is a hallmark of NaV channel function and is crit. for control of membrane excitability, but the structural basis for this process has remained elusive.  Here we report crystallog. snapshots of the wild-type NaVAb channel from Arcobacter butzleri captured in two potentially inactivated states at 3.2 Å resoln.  Compared to previous structures of NaVAb channels with cysteine mutations in the pore-lining S6 helixes, the S6 helixes and the intracellular activation gate have undergone significant rearrangements: one pair of S6 helixes has collapsed towards the central pore axis and the other S6 pair has moved outward to produce a striking dimer-of-dimers configuration.  An increase in global structural asymmetry is obsd. throughout our wild-type NaVAb models, reshaping the ion selectivity filter at the extracellular end of the pore, the central cavity and its residues that are analogous to the mammalian drug receptor site, and the lateral pore fenestrations.  The voltage-sensing domains have also shifted around the perimeter of the pore module in wild-type NaVAb, compared to the mutant channel, and local structural changes identify a conserved interaction network that connects distant mol. determinants involved in NaV channel gating and inactivation.  These potential inactivated-state structures provide new insights into NaV channel gating and novel avenues to drug development and therapy for a range of debilitating NaV channelopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk0RF98ffBHLVg90H21EOLACvtfcHk0ljbYUIZZjXgCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xot1Cnurc%253D&md5=2cbb80a554fac794c973e6f9097c878d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature11077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11077%26sid%3Dliteratum%253Aachs%26aulast%3DPayandeh%26aufirst%3DJ.%26aulast%3DGamal%2BEl-Din%26aufirst%3DT.%2BM.%26aulast%3DScheuer%26aufirst%3DT.%26aulast%3DZheng%26aufirst%3DN.%26aulast%3DCatterall%26aufirst%3DW.%2BA.%26atitle%3DCrystal%2520structure%2520of%2520a%2520voltage-gated%2520sodium%2520channel%2520in%2520two%2520potentially%2520inactivated%2520states%26jtitle%3DNature%26date%3D2012%26volume%3D486%26spage%3D135%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Payandeh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheuer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catterall, W. A.</span><span> </span><span class="NLM_article-title">The crystal structure of a voltage-gated sodium channel</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">475</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1038%2Fnature10238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=21743477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1OmsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=475&publication_year=2011&pages=353-358&author=J.+Payandehauthor=T.+Scheuerauthor=N.+Zhengauthor=W.+A.+Catterall&title=The+crystal+structure+of+a+voltage-gated+sodium+channel"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The crystal structure of a voltage-gated sodium channel</span></div><div class="casAuthors">Payandeh, Jian; Scheuer, Todd; Zheng, Ning; Catterall, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">475</span>
        (<span class="NLM_cas:issue">7356</span>),
    <span class="NLM_cas:pages">353-358</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Voltage-gated sodium (NaV) channels initiate elec. signalling in excitable cells and are the mol. targets for drugs and disease mutations, but the structural basis for their voltage-dependent activation, ion selectivity and drug block is unknown.  Here, we report the crystal structure of a voltage-gated Na+ channel from Arcobacter butzleri (NavAb) captured in a closed-pore conformation with four activated voltage sensors at 2.7 Å resoln.  The arginine gating charges make multiple hydrophilic interactions within the voltage sensor, including unanticipated hydrogen bonds to the protein backbone.  Comparisons to previous open-pore potassium channel structures indicate that the voltage-sensor domains and the S4-S5 linkers dilate the central pore by pivoting together around a hinge at the base of the pore module.  The NavAb selectivity filter is short, ∼4.6 Å wide, and water filled, with four acidic side chains surrounding the narrowest part of the ion conduction pathway.  This unique structure presents a high-field-strength anionic coordination site, which confers Na+ selectivity through partial dehydration via direct interaction with glutamate side chains.  Fenestrations in the sides of the pore module are unexpectedly penetrated by fatty acyl chains that extend into the central cavity, and these portals are large enough for the entry of small, hydrophobic pore-blocking drugs.  This structure provides the template for understanding elec. signalling in excitable cells and the actions of drugs used for pain, epilepsy and cardiac arrhythmia at the at. level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWTPZUI8wqg7Vg90H21EOLACvtfcHk0ljbYUIZZjXgCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1OmsLs%253D&md5=b24b729f516809e422a526b9b7727ee7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature10238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10238%26sid%3Dliteratum%253Aachs%26aulast%3DPayandeh%26aufirst%3DJ.%26aulast%3DScheuer%26aufirst%3DT.%26aulast%3DZheng%26aufirst%3DN.%26aulast%3DCatterall%26aufirst%3DW.%2BA.%26atitle%3DThe%2520crystal%2520structure%2520of%2520a%2520voltage-gated%2520sodium%2520channel%26jtitle%3DNature%26date%3D2011%26volume%3D475%26spage%3D353%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Ulbricht, W.</span><span> </span><span class="NLM_article-title">Sodium channel inactivation: Molecular determinants and modulation</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">1271</span><span class="NLM_x">–</span> <span class="NLM_lpage">1301</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2005&pages=1271-1301&author=W.+Ulbricht&title=Sodium+channel+inactivation%3A+Molecular+determinants+and+modulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUlbricht%26aufirst%3DW.%26atitle%3DSodium%2520channel%2520inactivation%253A%2520Molecular%2520determinants%2520and%2520modulation%26jtitle%3DPhysiol.%2520Rev.%26date%3D2005%26volume%3D85%26spage%3D1271%26epage%3D1301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Lai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span> </span><span class="NLM_article-title">The role of voltage-gated sodium channels in neuropathic pain</span> <span class="citation_source-journal">Curr. Opin. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=291-297&author=J.+Laiauthor=J.+C.+Hunterauthor=F.+Porreca&title=The+role+of+voltage-gated+sodium+channels+in+neuropathic+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DJ.%26aulast%3DHunter%26aufirst%3DJ.%2BC.%26aulast%3DPorreca%26aufirst%3DF.%26atitle%3DThe%2520role%2520of%2520voltage-gated%2520sodium%2520channels%2520in%2520neuropathic%2520pain%26jtitle%3DCurr.%2520Opin.%2520Neurobiol.%26date%3D2003%26volume%3D13%26spage%3D291%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Wood, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boorman, J.</span><span> </span><span class="NLM_article-title">Voltage-gated sodium channel blockers; target validation and therapeutic potential</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">529</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.2174%2F1568026054367584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=16022675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsVKltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=529-537&author=J.+N.+Woodauthor=J.+Boorman&title=Voltage-gated+sodium+channel+blockers%3B+target+validation+and+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage-gated sodium channel blockers; target validation and therapeutic potential</span></div><div class="casAuthors">Wood, John N.; Boorman, James</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">529-537</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Voltage-gated sodium channels are encoded by a family of 10 structurally-related genes that are expressed in spatially and temporally distinct patterns, mainly in excitable tissues.  They underlie elec. signalling in nerve and muscle.  It has long been known that sodium channel blockers are anesthetics as well as powerful analgesics when delivered at low concns.  In addn., cardiac arrhythmias and epileptic activity can be treated with sodium channel blockers.  As we have learned more about the subtypes of sodium channels and their distribution, new therapeutic opportunities have suggested themselves.  There are indications that sodium channel blockers may also be useful in affective disorders and schizophrenia.  The prodn. of tissue-specific and eventually inducible knock out mice as well as genetic studies has proved useful in understanding the specialized role of individual types of sodium channels.  The development of subtype-specific blockers has proved slower than anticipated, although the properties of naturally occurring toxin blockers suggest that subtype-specific blockers of sodium channels could be very useful clin. in the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro0_4sFMQybrVg90H21EOLACvtfcHk0lhQ1W3EmFYkIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsVKltro%253D&md5=1ed688405bc9f975b23d61fc2ada387c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F1568026054367584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054367584%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DJ.%2BN.%26aulast%3DBoorman%26aufirst%3DJ.%26atitle%3DVoltage-gated%2520sodium%2520channel%2520blockers%253B%2520target%2520validation%2520and%2520therapeutic%2520potential%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D529%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Costigan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolf, C. J.</span><span> </span><span class="NLM_article-title">Neuropathic pain: A maladaptive response of the nervous system to damage</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1146%2Fannurev.neuro.051508.135531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=19400724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsV2nur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2009&pages=1-32&author=M.+Costiganauthor=J.+Scholzauthor=C.+J.+Woolf&title=Neuropathic+pain%3A+A+maladaptive+response+of+the+nervous+system+to+damage"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropathic pain: a maladaptive response of the nervous system to damage</span></div><div class="casAuthors">Costigan, Michael; Scholz, Joachim; Woolf, Clifford J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-32</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Neuropathic pain is triggered by lesions to the somatosensory nervous system that alter its structure and function so that pain occurs spontaneously and responses to noxious and innocuous stimuli are pathol. amplified.  The pain is an expression of maladaptive plasticity within the nociceptive system, a series of changes that constitute a neural disease state.  Multiple alterations distributed widely across the nervous system contribute to complex pain phenotypes.  These alterations include ectopic generation of action potentials, facilitation and disinhibition of synaptic transmission, loss of synaptic connectivity and formation of new synaptic circuits, and neuroimmune interactions.  Although neural lesions are necessary, they are not sufficient to generate neuropathic pain; genetic polymorphisms, gender, and age all influence the risk of developing persistent pain.  Treatment needs to move from merely suppressing symptoms to a disease-modifying strategy aimed at both preventing maladaptive plasticity and reducing intrinsic risk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodJvh-ROUpD7Vg90H21EOLACvtfcHk0lhQ1W3EmFYkIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsV2nur8%253D&md5=7869abfea9d20587dd6894eba3669cd2</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.051508.135531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.051508.135531%26sid%3Dliteratum%253Aachs%26aulast%3DCostigan%26aufirst%3DM.%26aulast%3DScholz%26aufirst%3DJ.%26aulast%3DWoolf%26aufirst%3DC.%2BJ.%26atitle%3DNeuropathic%2520pain%253A%2520A%2520maladaptive%2520response%2520of%2520the%2520nervous%2520system%2520to%2520damage%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D2009%26volume%3D32%26spage%3D1%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Dib-Hajj, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waxman, S. G.</span><span> </span><span class="NLM_article-title">Voltage-gated sodium channels: Therapeutic targets for pain</span> <span class="citation_source-journal">Pain Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1260</span><span class="NLM_x">–</span> <span class="NLM_lpage">1269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1111%2Fj.1526-4637.2009.00719.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=19818036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A280%3ADC%252BD1MnosVGguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=1260-1269&author=S.+D.+Dib-Hajjauthor=J.+A.+Blackauthor=S.+G.+Waxman&title=Voltage-gated+sodium+channels%3A+Therapeutic+targets+for+pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage-gated sodium channels: therapeutic targets for pain</span></div><div class="casAuthors">Dib-Hajj Sulayman D; Black Joel A; Waxman Stephen G</div><div class="citationInfo"><span class="NLM_cas:title">Pain medicine (Malden, Mass.)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1260-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To provide an overview of the role of voltage-gated sodium channels in pathophysiology of acquired and inherited pain states, and of recent developments that validate these channels as therapeutic targets for treating chronic pain.  BACKGROUND:  Neuropathic and inflammatory pain conditions are major medical needs worldwide with only partial or low efficacy treatment options currently available.  An important role of voltage-gated sodium channels in many different pain states has been established in animal models and, empirically, in humans, where sodium channel blockers partially ameliorate pain.  Animal studies have causally linked changes in sodium channel expression and modulation that alter channel gating properties or current density in nociceptor neurons to different pain states.  Biophysical and pharmacological studies have identified the sodium channel isoforms Na(v)1.3, Na(v)1.7, Na(v)1.8, and Na(v)1.9 as particularly important in the pathophysiology of different pain syndromes.  Recently, gain-of-function mutations in SCN9A, the gene which encodes Na(v)1.7, have been linked to two human-inherited pain syndromes, inherited erythromelalgia and paroxysmal extreme pain disorder, while loss-of-function mutations in SCN9A have been linked to complete insensitivity to pain.  Studies on firing properties of sensory neurons of dorsal root ganglia demonstrate that the effects of gain-of-function mutations in Na(v)1.7 on the excitability of these neurons depend on the presence of Na(v)1.8, which suggests a similar physiological interaction of these two channels in humans carrying the Na(v)1.7 pain mutation.  CONCLUSIONS:  These studies suggest that isoform-specific blockers of these channels or targeting of their modulators may provide novel approaches to treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS28A9K4ifO7potVjB3IRIyfW6udTcc2eYNuJ688keWALntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MnosVGguw%253D%253D&md5=9c25c528ab8a56e4132a85969196f372</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1111%2Fj.1526-4637.2009.00719.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1526-4637.2009.00719.x%26sid%3Dliteratum%253Aachs%26aulast%3DDib-Hajj%26aufirst%3DS.%2BD.%26aulast%3DBlack%26aufirst%3DJ.%2BA.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DVoltage-gated%2520sodium%2520channels%253A%2520Therapeutic%2520targets%2520for%2520pain%26jtitle%3DPain%2520Med.%26date%3D2009%26volume%3D10%26spage%3D1260%26epage%3D1269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Theile, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummins, T. R.</span><span> </span><span class="NLM_article-title">Recent developments regarding voltage-gated sodium channel blockers for the treatment of inherited and acquired neuropathic pain syndromes</span> <span class="citation_source-journal">Front. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.3389%2Ffphar.2011.00054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BC38Xis1ahsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=54&author=J.+W.+Theileauthor=T.+R.+Cummins&title=Recent+developments+regarding+voltage-gated+sodium+channel+blockers+for+the+treatment+of+inherited+and+acquired+neuropathic+pain+syndromes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments regarding voltage-gated sodium channel blockers for the treatment of inherited and acquired neuropathic pain syndromes</span></div><div class="casAuthors">Theile, Jonathan W.; Cummins, Theodore R.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology of Ion Channels and Channelopathies</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">Oct.</span>),
    <span class="NLM_cas:pages">54</span>CODEN:
                <span class="NLM_cas:coden">FPICA4</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  Chronic and neuropathic pain constitute significant health problems affecting millions of individuals each year.  Pain sensations typically originate in sensory neurons of the peripheral nervous system which relay information to the central nervous system (CNS).  Pathol. pain sensations can arise as result of changes in excitability of these peripheral sensory neurons.  Voltage-gated sodium channels are key determinants regulating action potential generation and propagation; thus, changes in sodium channel function can have profound effects on neuronal excitability and pain signaling.  At present, most of the clin. available sodium channel blockers used to treat pain are non-selective across sodium channel isoforms and can contribute to cardio-toxicity, motor impairments, and CNS side effects.  Numerous strides have been made over the last decade in an effort to develop more selective and efficacious sodium channel blockers to treat pain.  The purpose of this review is to highlight some of the more recent developments put forth by research universities and pharmaceutical companies alike in the pursuit of developing more targeted sodium channel therapies for the treatment of a variety of neuropathic pain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXOR22u6_qp7Vg90H21EOLACvtfcHk0lgDzABj-CXjKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xis1ahsQ%253D%253D&md5=5bdb937ce99cf54a253439f9bf03861b</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2011.00054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2011.00054%26sid%3Dliteratum%253Aachs%26aulast%3DTheile%26aufirst%3DJ.%2BW.%26aulast%3DCummins%26aufirst%3DT.%2BR.%26atitle%3DRecent%2520developments%2520regarding%2520voltage-gated%2520sodium%2520channel%2520blockers%2520for%2520the%2520treatment%2520of%2520inherited%2520and%2520acquired%2520neuropathic%2520pain%2520syndromes%26jtitle%3DFront.%2520Pharmacol.%26date%3D2011%26volume%3D2%26spage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Zuliani, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costantino, G.</span><span> </span><span class="NLM_article-title">Sodium channel blockers for neuropathic pain</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">755</span><span class="NLM_x">–</span> <span class="NLM_lpage">779</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1517%2F13543771003774118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=20384535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFWqtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=755-779&author=V.+Zulianiauthor=M.+Rivaraauthor=M.+Fantiniauthor=G.+Costantino&title=Sodium+channel+blockers+for+neuropathic+pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Sodium channel blockers for neuropathic pain</span></div><div class="casAuthors">Zuliani, Valentina; Rivara, Mirko; Fantini, Marco; Costantino, Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">755-779</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The voltage-gated sodium channels (VGSCs) play a fundamental role in controlling cellular excitability and their abnormal activity is related to several pathol. processes, including cardiac arrhythmias, epilepsy, neurodegenerative diseases, spasticity, chronic and neuropathic pain.  In particular, neuropathic pain (e.g., postherpetic and trigeminal neuralgia, diabetic neuropathy and spinal cord injury) is a serious clin. problem that affects a high percentage of the world population.  Because an altered sodium channel isoform expression profile has been considered one reason for the changes in neuronal excitability, there is a continuous quest for new selective mols. targeting sodium channels for the treatment of chronic pain.  Areas covered in this review: PubMed, , SciFinder Scholar and were used as sources for this review and patents between 2007 and Sept. 2009 were taken into account for the sodium channel blockers mol. classes reviewed and discussed herein.What the reader will gain: The sodium channel blockers reported in this review have been categorized into different mol. classes on the basis of their wide structural diversity.  This classification, somewhat arbitrary, does not necessarily reflect the presence of pharmacophoric elements but offers a useful way to discuss and comment on structurally homogenous classes of chemotypes recently patented.  Take home message: The continuous discoveries in the field of sodium channel blockers, highlighted by the increasing nos. of patent applications published in the last few years and by the nos. of compds. currently in clin. development, underline the importance of this target for the treatment of neuropathic pain.  The great difficulty in the design of new selective and active structures, not obtained from old VGSC blockers that are often assocd. with high risk of adverse effects, is a strong challenge for medicinal chem. research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7kOVgiikYPrVg90H21EOLACvtfcHk0lgDzABj-CXjKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFWqtrs%253D&md5=375ee344a170ee1418c2e4f65e3fa7d2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1517%2F13543771003774118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543771003774118%26sid%3Dliteratum%253Aachs%26aulast%3DZuliani%26aufirst%3DV.%26aulast%3DRivara%26aufirst%3DM.%26aulast%3DFantini%26aufirst%3DM.%26aulast%3DCostantino%26aufirst%3DG.%26atitle%3DSodium%2520channel%2520blockers%2520for%2520neuropathic%2520pain%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D755%26epage%3D779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Hoyt, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">London, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyvratt, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbadie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felix, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priest, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaczorowski, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, W. H.</span><span> </span><span class="NLM_article-title">Discovery of a novel class of benzazepinone Na<sub>v</sub>1.7 blockers: Potential treatments for neuropathic pain</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4630</span><span class="NLM_x">–</span> <span class="NLM_lpage">4634</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4630-4634&author=S.+B.+Hoytauthor=C.+Londonauthor=D.+Gorinauthor=M.+J.+Wyvrattauthor=M.+H.+Fisherauthor=C.+Abbadieauthor=J.+P.+Felixauthor=M.+L.+Garciaauthor=X.+Liauthor=K.+A.+Lyonsauthor=E.+McGowanauthor=D.+E.+MacIntyreauthor=W.+J.+Martinauthor=B.+T.+Priestauthor=A.+Ritterauthor=M.+M.+Smithauthor=V.+A.+Warrenauthor=B.+S.+Williamsauthor=G.+J.+Kaczorowskiauthor=W.+H.+Parsons&title=Discovery+of+a+novel+class+of+benzazepinone+Nav1.7+blockers%3A+Potential+treatments+for+neuropathic+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoyt%26aufirst%3DS.%2BB.%26aulast%3DLondon%26aufirst%3DC.%26aulast%3DGorin%26aufirst%3DD.%26aulast%3DWyvratt%26aufirst%3DM.%2BJ.%26aulast%3DFisher%26aufirst%3DM.%2BH.%26aulast%3DAbbadie%26aufirst%3DC.%26aulast%3DFelix%26aufirst%3DJ.%2BP.%26aulast%3DGarcia%26aufirst%3DM.%2BL.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DMcGowan%26aufirst%3DE.%26aulast%3DMacIntyre%26aufirst%3DD.%2BE.%26aulast%3DMartin%26aufirst%3DW.%2BJ.%26aulast%3DPriest%26aufirst%3DB.%2BT.%26aulast%3DRitter%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DM.%2BM.%26aulast%3DWarren%26aufirst%3DV.%2BA.%26aulast%3DWilliams%26aufirst%3DB.%2BS.%26aulast%3DKaczorowski%26aufirst%3DG.%2BJ.%26aulast%3DParsons%26aufirst%3DW.%2BH.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520class%2520of%2520benzazepinone%2520Nav1.7%2520blockers%253A%2520Potential%2520treatments%2520for%2520neuropathic%2520pain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4630%26epage%3D4634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Hoyt, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">London, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbadie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felix, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jochnowitz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karanam, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priest, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas-Fowlkes, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaczorowski, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffy, J. L.</span><span> </span><span class="NLM_article-title">A novel benzazepinone sodium channel blocker with oral efficacy in a rat model of neuropathic pain</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3640</span><span class="NLM_x">–</span> <span class="NLM_lpage">3645</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=3640-3645&author=S.+B.+Hoytauthor=C.+Londonauthor=C.+Abbadieauthor=J.+P.+Felixauthor=M.+L.+Garciaauthor=N.+Jochnowitzauthor=B.+V.+Karanamauthor=X.+Liauthor=K.+A.+Lyonsauthor=E.+McGowanauthor=B.+T.+Priestauthor=M.+M.+Smithauthor=V.+A.+Warrenauthor=B.+S.+Thomas-Fowlkesauthor=G.+J.+Kaczorowskiauthor=J.+L.+Duffy&title=A+novel+benzazepinone+sodium+channel+blocker+with+oral+efficacy+in+a+rat+model+of+neuropathic+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoyt%26aufirst%3DS.%2BB.%26aulast%3DLondon%26aufirst%3DC.%26aulast%3DAbbadie%26aufirst%3DC.%26aulast%3DFelix%26aufirst%3DJ.%2BP.%26aulast%3DGarcia%26aufirst%3DM.%2BL.%26aulast%3DJochnowitz%26aufirst%3DN.%26aulast%3DKaranam%26aufirst%3DB.%2BV.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DMcGowan%26aufirst%3DE.%26aulast%3DPriest%26aufirst%3DB.%2BT.%26aulast%3DSmith%26aufirst%3DM.%2BM.%26aulast%3DWarren%26aufirst%3DV.%2BA.%26aulast%3DThomas-Fowlkes%26aufirst%3DB.%2BS.%26aulast%3DKaczorowski%26aufirst%3DG.%2BJ.%26aulast%3DDuffy%26aufirst%3DJ.%2BL.%26atitle%3DA%2520novel%2520benzazepinone%2520sodium%2520channel%2520blocker%2520with%2520oral%2520efficacy%2520in%2520a%2520rat%2520model%2520of%2520neuropathic%2520pain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D3640%26epage%3D3645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Waxman, S. G.</span><span> </span><span class="NLM_article-title">Mechanisms of disease: Sodium channels and neuroprotection in multiple sclerosis-current status</span> <span class="citation_source-journal">Nat. Clin. Pract. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1038%2Fncpneuro0735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=18227822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivVyjt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=159-169&author=S.+G.+Waxman&title=Mechanisms+of+disease%3A+Sodium+channels+and+neuroprotection+in+multiple+sclerosis-current+status"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of Disease: sodium channels and neuroprotection in multiple sclerosis-current status</span></div><div class="casAuthors">Waxman, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Clinical Practice Neurology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">159-169</span>CODEN:
                <span class="NLM_cas:coden">NCPND4</span>;
        ISSN:<span class="NLM_cas:issn">1745-834X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Axon degeneration is a major contributor to disability in multiple sclerosis, and sodium channels have been shown to have a crucial role in this process.  In this article, Waxman reviews the development of the concept of sodium channel blockers as neuroprotectants in multiple sclerosis, and discusses recent attempts to translate this approach from the lab. to the clinic.  Sodium channels can provide a route for a persistent influx of sodium ions into neurons.  Over the past decade, it has emerged that sustained sodium influx can, in turn, trigger calcium ion influx, which produces axonal injury in neuroinflammatory disorders such as multiple sclerosis (MS).  The development of sodium channel blockers as potential neuroprotectants in MS has proceeded rapidly, and two clin. trials are currently ongoing.  The route from the lab. to the clinic includes some complex turns, however, and a third trial was recently put on hold because of new data that suggested that sodium channel blockers might have multiple, complex actions.  This article reviews the development of the concept of sodium channel blockers as neuroprotectants in MS, the path from lab. to clinic, and the current status of research in this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzVatshdLc57Vg90H21EOLACvtfcHk0lhN_8EQVckYlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivVyjt7c%253D&md5=79a934e9b60a4732a88f03054fdc1507</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fncpneuro0735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncpneuro0735%26sid%3Dliteratum%253Aachs%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DMechanisms%2520of%2520disease%253A%2520Sodium%2520channels%2520and%2520neuroprotection%2520in%2520multiple%2520sclerosis-current%2520status%26jtitle%3DNat.%2520Clin.%2520Pract.%2520Neurol.%26date%3D2008%26volume%3D4%26spage%3D159%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Mongin, A. A.</span><span> </span><span class="NLM_article-title">Disruption of ionic and cell volume homeostasis in cerebral ischemia: The perfect storm</span> <span class="citation_source-journal">Pathophysiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1016%2Fj.pathophys.2007.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=17961999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSnsrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=183-193&author=A.+A.+Mongin&title=Disruption+of+ionic+and+cell+volume+homeostasis+in+cerebral+ischemia%3A+The+perfect+storm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Disruption of ionic and cell volume homeostasis in cerebral ischemia: The perfect storm</span></div><div class="casAuthors">Mongin, Alexander A.</div><div class="citationInfo"><span class="NLM_cas:title">Pathophysiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">183-193</span>CODEN:
                <span class="NLM_cas:coden">PTHOE7</span>;
        ISSN:<span class="NLM_cas:issn">0928-4680</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The mechanisms of brain tissue damage in stroke are strongly linked to the phenomenon of excitotoxicity, which is defined as damage or death of neural cells due to excessive activation of receptors for the excitatory neurotransmitters glutamate and aspartate.  Under physiol. conditions, ionotropic glutamate receptors mediate the processes of excitatory neurotransmission and synaptic plasticity.  In ischemia, sustained pathol. release of glutamate from neurons and glial cells causes prolonged activation of these receptors, resulting in massive depolarization and cytoplasmic Ca2+ overload.  High cytoplasmic levels of Ca2+ activate many degradative processes that, depending on the metabolic status, cause immediate or delayed death of neural cells.  This traditional view has been expanded by a no. of observations that implicate Cl- channels and several types of non-channel transporter proteins, such as the Na+,K+,2Cl- cotransporter, Na+/H+ exchanger, and Na+/Ca2+ exchanger, in the development of glutamate toxicity.  Some of these ion transporters increase tissue damage by promoting pathol. cell swelling and necrotic cell death, while others contribute to a long-term accumulation of cytoplasmic Ca2+.  This brief review is aimed at illustrating how the dysregulation of various ion transport processes combine in a perfect storm' that disrupts neural ionic homeostasis and culminates in the irreversible damage and death of neural cells.  The clin. relevance of individual transporters as targets for therapeutic intervention in stroke is also briefly discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1-1rnjhWuULVg90H21EOLACvtfcHk0lhN_8EQVckYlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSnsrbO&md5=2c7d2872b7f9996a4041b0504dd39a57</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.pathophys.2007.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pathophys.2007.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DMongin%26aufirst%3DA.%2BA.%26atitle%3DDisruption%2520of%2520ionic%2520and%2520cell%2520volume%2520homeostasis%2520in%2520cerebral%2520ischemia%253A%2520The%2520perfect%2520storm%26jtitle%3DPathophysiology%26date%3D2007%26volume%3D14%26spage%3D183%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Stankowski, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, R.</span><span> </span><span class="NLM_article-title">Therapeutic targets for neuroprotection in acute ischemic stroke: Lost in translation?</span> <span class="citation_source-journal">Antioxid. Redox Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1841</span><span class="NLM_x">–</span> <span class="NLM_lpage">1851</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1089%2Fars.2010.3292" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=20626319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVSqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=1841-1851&author=J.+N.+Stankowskiauthor=R.+Gupta&title=Therapeutic+targets+for+neuroprotection+in+acute+ischemic+stroke%3A+Lost+in+translation%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Targets for Neuroprotection in Acute Ischemic Stroke: Lost in Translation?</span></div><div class="casAuthors">Stankowski, Jeannette N.; Gupta, Rishi</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1841-1851</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  The development of a suitable neuroprotective agent to treat ischemic stroke has failed when transitioned to the clin. setting.  An understanding of the mol. mechanisms involved in neuronal injury during ischemic stroke is important, but must be placed in the clin. context.  Current therapeutic targets have focused on the preservation of the ischemic penumbra in the hope of improving clin. outcomes.  Unfortunately, most patients in the ultra-early time windows harbor penumbra but have tremendous variability in the size of the core infarct, the ultimate predictor of prognosis.  Understanding this variability may allow for proper patient selection that may better correlate to bench models.  Reperfusion therapies are rapidly evolving and have been shown to improve clin. outcomes.  The use of neuroprotective agents to prolong time windows prior to reperfusion or to prevent reperfusion injury may present future therapeutic targets for the treatment of ischemic stroke.  We review the mol. pathways and the clin. context from which future targets may be identified.  Antioxid. Redox Signal. 14, 1841-1851.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuCxAoHY0FY7Vg90H21EOLACvtfcHk0lhDKiaAJlv2Pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVSqsrk%253D&md5=d73db001d0ca7c944d11e0f086724acf</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1089%2Fars.2010.3292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2010.3292%26sid%3Dliteratum%253Aachs%26aulast%3DStankowski%26aufirst%3DJ.%2BN.%26aulast%3DGupta%26aufirst%3DR.%26atitle%3DTherapeutic%2520targets%2520for%2520neuroprotection%2520in%2520acute%2520ischemic%2520stroke%253A%2520Lost%2520in%2520translation%253F%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2011%26volume%3D14%26spage%3D1841%26epage%3D1851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Crumrine, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrand, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faison, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, B. R.</span><span> </span><span class="NLM_article-title">Lamotrigine protects hippocampal CA1 neurons from ischemic damage after cardiac arrest</span> <span class="citation_source-journal">Stroke</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">2230</span><span class="NLM_x">–</span> <span class="NLM_lpage">2236</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1997&pages=2230-2236&author=R.+C.+Crumrineauthor=K.+Bergstrandauthor=A.+T.+Cooperauthor=W.+L.+Faisonauthor=B.+R.+Cooper&title=Lamotrigine+protects+hippocampal+CA1+neurons+from+ischemic+damage+after+cardiac+arrest"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrumrine%26aufirst%3DR.%2BC.%26aulast%3DBergstrand%26aufirst%3DK.%26aulast%3DCooper%26aufirst%3DA.%2BT.%26aulast%3DFaison%26aufirst%3DW.%2BL.%26aulast%3DCooper%26aufirst%3DB.%2BR.%26atitle%3DLamotrigine%2520protects%2520hippocampal%2520CA1%2520neurons%2520from%2520ischemic%2520damage%2520after%2520cardiac%2520arrest%26jtitle%3DStroke%26date%3D1997%26volume%3D28%26spage%3D2230%26epage%3D2236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Fujitani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kataoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, T.</span><span> </span><span class="NLM_article-title">Lidocaine protects hippocampal neurons against ischemic damage by preventing increase of extracellular excitatory amino acids: A microdialysis study in Mongolian gerbils</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=1994&pages=91-94&author=T.+Fujitaniauthor=N.+Adachiauthor=H.+Miyazakiauthor=K.+Liuauthor=Y.+Nakamuraauthor=K.+Kataokaauthor=T.+Arai&title=Lidocaine+protects+hippocampal+neurons+against+ischemic+damage+by+preventing+increase+of+extracellular+excitatory+amino+acids%3A+A+microdialysis+study+in+Mongolian+gerbils"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFujitani%26aufirst%3DT.%26aulast%3DAdachi%26aufirst%3DN.%26aulast%3DMiyazaki%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DKataoka%26aufirst%3DK.%26aulast%3DArai%26aufirst%3DT.%26atitle%3DLidocaine%2520protects%2520hippocampal%2520neurons%2520against%2520ischemic%2520damage%2520by%2520preventing%2520increase%2520of%2520extracellular%2520excitatory%2520amino%2520acids%253A%2520A%2520microdialysis%2520study%2520in%2520Mongolian%2520gerbils%26jtitle%3DNeurosci.%2520Lett.%26date%3D1994%26volume%3D179%26spage%3D91%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Graham, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, R. P.</span><span> </span><span class="NLM_article-title">Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">854</span><span class="NLM_x">–</span> <span class="NLM_lpage">859</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=7910213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADyaK2cXkt1KmtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=854-859&author=S.+H.+Grahamauthor=J.+Chenauthor=J.+Lanauthor=M.+J.+Leachauthor=R.+P.+Simon&title=Neuroprotective+effects+of+a+use-dependent+blocker+of+voltage-dependent+sodium+channels%2C+BW619C89%2C+in+rat+middle+cerebral+artery+occlusion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion</span></div><div class="casAuthors">Graham, Steven H.; Chen, Jun; Lan, Jingquan; Leach, Michael J.; Simon, Roger P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">269</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">854-9</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">BW619C89 [4-amino-2-(4-methyl-1-piperazinyl)-5-(2,3,5-trichlorophenyl)pyrimidine] is a use-dependent blocker of voltage-dependent sodium channels that blocks veratrine-induced glutamate release in vitro.  The aim of this study is to det. if BW619C89 inhibits glutamate release and is neuroprotective in cerebral ischemia produced by proximal middle cerebral artery (MCA) occlusion in rats.  Infarct vol. was detd. at 24 h after permanent MCA occlusion from 2,3,5-triphenyltetrazolim hydrochloride-stained sections.  Pretreatment with BW619C89 (10, 20, 30 and 50 mg/kg i.v. of mesylate salt) decreased infarct vol. in a dose-dependent fashion maximal at 30 mg/kg compared to saline controls.  Treatment with 30 mg/kg up to 45 min after MCA occlusion also was effective.  Microdialyzate glutamate in rats treated with 30 mg/kg of drug before MCA occlusion was decreased in both caudate (ischemic core) and rostral cortex (penumbra) compared to controls.  BW619C89 did not induce significant arterial hypotension, except when it was administered by rapid bolus administration.  In this case, the hypotension was transient and did not reduce efficacy or superficial cortical blood flow.  BW619C89 did not induce the 72 kDa heat shock protein in cingulate gyrus or retrospleniald cortex as did MK801, suggesting that BW619C89 does not injure neurons in these regions as do N-methyl-D-aspartate antagonists.  These results suggest that inhibition of glutamate release by BW619C89 may be an effective and nontoxic treatment for stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAYi7iB3fv5rVg90H21EOLACvtfcHk0lhDKiaAJlv2Pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkt1KmtL0%253D&md5=d98f5ba882a388e8ccf1b54e79ee91d8</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGraham%26aufirst%3DS.%2BH.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DLeach%26aufirst%3DM.%2BJ.%26aulast%3DSimon%26aufirst%3DR.%2BP.%26atitle%3DNeuroprotective%2520effects%2520of%2520a%2520use-dependent%2520blocker%2520of%2520voltage-dependent%2520sodium%2520channels%252C%2520BW619C89%252C%2520in%2520rat%2520middle%2520cerebral%2520artery%2520occlusion%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1994%26volume%3D269%26spage%3D854%26epage%3D859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Lekieffre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meldrum, B. S.</span><span> </span><span class="NLM_article-title">The pyrimidine-derivative, BW1003C87, protects CA1 and striatal neurons following transient severe forebrain ischaemia in rats. A microdialysis and histological study</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1993&pages=93-99&author=D.+Lekieffreauthor=B.+S.+Meldrum&title=The+pyrimidine-derivative%2C+BW1003C87%2C+protects+CA1+and+striatal+neurons+following+transient+severe+forebrain+ischaemia+in+rats.+A+microdialysis+and+histological+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLekieffre%26aufirst%3DD.%26aulast%3DMeldrum%26aufirst%3DB.%2BS.%26atitle%3DThe%2520pyrimidine-derivative%252C%2520BW1003C87%252C%2520protects%2520CA1%2520and%2520striatal%2520neurons%2520following%2520transient%2520severe%2520forebrain%2520ischaemia%2520in%2520rats.%2520A%2520microdialysis%2520and%2520histological%2520study%26jtitle%3DNeuroscience%26date%3D1993%26volume%3D56%26spage%3D93%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Cheng, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Khoury, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zivin, J. A.</span><span> </span><span class="NLM_article-title">Neuroprotection for ischemic stroke: Two decades of success and failure</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=36-45&author=Y.+D.+Chengauthor=L.+Al-Khouryauthor=J.+A.+Zivin&title=Neuroprotection+for+ischemic+stroke%3A+Two+decades+of+success+and+failure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%2BD.%26aulast%3DAl-Khoury%26aufirst%3DL.%26aulast%3DZivin%26aufirst%3DJ.%2BA.%26atitle%3DNeuroprotection%2520for%2520ischemic%2520stroke%253A%2520Two%2520decades%2520of%2520success%2520and%2520failure%26jtitle%3DNeuroRx%26date%3D2004%26volume%3D1%26spage%3D36%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Onteniente, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasika, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benchoua, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guegan, C.</span><span> </span><span class="NLM_article-title">Molecular pathways in cerebral ischemia: Cues to novel therapeutic strategies</span> <span class="citation_source-journal">Mol. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1385%2FMN%3A27%3A1%3A33" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=12668901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtl2gtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2003&pages=33-72&author=B.+Ontenienteauthor=S.+Rasikaauthor=A.+Benchouaauthor=C.+Guegan&title=Molecular+pathways+in+cerebral+ischemia%3A+Cues+to+novel+therapeutic+strategies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular pathways in cerebral ischemia: Cues to novel therapeutic strategies</span></div><div class="casAuthors">Onteniente, Brigitte; Rasika, Sowmyalakshmi; Benchoua, Alexandra; Guegan, Christelle</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-72</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review with refs.  Stroke is one of the leading causes of death and severe disability in most industrialized countries.  Despite the extensive research efforts of both academic and industrial labs. during the last few decades, no changes have been brought about by the design of neuroprotective therapies.  The progressive decrease of stroke-induced death and disability is entirely attributable to improvements in the identification and redn. of risk factors.  Over the past few years, exptl. research has led to the emergence of a wealth of information regarding the complex and interrelated processes of neuronal degeneration and death triggered by ischemia.  This unprecedented insight has led to new theories on the mechanisms of ischemic damage, and has suggested new targets and strategies for therapeutic intervention designed to reduce the clin. consequences of stroke.  Among current developments, three strategies seem particularly appealing-namely, the limitation of initial or secondary neuronal death by inhibition of apoptotic mechanisms, the enhancement of the endogenous capacity of nervous structures to restore lost function, and the replacement of lost cells by transplantation therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGormEwCCnRR3bVg90H21EOLACvtfcHk0ljBFqNyGl5AuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtl2gtb0%253D&md5=b3561d41a729509ca59a53d7438f5ad4</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1385%2FMN%3A27%3A1%3A33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FMN%253A27%253A1%253A33%26sid%3Dliteratum%253Aachs%26aulast%3DOnteniente%26aufirst%3DB.%26aulast%3DRasika%26aufirst%3DS.%26aulast%3DBenchoua%26aufirst%3DA.%26aulast%3DGuegan%26aufirst%3DC.%26atitle%3DMolecular%2520pathways%2520in%2520cerebral%2520ischemia%253A%2520Cues%2520to%2520novel%2520therapeutic%2520strategies%26jtitle%3DMol.%2520Neurobiol.%26date%3D2003%26volume%3D27%26spage%3D33%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Kapoor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altmann, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chataway, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. H.</span><span> </span><span class="NLM_article-title">Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: A randomised, double-blind, placebo-controlled, parallel-group trial</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">681</span><span class="NLM_x">–</span> <span class="NLM_lpage">688</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1016%2FS1474-4422%2810%2970131-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=20621711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsFajur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=681-688&author=R.+Kapoorauthor=J.+Furbyauthor=T.+Haytonauthor=K.+J.+Smithauthor=D.+R.+Altmannauthor=R.+Brennerauthor=J.+Chatawayauthor=R.+A.+Hughesauthor=D.+H.+Miller&title=Lamotrigine+for+neuroprotection+in+secondary+progressive+multiple+sclerosis%3A+A+randomised%2C+double-blind%2C+placebo-controlled%2C+parallel-group+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial</span></div><div class="casAuthors">Kapoor, Raju; Furby, Julian; Hayton, Thomas; Smith, Kenneth J.; Altmann, Daniel R.; Brenner, Robert; Chataway, Jeremy; Hughes, Richard A. C.; Miller, David H.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">681-688</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Partial blockade of voltage-gated sodium channels is neuroprotective in exptl. models of inflammatory demyelinating disease.  In this phase 2 trial, we aimed to assess whether the sodium-channel blocker lamotrigine is also neuroprotective in patients with secondary progressive multiple sclerosis.  Patients with secondary progressive multiple sclerosis who attended the National Hospital for Neurol. and Neurosurgery or the Royal Free Hospital, London, UK, were eligible for inclusion in this double-blind, parallel-group trial.  Patients were randomly assigned via a website by minimisation to receive lamotrigine (target dose 400 mg/day) or placebo for 2 years.  Treating physicians, evaluating physicians, and patients were masked to treatment allocation.  The primary outcome was the rate of change of partial (central) cerebral vol. over 24 mo.  All patients who were randomly assigned were included in the primary anal.  This trial is registered with ClinicalTrials.gov, NCT00257855.  120 patients were randomly assigned to treatment (87 women and 33 men): 61 to lamotrigine and 59 to placebo.  108 Patients were analyzed for the primary endpoint: 52 in the lamotrigine group and 56 in the placebo group.  The mean change in partial (central) cerebral vol. per yr was -3.18 mL (SD -1.25) in the lamotrigine group and -2.48 mL (-0.97) in the placebo group (difference -0.71 mL, 95% CI -2.56 to 1.15; p = 0.40).  However, in an exploratory modeling anal., lamotrigine treatment seemed to be assocd. with greater partial (central) cerebral vol. loss than was placebo in the first year (p = 0.04), and vol. increased partially after treatment stopped (p = 0.04).  Lamotrigine treatment reduced the deterioration of the timed 25-ft walk (p = 0.02) but did not affect other secondary clin. outcome measures.  Rash and dose-related deterioration of gait and balance were experienced more by patients in the lamotrigine group than the placebo group.  The effect of lamotrigine on cerebral vol. of patients with secondary progressive multiple sclerosis did not differ from that of placebo over 24 mo, but lamotrigine seemed to cause early vol. loss that reversed partially on discontinuation of treatment.  Future trials of neuroprotection in multiple sclerosis should include investigation of complex early vol. changes in different compartments of the CNS, effects unrelated to neurodegeneration, and targeting of earlier and more inflammatory disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4qviTFXv17bVg90H21EOLACvtfcHk0ljBFqNyGl5AuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsFajur4%253D&md5=eb768255a842df2b97899df819f34b5c</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2810%2970131-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252810%252970131-9%26sid%3Dliteratum%253Aachs%26aulast%3DKapoor%26aufirst%3DR.%26aulast%3DFurby%26aufirst%3DJ.%26aulast%3DHayton%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DAltmann%26aufirst%3DD.%2BR.%26aulast%3DBrenner%26aufirst%3DR.%26aulast%3DChataway%26aufirst%3DJ.%26aulast%3DHughes%26aufirst%3DR.%2BA.%26aulast%3DMiller%26aufirst%3DD.%2BH.%26atitle%3DLamotrigine%2520for%2520neuroprotection%2520in%2520secondary%2520progressive%2520multiple%2520sclerosis%253A%2520A%2520randomised%252C%2520double-blind%252C%2520placebo-controlled%252C%2520parallel-group%2520trial%26jtitle%3DLancet%2520Neurol.%26date%3D2010%26volume%3D9%26spage%3D681%26epage%3D688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Van der Walt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butzkueven, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolbe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marriott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexandrou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gresle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilpatrick, T.</span><span> </span><span class="NLM_article-title">Neuroprotection in multiple sclerosis: A therapeutic challenge for the next decade</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">82</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1016%2Fj.pharmthera.2010.01.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=20122960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjt1KgsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2010&pages=82-93&author=A.+Van+der+Waltauthor=H.+Butzkuevenauthor=S.+Kolbeauthor=M.+Marriottauthor=E.+Alexandrouauthor=M.+Gresleauthor=G.+Eganauthor=T.+Kilpatrick&title=Neuroprotection+in+multiple+sclerosis%3A+A+therapeutic+challenge+for+the+next+decade"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotection in multiple sclerosis: A therapeutic challenge for the next decade</span></div><div class="casAuthors">Van der Walt, Anneke; Butzkueven, Helmut; Kolbe, Scott; Marriott, Mark; Alexandrou, Estella; Gresle, Melissa; Egan, Gary; Kilpatrick, Trevor</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">82-93</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Multiple sclerosis (MS) is the commonest cause of progressive neurol. disability amongst young, Caucasian adults.  MS is considered to be an auto-immune disease that results from an attack against myelin, the layer which surrounds axons.  The pathophysiol. of MS is complex, with both demyelination and axonal degeneration contributing to what is essentially an inflammatory neurodegenerative disease.  Axonal loss is increasingly being accepted as the histopathol. correlate of neurol. disability.  Currently, the underpinnings of neurodegeneration in MS, and how to promote neuroprotection are only partly understood.  No established treatments that directly reduce nervous system damage or enhance its repair are currently available.  Moreover, the ability of currently available immunomodulatory therapies used to treat MS, such as interferon-β, to prevent long-term disability is uncertain.  Results from short-term randomized-controlled trials suggest a partial benefit with regards to disability outcomes, but this is yet to be established in long-term studies.  Novel neuroprotective agents have been identified in preclin. studies but their development is being hampered by the absence of appropriate clin. platforms to test them.  In this article, we will discuss some of the principal therapeutic candidates that could provide neuroprotection in MS and emerging methodologies by which to test them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof51fBmuweUbVg90H21EOLACvtfcHk0ljBFqNyGl5AuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjt1KgsL4%253D&md5=306d97851cf31315df8ad0d4515ade97</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2010.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2010.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bder%2BWalt%26aufirst%3DA.%26aulast%3DButzkueven%26aufirst%3DH.%26aulast%3DKolbe%26aufirst%3DS.%26aulast%3DMarriott%26aufirst%3DM.%26aulast%3DAlexandrou%26aufirst%3DE.%26aulast%3DGresle%26aufirst%3DM.%26aulast%3DEgan%26aufirst%3DG.%26aulast%3DKilpatrick%26aufirst%3DT.%26atitle%3DNeuroprotection%2520in%2520multiple%2520sclerosis%253A%2520A%2520therapeutic%2520challenge%2520for%2520the%2520next%2520decade%26jtitle%3DPharmacol.%2520Ther.%26date%3D2010%26volume%3D126%26spage%3D82%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Yu, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catterall, W. A.</span><span> </span><span class="NLM_article-title">Overview of the voltage-gated sodium channel family</span> <span class="citation_source-journal">Genome Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1186%2Fgb-2003-4-3-207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=12620097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A280%3ADC%252BD3s7gvVWrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=207&author=F.+H.+Yuauthor=W.+A.+Catterall&title=Overview+of+the+voltage-gated+sodium+channel+family"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the voltage-gated sodium channel family</span></div><div class="casAuthors">Yu Frank H; Catterall William A</div><div class="citationInfo"><span class="NLM_cas:title">Genome biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">207</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Selective permeation of sodium ions through voltage-dependent sodium channels is fundamental to the generation of action potentials in excitable cells such as neurons.  These channels are large integral membrane proteins and are encoded by at least ten genes in mammals.  The different sodium channels have remarkably similar functional properties, but small changes in sodium-channel function are biologically relevant, as underscored by mutations that cause several human diseases of hyperexcitability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTuC-dT5iHA1skU0YCbOU3EfW6udTcc2eba4Gs1LT5ZfLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s7gvVWrsw%253D%253D&md5=0c86fe051b76e03ccb9fe9f5d85cc35b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1186%2Fgb-2003-4-3-207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fgb-2003-4-3-207%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DF.%2BH.%26aulast%3DCatterall%26aufirst%3DW.%2BA.%26atitle%3DOverview%2520of%2520the%2520voltage-gated%2520sodium%2520channel%2520family%26jtitle%3DGenome%2520Biol.%26date%3D2003%26volume%3D4%26spage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Whitaker, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faull, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldvogel, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plumpton, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emson, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clare, J. J.</span><span> </span><span class="NLM_article-title">Comparative distribution of voltage-gated sodium channel proteins in human brain</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1016%2FS0169-328X%2800%2900289-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BD3MXisVWgsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2001&pages=37-53&author=W.+R.+Whitakerauthor=R.+L.+Faullauthor=H.+J.+Waldvogelauthor=C.+J.+Plumptonauthor=P.+C.+Emsonauthor=J.+J.+Clare&title=Comparative+distribution+of+voltage-gated+sodium+channel+proteins+in+human+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative distribution of voltage-gated sodium channel proteins in human brain</span></div><div class="casAuthors">Whitaker, W. R. J.; Faull, R. L. M.; Waldvogel, H. J.; Plumpton, C. J.; Emson, P. C.; Clare, J. J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">37-53</span>CODEN:
                <span class="NLM_cas:coden">MBREE4</span>;
        ISSN:<span class="NLM_cas:issn">0169-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Antisera directed against unique peptide regions from each of the human brain voltage-gated Na+ channel α subunits were generated.  In immunoblots, these were found to be highly specific for the corresponding recombinant polypeptides and to recognize the native holoprotein in human brain membrane prepns.  These antisera were used to perform a comparative immunohistochem. distribution anal. of all 4 brain Na+ channel subtypes in selected human CNS regions.  Distinct but heterogeneous distribution patterns were obsd. for each of the α subunits.  In general, these were complementary to that previously shown for the corresponding human mRNAs.  A high degree of conservation with respect to the distribution found in rat was also evident.  The human α subunit proteins exhibited distinct subcellular localization patterns.  Type I, III, and VI immunoreactivity was found predominantly in neuronal cell bodies and proximal processes, whereas type II was concd. along axons.  This was similar to rat brain and suggested that the different Na+ channel subtypes have distinct functions which are highly conserved between human and rodents.  A notable difference was that the type III protein was detected in all human brain regions examd., unlike in rat brain where its expression in adults was very restricted.  Also, in contrast to rat brain, the human type VI protein was not detected in axons of unmyelinated neurons.  These differences may reflect true species variations and could have important implications for understanding the function of the Na+ channel subtypes and their roles in human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou-pZXdakIcLVg90H21EOLACvtfcHk0ljxFpkni9QPNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXisVWgsr8%253D&md5=e4929e3820b60dd8ebd83713f6d700d1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0169-328X%2800%2900289-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-328X%252800%252900289-8%26sid%3Dliteratum%253Aachs%26aulast%3DWhitaker%26aufirst%3DW.%2BR.%26aulast%3DFaull%26aufirst%3DR.%2BL.%26aulast%3DWaldvogel%26aufirst%3DH.%2BJ.%26aulast%3DPlumpton%26aufirst%3DC.%2BJ.%26aulast%3DEmson%26aufirst%3DP.%2BC.%26aulast%3DClare%26aufirst%3DJ.%2BJ.%26atitle%3DComparative%2520distribution%2520of%2520voltage-gated%2520sodium%2520channel%2520proteins%2520in%2520human%2520brain%26jtitle%3DBrain%2520Res.%26date%3D2001%26volume%3D88%26spage%3D37%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Kaplan, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullian, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isom, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levinson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barres, B. A.</span><span> </span><span class="NLM_article-title">Differential control of clustering of the sodium channels Na(v)1.2 and Na(v)1.6 at developing CNS nodes of Ranvier</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">119</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2001&pages=105-119&author=M.+R.+Kaplanauthor=M.+H.+Choauthor=E.+M.+Ullianauthor=L.+L.+Isomauthor=S.+R.+Levinsonauthor=B.+A.+Barres&title=Differential+control+of+clustering+of+the+sodium+channels+Na%28v%291.2+and+Na%28v%291.6+at+developing+CNS+nodes+of+Ranvier"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKaplan%26aufirst%3DM.%2BR.%26aulast%3DCho%26aufirst%3DM.%2BH.%26aulast%3DUllian%26aufirst%3DE.%2BM.%26aulast%3DIsom%26aufirst%3DL.%2BL.%26aulast%3DLevinson%26aufirst%3DS.%2BR.%26aulast%3DBarres%26aufirst%3DB.%2BA.%26atitle%3DDifferential%2520control%2520of%2520clustering%2520of%2520the%2520sodium%2520channels%2520Na%2528v%25291.2%2520and%2520Na%2528v%25291.6%2520at%2520developing%2520CNS%2520nodes%2520of%2520Ranvier%26jtitle%3DNeuron%26date%3D2001%26volume%3D30%26spage%3D105%26epage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Mao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Q. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J. Y.</span><span> </span><span class="NLM_article-title">The up-regulation of voltage-gated sodium channel Nav1.6 expression following fluid percussion traumatic brain injury in rats</span> <span class="citation_source-journal">Neurosurgery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1134</span><span class="NLM_x">–</span> <span class="NLM_lpage">1139</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=1134-1139&author=Q.+Maoauthor=F.+Jiaauthor=X.+H.+Zhangauthor=Y.+M.+Qiuauthor=J.+W.+Geauthor=W.+J.+Baoauthor=Q.+Z.+Luoauthor=J.+Y.+Jiang&title=The+up-regulation+of+voltage-gated+sodium+channel+Nav1.6+expression+following+fluid+percussion+traumatic+brain+injury+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DQ.%26aulast%3DJia%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DX.%2BH.%26aulast%3DQiu%26aufirst%3DY.%2BM.%26aulast%3DGe%26aufirst%3DJ.%2BW.%26aulast%3DBao%26aufirst%3DW.%2BJ.%26aulast%3DLuo%26aufirst%3DQ.%2BZ.%26aulast%3DJiang%26aufirst%3DJ.%2BY.%26atitle%3DThe%2520up-regulation%2520of%2520voltage-gated%2520sodium%2520channel%2520Nav1.6%2520expression%2520following%2520fluid%2520percussion%2520traumatic%2520brain%2520injury%2520in%2520rats%26jtitle%3DNeurosurgery%26date%3D2010%26volume%3D66%26spage%3D1134%26epage%3D1139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Waxman, S. G.</span><span> </span><span class="NLM_article-title">Axonal conduction and injury in multiple sclerosis: The role of sodium channels</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">932</span><span class="NLM_x">–</span> <span class="NLM_lpage">941</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1038%2Fnrn2023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=17115075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1WqurzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=932-941&author=S.+G.+Waxman&title=Axonal+conduction+and+injury+in+multiple+sclerosis%3A+The+role+of+sodium+channels"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Axonal conduction and injury in multiple sclerosis: the role of sodium channels</span></div><div class="casAuthors">Waxman, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">932-941</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Multiple sclerosis (MS) is the most common cause of neurol. disability in young adults.  Recent studies have implicated specific sodium channel isoforms as having an important role in several aspects of the pathophysiol. of MS, including the restoration of impulse conduction after demyelination, axonal degeneration and the mistuning of Purkinje neurons that leads to cerebellar dysfunction.  By manipulating the activity of these channels or their expression, it might be possible to develop new therapeutic approaches that will prevent or limit disability in MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomSCSd9htT3bVg90H21EOLACvtfcHk0ljxFpkni9QPNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1WqurzM&md5=cee2cf0db2e3eeed25230256e1a0b42b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnrn2023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2023%26sid%3Dliteratum%253Aachs%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DAxonal%2520conduction%2520and%2520injury%2520in%2520multiple%2520sclerosis%253A%2520The%2520role%2520of%2520sodium%2520channels%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2006%26volume%3D7%26spage%3D932%26epage%3D941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Yuen, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browne, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. H.</span><span> </span><span class="NLM_article-title">Sodium channelopathy induced by mild axonal trauma worsens outcome after a repeat injury</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">3620</span><span class="NLM_x">–</span> <span class="NLM_lpage">3625</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1002%2Fjnr.22161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=19565655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1yrsLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2009&pages=3620-3625&author=T.+J.+Yuenauthor=K.+D.+Browneauthor=A.+Iwataauthor=D.+H.+Smith&title=Sodium+channelopathy+induced+by+mild+axonal+trauma+worsens+outcome+after+a+repeat+injury"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Sodium channelopathy induced by mild axonal trauma worsens outcome after a repeat injury</span></div><div class="casAuthors">Yuen, Tracy J.; Browne, Kevin D.; Iwata, Akira; Smith, Douglas H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3620-3625</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">There is great concern that one mild traumatic brain injury (mTBI) predisposes individuals to an exacerbated response with a subsequent mTBI.  Although no mechanism has been identified, mounting evidence suggests traumatic axonal injury (TAI) plays a role in this process.  By using a cell culture system, a threshold of mild TAI was found where dynamic stretch of cortical axons at strains lower than 5% induced no overt pathol. changes.  However, the axons were found to display an increased expression of sodium channels (NaChs) by 24 h.  After a second, identical mild injury, pathol. increases in [Ca2+]i were obsd., leading to axon degeneration.  The central role of NaChs in this response was demonstrated by blocking NaChs with tetrodotoxin prior to the second injury, which completely abolished postinjury increases in [Ca2+]i.  These data suggest that mild TAI induces a form of sodium channelopathy on axons that greatly exaggerates the pathophysiol. response to subsequent mild injuries. © 2009 Wiley-Liss, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvbi-ixIDWdbVg90H21EOLACvtfcHk0lipROuIalckVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1yrsLvK&md5=ac06eefea4846df397460441a2131493</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fjnr.22161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.22161%26sid%3Dliteratum%253Aachs%26aulast%3DYuen%26aufirst%3DT.%2BJ.%26aulast%3DBrowne%26aufirst%3DK.%2BD.%26aulast%3DIwata%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DD.%2BH.%26atitle%3DSodium%2520channelopathy%2520induced%2520by%2520mild%2520axonal%2520trauma%2520worsens%2520outcome%2520after%2520a%2520repeat%2520injury%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2009%26volume%3D87%26spage%3D3620%26epage%3D3625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Wang, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banderali, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juranka, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, C. E.</span><span> </span><span class="NLM_article-title">Membrane trauma and Na<sup>+</sup> leak from Nav1.6 channels</span> <span class="citation_source-journal">Am. J. Physiol.: Cell Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">C823</span><span class="NLM_x">–</span> <span class="NLM_lpage">C834</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2009&pages=C823-C834&author=J.+A.+Wangauthor=W.+Linauthor=T.+Morrisauthor=U.+Banderaliauthor=P.+F.+Jurankaauthor=C.+E.+Morris&title=Membrane+trauma+and+Na%2B+leak+from+Nav1.6+channels"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%2BA.%26aulast%3DLin%26aufirst%3DW.%26aulast%3DMorris%26aufirst%3DT.%26aulast%3DBanderali%26aufirst%3DU.%26aulast%3DJuranka%26aufirst%3DP.%2BF.%26aulast%3DMorris%26aufirst%3DC.%2BE.%26atitle%3DMembrane%2520trauma%2520and%2520Na%252B%2520leak%2520from%2520Nav1.6%2520channels%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Cell%2520Physiol.%26date%3D2009%26volume%3D297%26spage%3DC823%26epage%3DC834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Boucher, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, C. E.</span><span> </span><span class="NLM_article-title">Coupled left-shift of Nav channels: Modeling the Na<sup>+</sup>-loading and dysfunctional excitability of damaged axons</span> <span class="citation_source-journal">J. Comput. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">319</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1007%2Fs10827-012-0387-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=22476614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A280%3ADC%252BC38ritlyguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=301-319&author=P.+A.+Boucherauthor=B.+Joosauthor=C.+E.+Morris&title=Coupled+left-shift+of+Nav+channels%3A+Modeling+the+Na%2B-loading+and+dysfunctional+excitability+of+damaged+axons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Coupled left-shift of Nav channels: modeling the Na -loading and dysfunctional excitability of damaged axons</span></div><div class="casAuthors">Boucher Pierre-Alexandre; Joos Bela; Morris Catherine E</div><div class="citationInfo"><span class="NLM_cas:title">Journal of computational neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">301-19</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Injury to neural tissue renders voltage-gated Na  (Nav) channels leaky.  Even mild axonal trauma initiates Na -loading, leading to secondary Ca2 -loading and white matter degeneration.  The nodal isoform is Nav1.6 and for Nav1.6-expressing HEK-cells, traumatic whole cell stretch causes an immediate tetrodotoxin-sensitive Na -leak.  In stretch-damaged oocyte patches, Nav1.6 current undergoes damage-intensity dependent hyperpolarizing- (left-) shifts, but whether left-shift underlies injured-axon Nav-leak is uncertain.  Nav1.6 inactivation (availability) is kinetically limited by (coupled to) Nav activation, yielding coupled left-shift (CLS) of the two processes: CLS should move the steady-state Nav1.6 "window conductance" closer to typical firing thresholds.  Here we simulated excitability and ion homeostasis in free-running nodes of Ranvier to assess if hallmark injured-axon behaviors--Na -loading, ectopic excitation, propagation block--would occur with Nav-CLS.  Intact/traumatized axolemma ratios were varied, and for some simulations Na/K pumps were included, with varied in/outside volumes.  We simulated saltatory propagation with one mid-axon node variously traumatized.  While dissipating the [Na ] gradient and hyperactivating the Na/K pump, Nav-CLS generated neuropathic pain-like ectopic bursts.  Depending on CLS magnitude, fraction of Nav channels affected, and pump intensity, tonic or burst firing or nodal inexcitability occurred, with [Na ] and [K ] fluctuating.  Severe CLS-induced inexcitability did not preclude Na -loading; in fact, the steady-state Na -leaks elicited large pump currents.  At a mid-axon node, mild CLS perturbed normal anterograde propagation, and severe CLS blocked saltatory propagation.  These results suggest that in damaged excitable cells, Nav-CLS could initiate cellular deterioration with attendant hyper- or hypo-excitability.  Healthy-cell versions of Nav-CLS, however, could contribute to physiological rhythmic firing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ5iPox2COc83T4ugvCDgnZfW6udTcc2eYHrLhNyFIEkrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38ritlyguw%253D%253D&md5=9b6f6ba2eefe0788ed4002ad04fcff90</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1007%2Fs10827-012-0387-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10827-012-0387-7%26sid%3Dliteratum%253Aachs%26aulast%3DBoucher%26aufirst%3DP.%2BA.%26aulast%3DJoos%26aufirst%3DB.%26aulast%3DMorris%26aufirst%3DC.%2BE.%26atitle%3DCoupled%2520left-shift%2520of%2520Nav%2520channels%253A%2520Modeling%2520the%2520Na%252B-loading%2520and%2520dysfunctional%2520excitability%2520of%2520damaged%2520axons%26jtitle%3DJ.%2520Comput.%2520Neurosci.%26date%3D2012%26volume%3D33%26spage%3D301%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Yao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortella, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dave, J. R.</span><span> </span><span class="NLM_article-title">Differential pattern of expression of voltage-gated sodium channel genes following ischemic brain injury in rats</span> <span class="citation_source-journal">Neurotoxic. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1080%2F10298420290007646" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=12826495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BD38Xmsl2jur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=67-75&author=C.+Yaoauthor=A.+J.+Williamsauthor=P.+Cuiauthor=R.+Bertiauthor=J.+C.+Hunterauthor=F.+C.+Tortellaauthor=J.+R.+Dave&title=Differential+pattern+of+expression+of+voltage-gated+sodium+channel+genes+following+ischemic+brain+injury+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Differential pattern of expression of voltage-gated sodium channel genes following ischemic brain injury in rats</span></div><div class="casAuthors">Yao, C.; Williams, A. J.; Cui, P.; Berti, R.; Hunter, J. C.; Tortella, E. C.; Dave, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Neurotoxicity Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-75</span>CODEN:
                <span class="NLM_cas:coden">NURRFI</span>;
        ISSN:<span class="NLM_cas:issn">1029-8428</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">This study investigated the effects of brain ischemia on sodium channel gene (NaCh) expression in rats.  Using quant. RT-PCR, our findings demonstrated the expression ratio of NaCh genes in normal rat brain to be Nav1.1 > Nav1.8 > Nav1.3 > Nav1.7 (rBI > PN3 > rBIII > PN1).  In contrast, brain injury caused by middle cerebral artery occlusion (MCAo) for 2 h followed by reperfusion significantly down-regulated Nav1.3 and Nav1.7 genes in both injured and contralateral hemispheres; whereas the Nav1.8 gene was down regulated in only the injured hemisphere (though only acutely at 2 or 2-6 h post-MCAo).  However, the time-course of NaCh gene expression revealed a significant down-regulation of Nav1.1 only in the ischemic hemisphere beginning 6 h post-MCAo and measured out to 48 h post-MCAo.  In a sep. preliminary study Nav1.2 (rBII) gene was found be expressed at levels greater than that of Nav1.1 in normal rats and was significantly down regulated at 24 h post-MCAo.  Our findings document, for the first time, quant. and relative changes in the expression of various NaCh genes following ischemic brain injury and suggest that the Nav1.1 sodium channel gene may play a key role in ischemic injury/recovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE-uu8eYxzVLVg90H21EOLACvtfcHk0lipROuIalckVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xmsl2jur8%253D&md5=67bf3163d08349d635b6a2e10eb04508</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1080%2F10298420290007646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10298420290007646%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DC.%26aulast%3DWilliams%26aufirst%3DA.%2BJ.%26aulast%3DCui%26aufirst%3DP.%26aulast%3DBerti%26aufirst%3DR.%26aulast%3DHunter%26aufirst%3DJ.%2BC.%26aulast%3DTortella%26aufirst%3DF.%2BC.%26aulast%3DDave%26aufirst%3DJ.%2BR.%26atitle%3DDifferential%2520pattern%2520of%2520expression%2520of%2520voltage-gated%2520sodium%2520channel%2520genes%2520following%2520ischemic%2520brain%2520injury%2520in%2520rats%26jtitle%3DNeurotoxic.%2520Res.%26date%3D2002%26volume%3D4%26spage%3D67%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Huang, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J. Y.</span><span> </span><span class="NLM_article-title">Expression of voltage-gated sodium channel Nav1.3 is associated with severity of traumatic brain injury in adult rats</span> <span class="citation_source-journal">J. Neurotrauma</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1089%2Fneu.2012.2508" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=22928478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A280%3ADC%252BC38bhvFagtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2013&pages=39-46&author=X.+J.+Huangauthor=Q.+Maoauthor=Y.+Linauthor=J.+F.+Fengauthor=J.+Y.+Jiang&title=Expression+of+voltage-gated+sodium+channel+Nav1.3+is+associated+with+severity+of+traumatic+brain+injury+in+adult+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of voltage-gated sodium channel Nav1.3 is associated with severity of traumatic brain injury in adult rats</span></div><div class="casAuthors">Huang Xian-jian; Mao Qing; Lin Yong; Feng Jun-feng; Jiang Ji-yao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurotrauma</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-46</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">During the secondary injury period after traumatic brain injury (TBI), depolarization of neurons mediated by voltage-gated sodium channels (VGSCs) leads to cellular abnormalities and neurological dysfunction.  Alterations in expression of different α subunits of VGSCs can affect early brain pathology following TBI.  This study detected the expression of Nav1.3 mRNA and protein in the rat cortex post-TBI.  Adult male Sprague-Dawley rats were randomly assigned to sham-TBI, mild-TBI (mTBI), or severe-TBI (sTBI) groups.  TBI was induced using a fluid percussion device at magnitudes of 1.5-1.6 atm (mTBI) and 2.9-3.0 atm (sTBI).  Nav1.3 mRNA and protein levels in the ipsilateral-injured cortex were examined at 2 h, 12 h, 24 h, and 72 h post-TBI by real-time reverse transcriptase quantitative polymerase chain reaction and Western blot.  Brains were collected at 24 h, 72 h, and 7 days post-TBI for TUNEL staining and cell count analysis.  Immunofluorescence was performed to localize expression of Nav1.3 protein in the ipsilateral-injured cortex.  Expression of Nav1.3 mRNA and protein were significantly upregulated in mTBI and sTBI groups when compared with the sham-TBI group at 2 h and 12 h post-TBI.  Nav1.3 mRNA and protein levels in the sTBI group were much higher than in the mTBI group at 12 h post-TBI.  TUNEL-positive cell numbers were significantly higher in the sTBI group than in the mTBI at 24 h, 72 h, and 7 days post-TBI.  Expression of Nav1.3 was observed predominantly in neurons of the cortex.  These findings indicated significant upregulation in the expression of Nav1.3 mRNA and protein in the rat ipsilateral-injured cortex at the very early stage post-TBI, and were also correlated with TBI severity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQKCZelbcW2ylw2ofyr07jXfW6udTcc2eZ9zax_NNbAabntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38bhvFagtQ%253D%253D&md5=c794fffb9f218b411cc95095acdcc521</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1089%2Fneu.2012.2508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fneu.2012.2508%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%2BJ.%26aulast%3DMao%26aufirst%3DQ.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DFeng%26aufirst%3DJ.%2BF.%26aulast%3DJiang%26aufirst%3DJ.%2BY.%26atitle%3DExpression%2520of%2520voltage-gated%2520sodium%2520channel%2520Nav1.3%2520is%2520associated%2520with%2520severity%2520of%2520traumatic%2520brain%2520injury%2520in%2520adult%2520rats%26jtitle%3DJ.%2520Neurotrauma%26date%3D2013%26volume%3D30%26spage%3D39%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Clutterbuck, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posada, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visintin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddall, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancaster, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gane, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garthwaite, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selwood, D. L.</span><span> </span><span class="NLM_article-title">Oxadiazolylindazole sodium channel modulators are neuroprotective toward hippocampal neurones</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2694</span><span class="NLM_x">–</span> <span class="NLM_lpage">2707</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801180p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvF2gsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2694-2707&author=L.+A.+Clutterbuckauthor=C.+G.+Posadaauthor=C.+Visintinauthor=D.+R.+Riddallauthor=B.+Lancasterauthor=P.+J.+Ganeauthor=J.+Garthwaiteauthor=D.+L.+Selwood&title=Oxadiazolylindazole+sodium+channel+modulators+are+neuroprotective+toward+hippocampal+neurones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Oxadiazolylindazole Sodium Channel Modulators are Neuroprotective toward Hippocampal Neurones</span></div><div class="casAuthors">Clutterbuck, Lisa A.; Garcia Posada, Cristina; Visintin, Cristina; Riddall, Dieter R.; Lancaster, Barrie; Gane, Paul J.; Garthwaite, John; Selwood, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2694-2707</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the discovery of a new class of neuroprotective voltage-dependent sodium channel modulators exemplified by (5-(1-benzyl-1H-indazol-3-yl)-1,2,4-oxadiazol-3-yl)methanamine 11 (CFM1178).  The compds. were inhibitors of [14C]guanidinium ion flux in rat forebrain synaptosomes and displaced binding of the sodium channel ligand [3H]BW202W92.  11 And the corresponding N2-benzyl isomer, 38 (CFM6058), demonstrated neuroprotective activity in hippocampal slices comparable to sipatrigine.  CYP450 enzyme inhibition obsd. with 11 was reduced with 38.  In electrophysiol. expts. on dissocd. hippocampal neurons, these two compds. caused use- and voltage-dependent block of sodium currents.  Sodium channel isoform profiling against Nav1.1-1.8 demonstrated that the std. sodium channel blocker lamotrigine had modest activity against Nav1.1, while sipatrigine was generally more potent and less selective.  11 And 38 showed potent activity against Nav1.6, pointing to pharmacol. block of this isoform being consistent with the neuroprotective effect.  38 Also showed use dependent block of Nav1.6 in HEK cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzQfFV_-fwe7Vg90H21EOLACvtfcHk0ljuyJy3d5fyxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvF2gsrs%253D&md5=706c835492da40e1b684431b6fdaa3eb</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm801180p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801180p%26sid%3Dliteratum%253Aachs%26aulast%3DClutterbuck%26aufirst%3DL.%2BA.%26aulast%3DPosada%26aufirst%3DC.%2BG.%26aulast%3DVisintin%26aufirst%3DC.%26aulast%3DRiddall%26aufirst%3DD.%2BR.%26aulast%3DLancaster%26aufirst%3DB.%26aulast%3DGane%26aufirst%3DP.%2BJ.%26aulast%3DGarthwaite%26aufirst%3DJ.%26aulast%3DSelwood%26aufirst%3DD.%2BL.%26atitle%3DOxadiazolylindazole%2520sodium%2520channel%2520modulators%2520are%2520neuroprotective%2520toward%2520hippocampal%2520neurones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2694%26epage%3D2707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Fowler, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span> </span><span class="NLM_article-title">Contributions of Na<sup>+</sup> flux and the anoxic depolarization to adenosine 5′-triphosphate levels in hypoxic/hypoglycemic rat hippocampal slices</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">722</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1998&pages=717-722&author=J.+C.+Fowlerauthor=Y.+Li&title=Contributions+of+Na%2B+flux+and+the+anoxic+depolarization+to+adenosine+5%E2%80%B2-triphosphate+levels+in+hypoxic%2Fhypoglycemic+rat+hippocampal+slices"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DJ.%2BC.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DContributions%2520of%2520Na%252B%2520flux%2520and%2520the%2520anoxic%2520depolarization%2520to%2520adenosine%25205%25E2%2580%25B2-triphosphate%2520levels%2520in%2520hypoxic%252Fhypoglycemic%2520rat%2520hippocampal%2520slices%26jtitle%3DNeuroscience%26date%3D1998%26volume%3D83%26spage%3D717%26epage%3D722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Watson, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davison, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, J. L.</span><span> </span><span class="NLM_article-title">Suppression of demyelination by mitoxantrone</span> <span class="citation_source-journal">Int. J. Immunopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">930</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1016%2F0192-0561%2891%2990045-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=1761358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADyaK38XktV0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1991&pages=923-930&author=C.+M.+Watsonauthor=A.+N.+Davisonauthor=D.+Bakerauthor=J.+K.+O%E2%80%99Neillauthor=J.+L.+Turk&title=Suppression+of+demyelination+by+mitoxantrone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of demyelination by mitoxantrone</span></div><div class="casAuthors">Watson, Carolyn M.; Davison, Alan N.; Baker, David; O'Neill, Janet K.; Turk, John L.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Immunopharmacology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">923-30</span>CODEN:
                <span class="NLM_cas:coden">IJIMDS</span>;
        ISSN:<span class="NLM_cas:issn">0192-0561</span>.
    </div><div class="casAbstract">The mode of action of the immunosuppressant mitoxantrone was examd. in murine models of demyelinating disease.  The drug has been shown to block antigen-induced proliferative activity and to inhibit myelin degrdn. by leukocytes from paralyzed mice.  Mitoxantrone blocked myelin breakdown by macrophages although phagocytosis was not affected.  Further evidence was obtained to indicate that mitoxantrone acts therapeutically in reducing, or at high dose, preventing signs of exptl. allergic encephalomyclitis developing in mice immunized with spinal cord homogenate and Freund's complete adjuvant.  Mitoxanthrone also significantly inhibited the incidence of relapse when treatment was initiated during the post-acute remission period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNqr4Nmo5hDrVg90H21EOLACvtfcHk0liKrjyDuM6ERQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XktV0%253D&md5=9f80efe4ad305127f399458db8cd93b5</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2F0192-0561%2891%2990045-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0192-0561%252891%252990045-9%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DC.%2BM.%26aulast%3DDavison%26aufirst%3DA.%2BN.%26aulast%3DBaker%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DJ.%2BK.%26aulast%3DTurk%26aufirst%3DJ.%2BL.%26atitle%3DSuppression%2520of%2520demyelination%2520by%2520mitoxantrone%26jtitle%3DInt.%2520J.%2520Immunopharmacol.%26date%3D1991%26volume%3D13%26spage%3D923%26epage%3D930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">O’Neill, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davison, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggon, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffee, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, J. L.</span><span> </span><span class="NLM_article-title">Therapy of chronic relapsing experimental allergic encephalomyelitis and the role of the blood-brain barrier: Elucidation by the action of Brequinar sodium</span> <span class="citation_source-journal">J. Neuroimmunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1016%2F0165-5728%2892%2990090-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=1577953" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADyaK38Xks1amtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1992&pages=53-62&author=J.+K.+O%E2%80%99Neillauthor=D.+Bakerauthor=A.+N.+Davisonauthor=K.+K.+Maggonauthor=B.+D.+Jaffeeauthor=J.+L.+Turk&title=Therapy+of+chronic+relapsing+experimental+allergic+encephalomyelitis+and+the+role+of+the+blood-brain+barrier%3A+Elucidation+by+the+action+of+Brequinar+sodium"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Therapy of chronic relapsing experimental allergic encephalomyelitis and the role of the blood-brain barrier:  elucidation by the action of Brequinar sodium</span></div><div class="casAuthors">O'Neill, J. K.; Baker, D.; Davison, A. N.; Maggon, K. K.; Jaffee, B. D.; Turk, J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroimmunology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">53-62</span>CODEN:
                <span class="NLM_cas:coden">JNRIDW</span>;
        ISSN:<span class="NLM_cas:issn">0165-5728</span>.
    </div><div class="casAbstract">The immunosuppressive effect of the novel 4-quinoline carboxylic acid deriv. Brequinar sodium on the chronic relapsing exptl. allergic encephalomyelitis CREAE model in the Biozzi AB/H mouse was investigated.  Although Brequinar sodium actively inhibited peripheral immune responses, it showed a limited potential to control an ongoing disease of the central nervous system (CNS).  Doses of 25 mg/kg inhibited in vivo induced proliferative response and prevented EAE when treated from day 9 post-inoculation (p.i.).  However, when administered from day 12 p.i. or during the post-acute remission phase-limited effects on the course of disease were obsd.  By comparison, treatment with a single high dose of cyclophosphamide (200 mg/kg) at these time points was significantly effective in controlling disease.  As a possible explanation of the obsd. results it is suggested that for a compd. to be effective in treating an ongoing immune response in the CNS, it must be capable of crossing the blood-brain barrier and act on the disease-inducing cells activated within the CNS.  This hypothesis is supported by the finding that intracerebral injections of Brequinar sodium on day 12 p.i. significantly inhibited disease progression.  This suggests that strategies aimed at controlling immune-mediated disease of the CNS require therapeutic doses of the compds. to be delivered into the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC_V4nOdzsJ7Vg90H21EOLACvtfcHk0li0Lad5kvubWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xks1amtrc%253D&md5=acd8d837f1529e5fbb02ec4798c045b9</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2F0165-5728%2892%2990090-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-5728%252892%252990090-8%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DJ.%2BK.%26aulast%3DBaker%26aufirst%3DD.%26aulast%3DDavison%26aufirst%3DA.%2BN.%26aulast%3DMaggon%26aufirst%3DK.%2BK.%26aulast%3DJaffee%26aufirst%3DB.%2BD.%26aulast%3DTurk%26aufirst%3DJ.%2BL.%26atitle%3DTherapy%2520of%2520chronic%2520relapsing%2520experimental%2520allergic%2520encephalomyelitis%2520and%2520the%2520role%2520of%2520the%2520blood-brain%2520barrier%253A%2520Elucidation%2520by%2520the%2520action%2520of%2520Brequinar%2520sodium%26jtitle%3DJ.%2520Neuroimmunol.%26date%3D1992%26volume%3D38%26spage%3D53%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Baker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davison, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, J. L.</span><span> </span><span class="NLM_article-title">Control of immune-mediated disease of the central nervous system requires the use of a neuroactive agent: Elucidation by the action of mitoxantrone</span> <span class="citation_source-journal">Clin. Exp. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">128</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1111%2Fj.1365-2249.1992.tb05843.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=1395092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADyaK38Xmt1Gqtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1992&pages=124-128&author=D.+Bakerauthor=J.+K.+O%E2%80%99Neillauthor=A.+N.+Davisonauthor=J.+L.+Turk&title=Control+of+immune-mediated+disease+of+the+central+nervous+system+requires+the+use+of+a+neuroactive+agent%3A+Elucidation+by+the+action+of+mitoxantrone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Control of immune-mediated disease of the central nervous system requires the use of a neuroactive agent:  elucidation by the action of mitoxantrone</span></div><div class="casAuthors">Baker, D.; O'Neill, J. K.; Davison, A. N.; Turk, J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Immunology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">124-8</span>CODEN:
                <span class="NLM_cas:coden">CEXIAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-9104</span>.
    </div><div class="casAbstract">Mitoxantrone was used as an immunosuppressive probe to elucidate a means for the control of exptl. allergic encephalomyelitis (EAE) induced in Biozzi AB/H mice following injection of spinal cord homogenate emulsified in Freund's adjuvant.  A single i.p. injection of 2.5 mg/kg of mitoxantrone, 1-2 days before the anticipated onset of EAE, failed to prevent the majority of animals from developing clin. disease, whereas when the compd. was injected directly into the central nervous system (CNS), at this time point, significantly increased therapeutic benefit was evident, with most animals failing to develop clin. EAE.  Although the clin. use of intrathecal mitoxantrone is strongly contraindicated, these data suggest that increased therapeutic benefit may be achieved in immune-mediated disease of the CNS by targeting immunosuppressive doses of suitable agents, on lymphocyte activation within the CNS.  In addn., direct administration of immunosuppressive doses into the CNS may reduce potentially unwanted (side) effects in the periphery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGbEYOuumIOrVg90H21EOLACvtfcHk0li0Lad5kvubWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xmt1Gqtrg%253D&md5=7003bc5cfc390adb2869be12322f910a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2249.1992.tb05843.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2249.1992.tb05843.x%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DJ.%2BK.%26aulast%3DDavison%26aufirst%3DA.%2BN.%26aulast%3DTurk%26aufirst%3DJ.%2BL.%26atitle%3DControl%2520of%2520immune-mediated%2520disease%2520of%2520the%2520central%2520nervous%2520system%2520requires%2520the%2520use%2520of%2520a%2520neuroactive%2520agent%253A%2520Elucidation%2520by%2520the%2520action%2520of%2520mitoxantrone%26jtitle%3DClin.%2520Exp.%2520Immunol.%26date%3D1992%26volume%3D90%26spage%3D124%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Lidster, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munro, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giovannoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D.</span><span> </span><span class="NLM_article-title">Neuroprotection in a novel mouse model of multiple sclerosis</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e79188-1</span><span class="NLM_x">–</span> <span class="NLM_lpage">e79188-15</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e79188-1-e79188-15&author=K.+Lidsterauthor=S.+J.+Jacksonauthor=Z.+Ahmedauthor=P.+Munroauthor=P.+Coffeyauthor=G.+Giovannoniauthor=M.+D.+Bakerauthor=D.+Baker&title=Neuroprotection+in+a+novel+mouse+model+of+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLidster%26aufirst%3DK.%26aulast%3DJackson%26aufirst%3DS.%2BJ.%26aulast%3DAhmed%26aufirst%3DZ.%26aulast%3DMunro%26aufirst%3DP.%26aulast%3DCoffey%26aufirst%3DP.%26aulast%3DGiovannoni%26aufirst%3DG.%26aulast%3DBaker%26aufirst%3DM.%2BD.%26aulast%3DBaker%26aufirst%3DD.%26atitle%3DNeuroprotection%2520in%2520a%2520novel%2520mouse%2520model%2520of%2520multiple%2520sclerosis%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De79188-1%26epage%3De79188-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Black, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waxman, S. G.</span><span> </span><span class="NLM_article-title">Sodium channels and microglial function</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">234</span><span class="NLM_x">, </span> <span class="NLM_fpage">302</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1016%2Fj.expneurol.2011.09.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=21985863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Gru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=234&publication_year=2012&pages=302-315&author=J.+A.+Blackauthor=S.+G.+Waxman&title=Sodium+channels+and+microglial+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Sodium channels and microglial function</span></div><div class="casAuthors">Black, Joel A.; Waxman, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">234</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">302-315</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Microglia are resident immune cells that provide continuous surveillance within the central nervous system (CNS) and respond to perturbations of brain and spinal cord parenchyma with an array of effector functions, including proliferation, migration, phagocytosis, secretions of multiple cytokines/chemokines and promotion of repair.  To sense alterations within their environment, microglia express a large no. of cell surface receptors, ion channels and adhesion mols., which activate complex and dynamic signaling pathways.  In the present chapter, we review studies that demonstrate that microglia in vivo and in vitro express specific voltage-gated sodium channel isoforms, and that blockade of sodium channel activity can attenuate several effector functions of microglia.  These studies also provide strong evidence that Nav1.6 is the predominant sodium channel isoform expressed in microglia and that its activity contributes to the response of microglia to multiple activating signals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru0wXJlR3gGLVg90H21EOLACvtfcHk0li0Lad5kvubWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Gru78%253D&md5=37bd14b08226ec15d3a1c9de76703fc2</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2011.09.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2011.09.030%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DJ.%2BA.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DSodium%2520channels%2520and%2520microglial%2520function%26jtitle%3DExp.%2520Neurol.%26date%3D2012%26volume%3D234%26spage%3D302%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Morsali, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bechtold, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauhdry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palchaudhuri, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassoon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snell, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malpass, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pocock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. J.</span><span> </span><span class="NLM_article-title">Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">1067</span><span class="NLM_x">–</span> <span class="NLM_lpage">1082</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2013&pages=1067-1082&author=D.+Morsaliauthor=D.+Bechtoldauthor=W.+Leeauthor=S.+Chauhdryauthor=U.+Palchaudhuriauthor=P.+Hassoonauthor=D.+M.+Snellauthor=K.+Malpassauthor=T.+Piersauthor=J.+Pocockauthor=A.+Roachauthor=K.+J.+Smith&title=Safinamide+and+flecainide+protect+axons+and+reduce+microglial+activation+in+models+of+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorsali%26aufirst%3DD.%26aulast%3DBechtold%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DW.%26aulast%3DChauhdry%26aufirst%3DS.%26aulast%3DPalchaudhuri%26aufirst%3DU.%26aulast%3DHassoon%26aufirst%3DP.%26aulast%3DSnell%26aufirst%3DD.%2BM.%26aulast%3DMalpass%26aufirst%3DK.%26aulast%3DPiers%26aufirst%3DT.%26aulast%3DPocock%26aufirst%3DJ.%26aulast%3DRoach%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26atitle%3DSafinamide%2520and%2520flecainide%2520protect%2520axons%2520and%2520reduce%2520microglial%2520activation%2520in%2520models%2520of%2520multiple%2520sclerosis%26jtitle%3DBrain%26date%3D2013%26volume%3D136%26spage%3D1067%26epage%3D1082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Lidster, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D.</span><span> </span><span class="NLM_article-title">Optical coherence tomography detection of neurodegeneration in multiple sclerosis</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">518</span><span class="NLM_x">–</span> <span class="NLM_lpage">527</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.2174%2F187152712801661185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm401881q&amp;key=22583437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtF2jur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=518-527&author=K.+Lidsterauthor=D.+Baker&title=Optical+coherence+tomography+detection+of+neurodegeneration+in+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Optical coherence tomography detection of neurodegeneration in multiple sclerosis</span></div><div class="casAuthors">Lidster, Katie; Baker, David</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">518-527</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The pathophysiol. of multiple sclerosis (MS) is typically characterised by inflammation and demyelination leading to neurodegeneration, which is assocd. with disability and the progressive stages of MS.  The visual system is a valuable tool for studying neurodegeneration and potential neuroprotection in the central nervous system due to its ease of accessibility.  Optical coherence tomog. (OCT) is a non-invasive tool, which can be used to measure the thickness of the retinal nerve fiber layer (RNFL).  The thickness of RNFL is reduced following the development of MS and optic neuritis and can therefore be used as a correlate of global axonal loss.  OCT is currently being investigated as a structural outcome measure for neuroprotective clin. trials of MS.  This review describes the relationship between MS and optic neuritis and the assocd. RNFL thinning, the technol. and advancements of OCT, the role of OCT in clin. trials for new neuroprotective therapies in MS and the future role of OCT in MS research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBSGFfTx-ZlrVg90H21EOLACvtfcHk0liBF_zWrtmvGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtF2jur3I&md5=1c1107d25c810b4ecdcea8002d5cc633</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.2174%2F187152712801661185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152712801661185%26sid%3Dliteratum%253Aachs%26aulast%3DLidster%26aufirst%3DK.%26aulast%3DBaker%26aufirst%3DD.%26atitle%3DOptical%2520coherence%2520tomography%2520detection%2520of%2520neurodegeneration%2520in%2520multiple%2520sclerosis%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2012%26volume%3D11%26spage%3D518%26epage%3D527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Raftopoulos, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapoor, R.</span><span> </span><span class="NLM_article-title">Neuroprotection for acute optic neuritis—Can it work?</span> <span class="citation_source-journal">Mult. Scler. Relat. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">311</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1016%2Fj.msard.2013.02.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=307-311&author=R.+E.+Raftopoulosauthor=R.+Kapoor&title=Neuroprotection+for+acute+optic+neuritis%E2%80%94Can+it+work%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.msard.2013.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.msard.2013.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DRaftopoulos%26aufirst%3DR.%2BE.%26aulast%3DKapoor%26aufirst%3DR.%26atitle%3DNeuroprotection%2520for%2520acute%2520optic%2520neuritis%25E2%2580%2594Can%2520it%2520work%253F%26jtitle%3DMult.%2520Scler.%2520Relat.%2520Disord.%26date%3D2013%26volume%3D2%26spage%3D307%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Bostrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plowright, A. T.</span><span> </span><span class="NLM_article-title">Oxadiazoles in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1817</span><span class="NLM_x">–</span> <span class="NLM_lpage">1830</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2013248" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm401881q&amp;key=1%3ACAS%3A280%3ADC%252BC383pt1Oisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1817-1830&author=J.+Bostromauthor=A.+Hognerauthor=A.+Llinasauthor=E.+Wellnerauthor=A.+T.+Plowright&title=Oxadiazoles+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Oxadiazoles in medicinal chemistry</span></div><div class="casAuthors">Bostrom Jonas; Hogner Anders; Llinas Antonio; Wellner Eric; Plowright Alleyn T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1817-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Oxadiazoles are five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom, and they exist in different regioisomeric forms.  Oxadiazoles are frequently occurring motifs in druglike molecules, and they are often used with the intention of being bioisosteric replacements for ester and amide functionalities.  The current study presents a systematic comparison of 1,2,4- and 1,3,4-oxadiazole matched pairs in the AstraZeneca compound collection.  In virtually all cases, the 1,3,4-oxadiazole isomer shows an order of magnitude lower lipophilicity (log D), as compared to its isomeric partner.  Significant differences are also observed with respect to metabolic stability, hERG inhibition, and aqueous solubility, favoring the 1,3,4-oxadiazole isomers.  The difference in profile between the 1,2,4 and 1,3,4 regioisomers can be rationalized by their intrinsically different charge distributions (e.g., dipole moments).  To facilitate the use of these heteroaromatic rings, novel synthetic routes for ready access of a broad spectrum of 1,3,4-oxadiazoles, under mild conditions, are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSO9RQiG9xFS2Zyxfu64m4ffW6udTcc2ea34Va7k7jZ77ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC383pt1Oisw%253D%253D&md5=b934995431ced1be297e6f126262f3cb</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm2013248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2013248%26sid%3Dliteratum%253Aachs%26aulast%3DBostrom%26aufirst%3DJ.%26aulast%3DHogner%26aufirst%3DA.%26aulast%3DLlinas%26aufirst%3DA.%26aulast%3DWellner%26aufirst%3DE.%26aulast%3DPlowright%26aufirst%3DA.%2BT.%26atitle%3DOxadiazoles%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1817%26epage%3D1830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Al-Izki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pryce, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hankey, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lidster, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Kutzleben, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browne, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clutterbuck, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posada, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edith Chan, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerritsen, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ummenthum, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peferoen-Baert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Valk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montoya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joel, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garthwaite, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giovannoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selwood, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D.</span><span> </span><span class="NLM_article-title">Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">92</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2013&pages=92-98&author=S.+Al-Izkiauthor=G.+Pryceauthor=D.+J.+Hankeyauthor=K.+Lidsterauthor=S.+M.+von+Kutzlebenauthor=L.+Browneauthor=L.+Clutterbuckauthor=C.+Posadaauthor=A.+W.+Edith+Chanauthor=S.+Amorauthor=V.+Perkinsauthor=W.+H.+Gerritsenauthor=K.+Ummenthumauthor=R.+Peferoen-Baertauthor=P.+van+der+Valkauthor=A.+Montoyaauthor=S.+P.+Joelauthor=J.+Garthwaiteauthor=G.+Giovannoniauthor=D.+L.+Selwoodauthor=D.+Baker&title=Lesional-targeting+of+neuroprotection+to+the+inflammatory+penumbra+in+experimental+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Izki%26aufirst%3DS.%26aulast%3DPryce%26aufirst%3DG.%26aulast%3DHankey%26aufirst%3DD.%2BJ.%26aulast%3DLidster%26aufirst%3DK.%26aulast%3Dvon%2BKutzleben%26aufirst%3DS.%2BM.%26aulast%3DBrowne%26aufirst%3DL.%26aulast%3DClutterbuck%26aufirst%3DL.%26aulast%3DPosada%26aufirst%3DC.%26aulast%3DEdith%2BChan%26aufirst%3DA.%2BW.%26aulast%3DAmor%26aufirst%3DS.%26aulast%3DPerkins%26aufirst%3DV.%26aulast%3DGerritsen%26aufirst%3DW.%2BH.%26aulast%3DUmmenthum%26aufirst%3DK.%26aulast%3DPeferoen-Baert%26aufirst%3DR.%26aulast%3Dvan%2Bder%2BValk%26aufirst%3DP.%26aulast%3DMontoya%26aufirst%3DA.%26aulast%3DJoel%26aufirst%3DS.%2BP.%26aulast%3DGarthwaite%26aufirst%3DJ.%26aulast%3DGiovannoni%26aufirst%3DG.%26aulast%3DSelwood%26aufirst%3DD.%2BL.%26aulast%3DBaker%26aufirst%3DD.%26atitle%3DLesional-targeting%2520of%2520neuroprotection%2520to%2520the%2520inflammatory%2520penumbra%2520in%2520experimental%2520multiple%2520sclerosis%26jtitle%3DBrain%26date%3D2013%26volume%3D137%26spage%3D92%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Black, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hains, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saab, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waxman, S. G.</span><span> </span><span class="NLM_article-title">Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">3196</span><span class="NLM_x">–</span> <span class="NLM_lpage">3208</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2006&pages=3196-3208&author=J.+A.+Blackauthor=S.+Liuauthor=B.+C.+Hainsauthor=C.+Y.+Saabauthor=S.+G.+Waxman&title=Long-term+protection+of+central+axons+with+phenytoin+in+monophasic+and+chronic-relapsing+EAE"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DJ.%2BA.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DHains%26aufirst%3DB.%2BC.%26aulast%3DSaab%26aufirst%3DC.%2BY.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DLong-term%2520protection%2520of%2520central%2520axons%2520with%2520phenytoin%2520in%2520monophasic%2520and%2520chronic-relapsing%2520EAE%26jtitle%3DBrain%26date%3D2006%26volume%3D129%26spage%3D3196%26epage%3D3208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Al-Izki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pryce, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giovannoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D.</span><span> </span><span class="NLM_article-title">Practical guide to the induction of relapsing progressive experimental autoimmune encephalomyelitis in the Biozzi ABH mouse</span> <span class="citation_source-journal">Mult. Scler. Relat. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm401881q&amp;key=10.1016%2Fj.msard.2011.09.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2012&pages=29-38&author=S.+Al-Izkiauthor=G.+Pryceauthor=J.+K.+O%E2%80%99Neillauthor=C.+Butterauthor=G.+Giovannoniauthor=S.+Amorauthor=D.+Baker&title=Practical+guide+to+the+induction+of+relapsing+progressive+experimental+autoimmune+encephalomyelitis+in+the+Biozzi+ABH+mouse"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.msard.2011.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.msard.2011.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Izki%26aufirst%3DS.%26aulast%3DPryce%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DJ.%2BK.%26aulast%3DButter%26aufirst%3DC.%26aulast%3DGiovannoni%26aufirst%3DG.%26aulast%3DAmor%26aufirst%3DS.%26aulast%3DBaker%26aufirst%3DD.%26atitle%3DPractical%2520guide%2520to%2520the%2520induction%2520of%2520relapsing%2520progressive%2520experimental%2520autoimmune%2520encephalomyelitis%2520in%2520the%2520Biozzi%2520ABH%2520mouse%26jtitle%3DMult.%2520Scler.%2520Relat.%2520Disord.%26date%3D2012%26volume%3D1%26spage%3D29%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i26"><a href="/doi/suppl/10.1021/jm401881q">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_18723"></div></div></div></div></div><hr /></hr><p class="last">Additional biological methods and experimental details for synthesized compounds. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401881q/suppl_file/jm401881q_si_001.pdf">jm401881q_si_001.pdf (287.84 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm401881q&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm401881q%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-7%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm401881q" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a1a23dc403d1e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
